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Perennial ryegrass  
Perennial ryegrass (Lolium perenne) is an important forage grass growing in the temperate regions 
of the world [1, 2]. It is widely used as a pasture plant and for silage production because of the high 
digestibility, outstanding palatability, and rich nutritional value [1, 2]. However, the susceptibility to 
pathogens is a threat to its application. Diseases that cause severe damage in perennial ryegrass 
include ergot (Claviceps purpurea), leaf spot (Drechslera sp.), fusarium (Fusarium sp.), brown blight 
(Drechslera siccans), snow molds (Typhus sp., Fusarium sp., and Sclerotinia sp.), crown rust 
(Puccinia coronata), stem rust (P. graminis subsp. graminicola), bacterial wilt (Xanthomonas 
campestris pv. graminis) [1-3]. Moreover, some fungal endophytes of perennial ryegrass can cause 
disease in ruminants. Representative examples are ryegrass staggers and facial eczema caused 
by Neotyphodium lolii and Pithomyces chartarum, respectively [4-6]. Therefore, it is important to 
ensure the health of perennial ryegrass. Chemical pesticides have been widely used in the past 
decades for this purpose. However, their application causes a lot of environmental problems, 
including soil pollution and water pollution [7]. Thus, it is necessary to look for environmentally 
friendly alternatives. 
Plant growth-promoting rhizobacteria 
Plant growth-promoting rhizobacteria (PGPR) are bacteria that live in the rhizosphere, a narrow 
region of soil influenced by root exudates [8], and are able to enhance the growth of plants [9, 10]. 
They were first defined by Klopper and Schroth and have been widely reported in the past decades 
[11, 12]. Because of the great efficacy in plant-growth stimulation and plant disease control, they 
are considered to be environmentally friendly alternatives to chemical fertilizers and pesticides. A 
broad range of bacterial species such as Bacillus, Burkholderia, Azospirillum, Azotobacter, 
Rhizobium, and Pseudomonas have been reported to be PGPR, among which Bacillus, Rhizobium, 
and Pseudomonas are the most well-known species [9]. PGPR have been applied to a diverse array 
of plants including chickpea, maize, pea, peanut, rice, soybean, sugarcane, wheat, and sugarbeet 
[9, 13]. 
Mechanisms of PGPR  
The mechanisms of PGPR have been investigated thoroughly. In general, they are classified into 
two different categories: direct stimulation or indirect protection. As direct mechanisms, PGPR 
enhance plant growth by facilitating nutrient acquisition or modulating plant hormone levels. Apart 
from that, PGPR produce secondary metabolites to combat plant pathogens or elicit induced 
systemic resistance (ISR) of plants, thus indirectly protecting the plant from pathogens (Figure 1) [9, 















Figure 1. The mechanisms of plant-microbe interaction. Biocontrol mechanisms of PGPR are classified 
into two different categories: direct mechanism (blue routes) and indirect mechanisms (red routes). Black routes 
indicate other interactions and regulations. “+”, stimulation; “-”, inhibition. 
 
Direct mechanisms 
Nitrogen (N) is one of the most vital elements for plant growth [15]. Even though N2 constitutes 78% 
of the air, it is not directly available for plants. Biological N2 fixation is an essential process to convert 
N2 into a plant-available form. This process is catalyzed by nitrogenases that are harbored by N2-
fixing microbes [16]. The most well-known nitrogen-fixing bacteria are Rhizobium, Bradyrbizobium, 
and Azosporillum [17]. They can form nodules with legume plants such as soybean, pea, peanut, 
alfalfa, and are defined as symbiotic nitrogen-fixing bacteria [17]. Another type of nitrogen-fixing 
bacteria such as Klebsiella pneumoniae, Paenibacillus polymyxa, Paenibacillus massiliensis, 
Bacillus megaterium, and Bacillus marisflavi are free-living diazotrophs that convert N2 into ammonia 
[18-20]. 
Phosphorus (P) is another essential element for growing plants [15]. Although P is highly abundant 
in the soil, the available form, i.e. soluble P, is limited. To fulfill the P requirement of crops, phosphatic 














phosphate solubilizing microorganisms (PSM) provide the available form of P to the plants. The 
capability of phosphate solubilization has been reported in bacteria including Azotobacter, Bacillus, 
Burkholderia, and Pseudomonas [21-24]. The underlying mechanism is related to the production of 
low molecular weight organic acids and phosphatases, which solubilize inorganic phosphorus and 
mineralize organic phosphorus, respectively [14, 25]. 
Phytohormones are important signal molecules that regulate all aspects of plant growth and 
development [26]. It has been known for a long time that PGPR can produce phytohormones. One 
of the most important phytohormones produced by microorganisms is the hormone auxin (indole-3-
acetic acid/indole acetic acid/IAA). It regulates important cellular processes including plant cell 
proliferation, root development, and photosynthesis [26]. IAA production has been reported in PGPR 
including Rhizobium, Pseudomonas, and Bacillus spp. [27-30], and its production is relevant to the 
amino acid tryptophan, which is commonly found in the root exudates [31]. Other phytohormones 
such as gibberellins and cytokinins were also reported produced by PGPR and play an important 
role in the plant growth regulation [32].  
Other plant growth-promoting traits such as siderophore production, 1-Aminocyclopropane-1-
carboxylate (ACC) deaminase production, volatile production, also stimulate the growth of plants 
directly. Siderophores are iron-chelating compounds produced by microorganisms that assist in the 
acquisition of iron by bacteria [33]. The siderophore-Fe complex can be assimilated by plants, thus 
making it a source of iron to plants [34]. ACC is the precursor of ethylene, which is an important 
plant hormone relevant to stress response [35]. Bacteria that produce ACC deaminase can take up 
ACC, thus decreasing the level of ethylene and enhancing the growth of plants [36]. B. subtilis 
species can also stimulate the growth of plants by producing volatile organic compounds (VOCs) 
such as 2,3-butanediol and acetoin [37]. 
Indirect mechanisms 
During plant-microbe interaction, biological or chemical compounds can induce resistance of non-
exposed plant parts to pathogenic microorganisms. This phenomenon is called induced systemic 
resistance (ISR) [38]. It is different from the systemic acquired resistance (SAR), which is triggered 
by an incompatible necrotizing pathogen and renders the host resistant to subsequent infection [39, 
40]. PGPR such as Pseudomonas and Bacillus species are well-known ISR inducers [41, 42]. The 
ISR has been proven induced by cell envelope components, iron-regulated metabolites, and 
antibiotics [41]. Moreover, some volatile organic compounds (VOCs) produced by microorganisms 














(ET) and jasmonic acid (JA) and independent of salicylic acid and pathogenesis-related (PR) 
proteins [44].  
Production of secondary metabolites is another important weapon of PGPR. Based on the 
biosynthesis pathway, bacterial secondary metabolites are classified into three categories: 
bacteriocins, nonribosomal peptides (NRPs), and polyketides (PKs). Bacteriocins are ribosomally 
synthesized and comprise three different classes: ribosomally synthesized and post-translationally 
modified peptides (RiPPs), unmodified bacteriocins, and large antimicrobial proteins [45, 46]. 
Among them, RiPPs are most well studied and have been proven to have good potential in 
controlling plant diseases caused by pathogenic organisms [46]. For example, plantazolicin 
produced by B. velezensis FZB42 is able to combat nematodes, which have caused serious losses 
to a variety of crops worldwide [47]. NRPs and PKs are synthesized in a nonribosomal way through 
nonribosomal peptide synthetases (NRPSs) and polyketide synthetases (PKSs), respectively. Many 
NRPs and PKs were shown to antagonize pathogenic organisms. For example, difficidin and 
bacilysin from B. velezensis FZB42 are active against the bacterial pathogen Xanthomonas oryzae 
[48]. Fusaricidins produced by Paenibacillus polymyxa can antagonize the fungal pathogen 
Fusarium oxysporum f.sp. nevium [49]. Locillomycin from B. subtilis is active against bacteria and 
viruses, while octapeptins from Paenibacillus spp. can combat bacteria, fungi, protozoa, and yeast 
[50, 51].  
Apart from antimicrobial activity, secondary metabolites also play other roles that are relevant to 
biocontrol. For example, surfactins, iturins, and fengycins produced by Bacillus spp. are involved in 
ISR induction [40, 52]. Moreover, surfactins also play a crucial role in motility, biofilm formation, and 
quorum sensing of bacteria [53]. The motility of bacteria is important for their translocation to the 
plant surface, which is usually rich in nutrients. Biofilm formation of bacteria is relevant to their 
colonization into plants. Quorum sensing of bacteria plays an important role in the regulation of 
lipopeptide production [53].  
Apart from the induction of ISR and the production of antimicrobials, other properties of PGPR can 
also contribute to the biocontrol of pathogens. For example, lactonases produced by B. thuringiensis 
can degrade the homoserine lactones (AHLs), which play a role in the synthesis of cell-wall 
degrading enzymes of the plant pathogen Erwinia carotovora, thus affecting its pathogenicity [54]. 
Lytic enzymes produced by some fungal Tricboderma species can destruct the cell wall of fungal 
pathogens [55]. Hydrogen cyanide (HCN) produced by Pseudomonas can inhibit the development 
of plant disease in tomato [56]. Pseudomonas fluorescens WCS365 can colonize the hyphae of the 















Bacillus and closely related species as PGPR 
Bacillus and closely related species such as Paenibacillus and Brevibacillus have certain 
advantages to be used as PGPR. First of all, they are great producers of antimicrobials. Around 4-
5% of the genome of Bacillus subtilis is devoted to the biosynthesis of secondary metabolites, while 
this number for Bacillus velezensis reaches 8.5% [58, 59]. A total of 11 different secondary 
metabolites have been identified from the PGPR strain B. velezensis FZB42 [52] and up to 26 BGCs 
were predicted from the biocontrol strain Brevibacillus laterosporus MG64 [60]. Moreover, Bacillus 
and closely related species are endospore-forming bacteria. They can form endospores when 
encountering stresses. This property confers them a better survival ability in fluctuating 
environments [61] and makes them easier formulated for the development of biocontrol agents [62]. 
Secondary metabolites produced by Bacillus, Paenibacillus, and Brevibacillus  
Many secondary metabolites have been identified from Bacillus and closely related species, in 
particular the Bacillus subtilis group, Paenibacillus, and Brevibacillus species. A total of 59 
compounds (compound classes) have been reported from these species. Among them, 30 are NRPs, 
2 are NRPs-PKs hybrids, 6 are PKs, 20 are bacteriocins, while the last one, rhizocticin A, is a 
phosphonate-containing oligopeptide (Table 1).  
The secondary metabolites derived from the B. subtilis group, Paenibacillus, and Brevibacillus are 
structurally diverse (Table 1). Surfactins, iturins, fengycins, fusaricidins, locillomycin, koranimine, 
and marthiapeptide are circular noncationic NRPs. They contain a big ring that is formed with several 
amino acid residues and do not have positively charged residues. Polymyxins, octapeptins, 
tyrocidines, gramicidin S, loloatins, laterocidin, brevistin, relacidines, paenibacterin, and bacitracin 
are circular cationic NRPs. They comprise at least one positively charged amino acid residue, thus 
making them have a net positive charge at neutral conditions. Tridecaptins, gramicidins, edeine, 
spergualin, bogorols, succilins, tauramanide and tostadins form a different class of NRPs, which is 
linear and noncationic. Bacillibactin, bacilysin, sevadicin, and paenibactin are structurally distinct 
from others. They are either synthesized by iterative modules (bacillibactin and paenibactin) or 
simply comprise of 2-3 amino acid residues (bacilysin and sevadicin). Paenilipoheptin and 
paenilamicin are NRPs-PKs hybrids, which contain both amino acid residues and beta-keto moieties. 
Macrolactin, bacillaene, difficidin, basiliskamides, macrobrevin, and aurantinin are PKs that 
comprise several beta-keto functional groups. Subtilin, ericins, mersacidin, sublancin 168, 
subtilomycin, entianin, amyloliquecidin, lichenicidin, penisin, paenicidins, paenibacillin, and paenilan 














Plantazolicin, subtilosin A, and paeninodin belong to linear azole-containing peptides (LAPs), 
sactipeptides, and lasso peptides, respectively. Amylocyclicin and pumilarin are head-to-tail cyclized 
peptides. Different to these ribosomally synthesized and post-translationally modified peptides 
(RiPPs), lichenin, laterosporulin, laterosporulin 10, and bac-GM100 are unmodified bacteriocins, 
which are generally small (less than 10 kDa) and heat stable. 
Apart from their structural diversity, the functionality of these secondary metabolites in biocontrol is 
also very diverse (Table 1). Most of the compounds have been reported to exert antagonistic activity 
against pathogenic microorganisms, including Gram-positive bacteria, Gram-negative bacteria, 
fungi, yeasts, viruses, and protozoa. Moreover, surfactins, fengycins, and iturins are involved in the 
ISR induction of plant, thus arming the plant against phytopathogens [63-66]. Surfactins also play a 
key role in biofilm formation, which assists the colonization of the plants [67, 68]. Bacillibactin and 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Note: NRPs-I, circular noncationic NRPs; NRPs-II, circular cationic NRPs; NRPs-III, linear cationic NRPs; 
NRPs-IV, other types of NRPs; PKs-I, synthesized by modular type I PKSs; Bacteriocins-I, lanthipeptides; 
Bacteriocins-II, linear azole-containing peptides (LAPs); Bacteriocins-III, head-to-tail cyclized peptides; 
Bacteriocins-IV, sactipeptides; Bacteriocins-V, lasso peptides; Bacteriocins-VI, unmodified bacteriocins; 1 
peptides belonging to this family: esperin, lichenysin, pumilacidin, halobacillin, isohalobacillin; 2 peptides 
belonging to this family: bacillomycins, mycosubtilin, bacillopeptin, mixirin, subtulene, mojavensin, paenilarvins; 
3 peptides belonging to this family: plipastatins; 4 peptides belonging to this family: gatavalin; 5 peptides 
belonging to this family: colistin, mattacin; 6 peptides belonging to this family: battacin; 7 peptides belonging to 
this family: pelgipeptins; 8 peptides belonging to this family: brevicidine, laterocidine; 9 peptides belonging to 
this family: brevibacillins, BT peptide, BL-A60 
 
Biosynthesis of NRPs, PKs, and RiPPs 
NRPs, PKs, and RiPPs are the predominant secondary metabolites reported in Bacillus, 
Paeniabcillus, and Brevibacillus (Table 1). Their biosynthetic machinery is completely different from 
each other. NRPs are peptidic natural products assembled by large enzyme complexes termed 
nonribosomal synthetases (NRPSs) (Figure 2). Similarly, PKs are synthesized through multidomain 
enzymes, i.e. polyketide synthetases (PKSs) (Figure 3). In contrast to them, RiPPs are synthesized 
in a ribosomal pathway and usually involved in many post-translational modifications.  
Biosynthesis of NRPs through NRPSs 
NRPSs comprise different domains with different functions (Figure 2). The adenylation (A) domain, 
thiolation (T) domain, condensation (C) domain, and thioesterase (TE) domain/terminal reductase 
(R) domain are essential domains for the biosynthesis of NRPs [137]. The A domain is responsible 
for the activation of amino acid residues and usually has substrate specificity [137]. The T domain 
is also called peptide carrier protein (PCP), which is attached with 4’-phosphopantetheine and 
responsible for the carrying of substrates activated by the A domain [137]. The C domain catalyzes 
the formation of an amide bond between the thioester group and the amino group, thus elongate the 
peptide chain [137]. The TE domain is responsible for the hydrolysis of the polypeptide chain from 
the T domain. This process is usually accompanied by the formation of cyclic amides (lactams) or 
cyclic esters (lactones). At the end of this process, peptides are released from the assembly line 
[138]. The R domain is an alternative release mechanism to the TE domain. It reduces the thioester 
bond to terminal aldehyde or alcohol [138]. Apart from the four essential domains (A, T, C, TE/R), 
the epimerization (E) domain is also prevalent in NRPSs. The E domain is located right after the T 
domain and is responsible for the alteration of L-amino acids into D configurations [137]. These 
domains form different modules (typically comprised of C-A-T) that constitute an assembly line for 














N terminus, a lipinitiation is involved. The fatty acid is activated by ligating to a coenzyme A (CoA) 
by a fatty acid-CoA ligase (FACL), which is usually not present in the BGC. The activated fatty acid 
is then transferred and incorporated into the assembly line under the catalysis of a C domain, which 
is specifically termed starter C domain [139].  
 
Figure 2. Surfactin-associated NRPS incorporating a fatty acid tail and seven amino acid residues. CoA, 
coenzyme A; FACL, fatty acid-CoA ligase; FA, fatty acid; C, condensation domain; A, adenylation domain; T, 
thiolation domain; E, epimerization domain; TE, thioesterase. The core biosynthetic genes are indicated in red 
while the additional biosynthetic gene is indicated in pink. 
 
There are also many tailoring enzymes involved in the biosynthesis of NRPs. For example, 
halogenation, which adds a halogen to the Hpg13 residue of enduracidin and the Hpg17 residue of 
ramoplanin, is catalyzed by a flavin-dependent halogenase [140, 141]. Mannosylation of ramoplanin 
is mediated by a mannosyltransferase [142, 143]. N-acylation of the glucosamine moiety of 
teicoplanin is catalyzed by an acyltransferase [144]. Recently, a sulfotransferase was discovered 
from an environmental DNA library. It is involved in the production of monosulfated analogs of 
teicoplanin [145]. These modifications are usually important for the bioactivity of the final products.  
Biosynthesis of PKs through PKSs 
PKSs are classified into three different types: type I that comprises various catalytic domains (Figure 
3), type II that comprises catalytic domains as well as two typical KS domains (KSα and KSβ), and 
type III that typically lack multiple catalytic domains and employ an ACP independent mechanism 
[146]. The type I PKSs are further divided into iterative type I that utilize the domains in a cyclic 














The predominant PKs produced by bacteria are synthesized by modular type I PKSs. 
Acyltransferase (AT), acyl carrier protein (ACP), ketosynthase (KS) and thioesterase (TE) are 
essential domains in modular type I PKSs. The AT domain initiates the assembly line by selecting 
a specific acyl-CoA and loads it onto the ACP domain. The KS domain, which is similar to the C 
domain in NRPSs, is responsible for the elongation. Following the chain extension, the polyketide 
chain can be optionally modified by ketoreductase (KR), dehydratase (DH), and enoylreductase 
(ER). The final polyketide is released from the ACP domain by a TE domain [146, 147]. A 
characteristic of modular type I PKSs is that the number of precursors incorporated into the final 
product is consistent with the number of modules.  
The biosynthetic domains of iterative type I PKSs are the same as the modular type I PKSs. The 
only difference is that the extender domains are repetitively used in the iterative type I PKSs. A 
representative example is the lovastatin PKS, in which one starter unit (acetyl-CoA) is condensed 
with eight extender units (malonyl-CoA) and S-adenosylmethionine (SAM) to produce the 
intermediate dihydromonacolin L. Iterative type I PKSs are previously believed only present in fungi. 
However, they have been reported also from many bacteria in recent years [146, 147].  
Type II PKSs comprise similar catalytic domains as type I PKSs, with the exception that they also 
contain the typical KSα and KSβ. KSα is equivalent to the KS of type I PKSs and responsible for the 
elongation, while KSβ controls the length of the final product. The domains of type II PKSs are also 
iteratively used and the reduction of the β-keto group will only occur when the polyketide is fully 
synthesized. The anticancer drugs daunorubicin and doxorubicin are synthesized by type II PKSs 
[146, 147]. 
Type III PKSs also generate a poly-β-keto chain as other types of PKSs do. However, it is 
independent of the ACP, and only comprises simple homodimers of KS that catalyze the 
condensation of a starter unit to a series of extender units. Type III PKSs were formerly believed to 
be only harbored by plants, but they have also been found in many bacteria in recent years. The red 

















Figure 3. Macrolactin A-associated modular type I PKS, which is the predominant type of PKSs found in Bacillus 
spp. AT, Acyltransferase; KS, ketosynthase; KR, ketoreductase; ACP, acyl carrier protein; TE, thioesterase; 
DH, dehydratase.  
 
Biosynthesis of RiPPs in a ribosomal pathway 
The predominant bacteriocins produced by bacteria are belonging to the RiPPs family. The BGCs 
of RiPPs typically comprise a core biosynthetic gene and several modification-related and transport-
related genes. The core biosynthetic gene encodes a precursor peptide, which usually comprises a 
leader peptide and a core peptide. In some special cases, a signal peptide at the N terminus or a 
recognition sequence at the C terminus is found. The precursor peptide is typically ~20-110 residues 
in length and usually does not display bioactivity. To activate the peptide, the precursor peptide has 
to undergo posttranslational modifications, after which the leader peptide is cleaved by enzymes 
and a mature peptide with bioactivity is yielded [149]. Based on the structures, which is relevant to 
the posttranslational modifications, RiPPs can be classified into different classes. Here, we only 
introduce those found in the B. subtilis group, Paenibacillus, and Brevibacillus. 
Lanthipeptides are a class of peptides containing meso-lanthionine and 3-methyllanthionine. The 
Ser and Thr residues in the precursor peptide of lanthipeptides typically undergo dehydration to form 
dehydroalanine (Dha) and dehydrobutyrine (Dhb), respectively. Lanthionines are subsequently 
formed between a dehydroalanine or dehydrobutyrine and a cysteine residue via a thioether linkage. 
Enzymes involved in the modifications include a dehydratase (LanB) and a cyclase (LanC). In some 














The most well-studied lanthipeptide is nisin, which is produced by Lactococcus, Streptococcus, and 
Enterococcus and displays a broad inhibitory spectrum against Gram-positive bacteria [150-152].  
Linear azole-containing peptides (LAPs) are a group of RiPPs that typically contain oxazoles or 
thiazoles. The precursor of LAPs comprises abundant cysteine, serine, or threonine residues. These 
residues will first undergo a backbone cyclodehydration by the catalysis of cyclodehydratases. The 
resulting azoline heterocycles will be further processed by a dehydrogenase, thus forming azoles 
[149]. The plantazolicin produced by the well-known PGPR strain B. amyloliquefaciens FZB42 
belongs to the LAPs family and displays striking antimicrobial activity to Bacillus anthracis [124].  
Head-to-tail cyclized peptides are relatively large (35-70 residues) and typically form a peptide bond 
between the C and N termini. The leader sequence of head-to-tail cyclized peptides ranges from 2 
to 35 residues. The leader peptide is cleaved and an amide bond is formed between two 
hydrophobic residues to realize a head-to-tail ligation [149]. The enzymes responsible for the 
cyclization are not yet identified to date. The most well-known head-to-tail cyclized peptide is 
enterocin AS-48, a potent antimicrobial agent produced Enterococcus spp. [153]. Amylocyclicin 
produced by B. amyloliquefaciens FZB42 also belongs to this class [125]. 
Sactipeptides are a class of peptides with crosslinks between cysteine sulfur and α-carbon. The 
crosslinking modification is proposed to be mediated by a radical S-adenosylmethionine (SAM) 
enzyme in a leader peptide-dependent manner. This modification is crucial for the bioactivity of 
sactipeptides [149]. The most well-understood sactipeptide is subtilosin A, which is produced by B. 
subtilis and displays good activity against Gram-positive bacteria [128]. Other sactipeptides 
produced by Bacillus spp. include the sporulation killing factor (SKF) and thuricins such as thuricin 
H [149]. 
Lasso peptides contain a characteristic lasso fold, which is formed by the N-terminal macrolactam 
macrocycle trapping the C-terminal tail. The lasso fold is likely formed by the catalysis of a cysteine 
protease (homolog) and an Asn synthetase (homolog) [149]. Microcin J25 is a lasso peptide 
produced by E. coli and inhibits RNA polymerase of bacterial pathogens [154]. Paeninodin, whose 
C-terminal serine residue is specifically phosphorylated by a novel kinase, also belongs to lasso 
peptides [129].  
Mode of action of antimicrobials  
Antimicrobials employ various mechanisms to antagonize other bacteria. Understanding their 
modes of action can help us better understand their potential in applications and is a prerequisite to 














Cellular components including cell walls, cell membranes, and proteins have been reported to be 
targets of antimicrobials [155]. 
The bacterial cell wall is essential to maintain the structural integrity of cells. It consists of 
peptidoglycan, which is made from polysaccharide chains. The peptidoglycan layer constitutes as 
much as 95% of the Gram-positive cell wall and as little as 5-10% of the Gram-negative cell wall 
[156]. Some antimicrobials can inhibit the biosynthesis of peptidoglycan. For instance, bacitracin, 
subtilin, and mersacidin can bind to lipid II, which is a precursor of peptidoglycan, thus affecting the 
biosynthesis of peptidoglycan [157]. Some of the Gram-positive cell walls can be dissolved by 
lysozymes, an antimicrobial enzyme produced by animals [158]. 
The bacterial cell membrane physically separates the intracellular components from the extracellular 
environment. It serves as a permeability barrier for most molecules and ions. The cell membrane of 
Gram-negative bacteria consists of two layers: the inner membrane and the outer membrane. The 
inner membrane is the plasma membrane, while the outer membrane is constituted with glycerol 
phospholipids and lipopolysaccharides (LPS) [156]. Many antimicrobials can bind to the LPS and 
subsequently penetrate the cell membrane, thus depolarizing the cell membrane potential and finally 
killing the cells. For example, polymyxins, tyrocidines, and brevibacillins can disrupt the integrity of 
cell membranes by forming pores, thus causing a lethal effect on cells [159-161].  
Apart from the cell wall and cell membrane, the intracellular components are also common targets 
of antimicrobials. Quinolones such as levofloxacin and ciprofloxacin interfere with DNA synthesis by 
inhibiting topoisomerase [155]. Rifampicin and fidaxomicin inhibit RNA polymerase, thus blocking 
the synthesis of RNA [155, 162, 163]. Several types of antibacterial agents such as chloramphenicol 
and tetracyclines inhibit protein synthesis by binding to subunits of the intracellular ribosomes [155]. 
Oligomycins bind to the F0 subunit of ATP synthase, thus disrupting the biosynthesis of ATP [164]. 
Methodology to study antimicrobials  
The rediscovery of known compounds has become a limit to discovering novel antimicrobials. The 
co-culture of microorganisms has been proven to be an effective way to overcome this limitation. It 
allows the microorganisms to interact and sometimes can yield novel secondary metabolites that 
are not observed in the pure culture. Many novel compounds have been identified using this method. 
For example, the co-culture of Trichoderma harzianum M10 and Talaromyces pinophilus F36CF 
yields harziaphilic acid [19], while phexandiols and phomesters were identified through the co-














The development of several new techniques also contributes to the identification of novel 
antimicrobials. The easy access to genomic sequences of microorganisms makes it possible to mine 
for antimicrobial BGCs. Many pipelines including antiSMASH and PRISM have been developed for 
this purpose [165]. However, genome mining cannot distinguish the active BGCs from the silent 
ones. Transcriptomics and comparative transcriptomics can overcome this shortage. Moreover, 
transcriptomics is used to study antimicrobial resistance [166]. Apart from them, more efficient 
techniques have been developed in recent years. Liquid extraction surface analysis (LESA) in 
combination with mass spectrometry (MS) allows rapid identification of secondary metabolites from 
the surface of bacterial colonies [167-169]. Nanospray desorption electrospray ionization (nanoDESI) 
MS is a similar technique for direct chemical monitoring of living microbial colonies. MS data 
combined with molecular networks enable one to visualize the produced molecules as familial 
groupings [170, 171]. Imaging mass spectrometry (IMS), in which the mass spectral data is acquired 
in a spatial manner and can be intuitively reconstructed as an image, is another newly developed 
technique to monitor the production of secondary metabolites from microbial colonies [172, 173]. 
These new techniques make it possible to study the antimicrobials without performing the tedious 
extraction process. 
Scope of this thesis 
In this thesis, we describe the isolation and screening of PGPR strains from perennial ryegrass for 
use in biocontrol of plant pathogens. We also report the identification and characterization of the 
antimicrobials produced by the isolated PGPR strains. In chapter 2, we screened seven potential 
PGPR strains out of 90 rhizosphere bacteria isolated from local grasslands. We further mined into 
their genomic sequences and discovered eleven novel secondary metabolites BGCs, including two 
NRPSs, four NRPS-PKS hybrids, and five bacteriocins. In chapter 3, we characterized a novel class 
of cationic circular peptide called relacidines, which selectively combat Gram-negative bacteria. 
Further investigation of their mode of action revealed that relacidines do not damage the cell 
membrane. Instead, they affect the oxidative phosphorylation process of cells and deplete the ATP. 
In chapter 4, we identified novel variants of bogorols (a class of cationic linear lipopeptides) and a 
novel class of peptides called succilins (succinylated bogorols). We show that bogorols are active 
against both Gram-positive and Gram-negative bacteria while succilins displayed limited bioactivity. 
We also report the special lipinitiation, the formation of valinol, the succinylation, and the mode of 
action (form pores in the cell membrane) of the bogorol family peptides. In chapter 5, we employ a 
comparative transcriptomic method to study the interaction of Brevibacillus laterosporus MG64 and 
different pathogens. We show that the expression of sporulation genes and secondary metabolites 














understanding of the PGPR strains, in particular strain B. laterosporus MG64, as well as their 
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Background: Plant growth-promoting rhizobacteria (PGPR) are good alternatives for chemical 
fertilizers and pesticides, which cause severe environmental problems worldwide. Even though 
many studies focus on PGPR, most of them are limited in plant-microbe interaction studies and 
neglect the pathogens affecting ruminants that consume plants. In this study, we expand the view 
to the food chain of grass-ruminant-human. We aimed to find biocontrol strains that can antagonize 
grass pathogens and mammalian pathogens originated from grass, thus protecting this food chain. 
Furthermore, we deeply mined into bacterial genomes for novel biosynthetic gene clusters (BGCs) 
that can contribute to biocontrol. 
Results: We screened 90 bacterial strains from the rhizosphere of healthy Dutch perennial ryegrass 
and characterized seven strains (B. subtilis subsp. subtilis MG27, B. velezensis MG33 and MG43, 
B. pumilus MG52 and MG84, B. altitudinis MG75, and B. laterosporus MG64) that showed a 
stimulatory effect on grass growth and pathogen antagonism on both phytopathogens and 
mammalian pathogens. Genome-mining of the seven strains discovered abundant BGCs, with some 
known, but also several potential novel ones. Further analysis revealed potential intact and novel 
BGCs, including two NRPSs, four NRPS-PKS hybrids, and five bacteriocins.  
Conclusion: Abundant potential novel BGCs were discovered in functional protective isolates, 
especially in B. pumilus, B. altitudinis and Brevibacillus strains, indicating their great potential for the 
production of novel secondary metabolites. Our report serves as a basis to further identify and 
characterize these compounds and study their antagonistic effects against plant and mammalian 
pathogens. 
Keywords: Bacillus, Brevibacillus, plant growth-promoting rhizobacteria, biosynthetic gene clusters, 





















Perennial ryegrass (Lolium perenne) is one of the most important pasture plants in the world due to 
its high levels of palatability and nutritional value for ruminants [1]. The biomass and quality of 
perennial ryegrass are very crucial for the food chain of grass-ruminant-human since it not only 
produces food to ruminants but also determines the quality of meat and dairy products for human 
beings [2, 3]. The susceptibility of plants and potential causes of ruminant diseases by plant-
originated pathogens are threats to the safety of this food chain. Although chemical fertilizers and 
pesticides can ensure the biomass production and the quality of the perennial ryegrass (if not 
vestigial), their usage may cause severe environmental problems. Thus, there is a need to find an 
environmentally friendly way to ensure the production of healthy grass.  
Plant growth-promoting rhizobacteria (PGPR) have been widely reported to be effective in 
stimulating the growth of plants as well as protecting the plants from pathogens, which could be an 
alternative for chemical fertilizers and pesticides. Bacillus is one of the most famous PGPR because 
of its endospore-forming capability, which confers them better survival in the environment [4], and 
abundant plant growth-promoting traits, including nitrogen fixation, phosphorus solubilization, 
induced systemic resistance (ISR) induction, and most importantly antimicrobial production [5, 6].  
Antimicrobials produced by Bacillus and closely related species are very diverse [7]. Based on their 
biosynthesis pathway, these antimicrobials are classified into three main groups: nonribosomal 
peptides (NRPs), polyketides (PKs), and bacteriocins. NRPs are synthesized in a nonribosomal 
pathway through nonribosomal peptide synthetases (NRPSs), which are huge enzymes constituted 
by different modules. Each module incorporates one amino acid residue, including non-proteinic 
amino acids. NRPs such as surfactin, fengycin, bacillomycin D, polymyxin, fusaricidin, etc. are very 
well-known antimicrobials produced by different Bacillus and Paenibacillus strains [8-10]. PKs are 
another class of antimicrobials synthesized with mega enzymes, which are called polyketide 
synthetases (PKSs). Well-known PKs produced by Bacillus or Brecvibacillus include difficidin, 
bacillaene, macrolactin, basiliskamides, etc. [11-13]. Contrary to NRPs and PKs, bacteriocins are a 
class of antimicrobials synthesized in a ribosomal pathway. Bacillus-originated bacteriocins such as 
subtilosin A, plantozolicin, and subtilomycin are well studied [14-16]. 
Antimicrobials produced by Bacillus and closely related species were reported playing very 
important roles in biocontrol. The abolishment of surfactin production in Bacillus subtilis 6051 
reduced its colonization to Arabidopsis roots and suppression of Pseudomonas-originated disease 
[17]. Iturins and fengycins produced by B. subtilis contribute to antagonism against Podosphaera 



















(formerly Bacillus amyloliquefaciens FZB42), the Gram-positive model bacterium in biocontrol, 
employs difficidin, bacilysin, and bacillaene to suppress fire blight disease of orchard trees [19]. In 
addition, siderophores (bacillibactin), cyclic lipopeptides (surfactin, fengycin, fusaricidin, etc.) can 
elicit induced systemic resistance (ISR) of plants, thus arming the plant against diseases caused by 
pathogens [5, 8, 20, 21]. In recent decades, volatiles such as 2,3-butanediol produced by Bacillus 
were also found to be elicitors of ISR [22].  
Even though abundant studies focus on Bacillus and closely related PGPR, most of them are limited 
to the plant pathogens and neglect the mammalian pathogens that may enter the body of animals 
through grazing. For example, Claviceps purpurea f. secalis, a fungal pathogen that causes ergotism 
in ruminants and humans [23], is originated from forage plants. Pithomyces chartarum, a fungal 
pathogen produces sporidesmin that causes facial eczema in sheep [24],  also originates from the 
grass. PGPR that can antagonize both phytopathogens and mammalian pathogens would ensure 
the safety of this food chain. Therefore, we aimed to isolate and screen Bacillus sp. and closely 
related PGPR strains from the rhizosphere of healthy perennial ryegrass and further mine into the 
genomes of the candidate PGPR strains to find novel biosynthetic gene clusters (BGCs) that are 
potentially involved in phytopathogen and plant-originated mammalian pathogen antagonism.  
Results and discussion 
Characterization of strains 
A total of 90 Gram-positive bacterial strains were isolated from the rhizosphere of perennial ryegrass 
[25]. To characterize the strains, 16S rRNA genes were amplified and sequenced. A phylogenetic 
tree was constructed with the obtained sequences as well as 16S rRNA sequences of representative 
strains (Fig. 1). The strains were clustered into 4 different genera: Bacillus (83 strains), Lysinibacillus 
(4 strains), Solibacillus (2 strains), and Brevibacillus (1 strain). Among the dominant genus of 
Bacillus, 37 and 30 strains belong to the B. subtilis and B. cereus groups, respectively, while the 
rest 16 strains form an independent group that consists of B. megaterium and B. simplex. The great 
abundance of Bacillus is consistent with the study by Garbeva et al. [26], in which up to 95% of 




















Fig. 1 Phylogenetic analysis of the 90 bacterial isolates in this study. Neighbor-joining phylogenetic tree based 
on partial 16S rRNA sequences was constructed with MEGA7 [57]. The sequences of reference strains were 
retrieved from the NCBI database. The reference strains are highlighted in blue and different groups were 
shaded with different colors. 
 
Antimicrobial activity 
We evaluated all 90 strains for their antimicrobial activity against two pathogens: Xanthomonas 
translucens pv. graminis LMG587 and Magnaporthe oryzae Guy11. The rationale behind the 
selection is to cover the two major classes of pathogens (i.e. Gram-negative bacteria and fungi) in 
perennial ryegrass. X. translucens pv. graminis is a Gram-negative phytopathogen that causes 



















oryzae is a fungal pathogen that causes severe blast disease in many Poaceae plants, including 
perennial ryegrass [28, 29]. In total 30 strains showed inhibition against X. translucens pv. graminis 
LMG587 and 23 strains against M. oryzae Guy11. Of all strains, 16 showed antagonistic activity 
against both pathogens and 15 of them belong to the B. subtilis group, while the last one belongs to 
the genus of Brevibacillus (Additional file 1: Table S1). A total of 7 most inhibitory strains (i.e. MG27, 
MG33, MG43 MG52, MG64, MG75, and MG84) were selected to extend their antimicrobial spectrum 
and for further evaluation of their plant growth promotion potential. 
Soil-borne plant pathogens and animal pathogens widely exist and cause serious diseases in higher 
organisms [30, 31]. Some animal pathogens can first adapt to the plant host and finally transmit to 
animals [32]. Plant pathogens and plant-originated mammalian pathogens that are a potential threat 
to perennial ryegrass and mammals in the food chain of grass-ruminant-human, were selected as 
indicators for the antimicrobial activity test. As indicated in Table 1, MG27, MG33, MG43, and MG64 
showed very broad inhibitory spectra. They can antagonize Gram-positive bacteria, Gram-negative 
bacteria, fungi, and oomycetes (Table 1). In contrast to that, MG52, MG75, and MG84 showed better 
activity on bacteria than on fungi and oomycetes (Table 1). It is worth to note that some of the 
selected strains displayed antimicrobial activity against the fungal mammalian pathogens. MG27, 
MG33, MG43, and MG64 can antagonize C. purpurea f. secalis and P. chartarum, while MG75 and 
MG84 showed activity against C. purpurea f. secalis. This result suggests the possibility of using 
PGPR to control animal pathogens, thus safeguarding the food chain of grass-ruminant-human. 
However, we also realize the current knowledge gaps in this area. The mechanisms underlying the 
interaction of animal pathogens, plants, and PGPR are largely unknown. How to employ PGPR to 
control animal pathogens in the natural environment is a big question need to be answered. More 
in-depth studies will be needed before its application.  
Plant growth-promoting effect of the selected strains 
The plant growth-promotion effect of the candidate strains was tested with two different methods: 1) 
by inoculating onto the root tips of perennial ryegrass seedlings to test direct plant growth-promoting 
effect of the isolates; 2) via two-compartment petri dishes, where bacteria can only stimulate plant 
growth through volatile organic compounds (VOCs). When inoculated to root tips, MG27 and MG33 
showed more than a 2.5-fold increase on shoot biomass and an approximately two-fold increase on 
root biomass compared to control. MG43 showed more than a two-fold increase in shoot biomass 
and no increase in root biomass. Other strains tested did not show any significant plant growth-
promotion effect (Additional file 1: Figure S1). When the bacteria were inoculated with two-
compartment petri dishes, all tested strains showed significant increases in shoot and root biomass 



















increase of both shoot and root biomass, while other strains showed more than a 2.5-fold increase 
of both shoot and root biomass (Additional file 1: Figure S1). 
Table 1 Antimicrobial activity of the seven selected bacterial strains from perennial ryegrass 
Pathogen 
types 




Erwinia carotovora subsp. 
brasiliensis LMG21371 
+ + + - - - - 
Pectobacterium 
carotovorum LMG05863 
+ + + - + - - 
Pseudomonas syringae 
pv. antirrhini LMG02131 
+ + + ++ + + ++ 
Pseudomonas syringae 
pv. tomato DC3000 
+ + + ++ + + ++ 
Ralstonia syzygii subsp. 
syzygii LMG06969 
+ + + - + - - 
Xanthomonas campestris 
pv. campestrisNCCB92058 
+ ++ ++ ++ + + ++ 
Xanthomonas translucens 
pv. graminisLMG587* 






+ + + ++ + - ++ 
Fungi 
Botrytis cinerea ● ● ● ○ ● ○ ○ 
Fusarium culmorum ● ● ● ○ ● ○ ○ 
Fusarium oxysporum ● ● ● ○ ● ○ ○ 
Rhizoctonia solani ● ● ● ○ ● ● ● 
Magnaporthe oryzae Guy 
11* 
● ● ● ○ ● ○ ○ 
Pithomyces chartarum 
CBS485.71#  
● ● ● ○ ● ○ ○ 
Claviceps purpurea f. 
secalis CBS112.45# 
● ● ● ○ ● ● ● 
Oomycetes 
Pythium aphanidermatum ● ● ● ○ ● ○ ○ 
Pythium ultimum ● ● ● ○ ● ○ ○ 
In the antibacterial assay, no inhibition (-), inhibitory zone < 5 mm (+), inhibitory zone ≥ 5 mm (++). In the 
antifungal/oomycetal assay, no inhibition (○), clear inhibition (●).  
* Pathogens used to screen the isolated strains. 
# Mammalian pathogens 
Genome sequencing of the selected strains and phylogenetic analysis 
The genomes of the seven selected strains were sequenced and their DNA sequences were 
described previously [25]. Phylogenetic analysis using whole-genome sequences was conducted 
with Gegenees [33] and a phylogenetic tree was built with SplitTree [34]. As presented in Fig. 2, 
MG27, MG33, and MG43 fall into the B. subtilis subgroup, while MG52, MG75, and MG84 belong 



















subgroups did not clearly separate (Fig. 1). There are no strains belonging to the group of B. cereus, 
which is in accordance with the 16S rRNA phylogenetic tree (Fig. 1). MG64 was clustered to the 
genus of Brevibacillus, which is far away from the Bacillus genus phylogenetically (Fig. 2). The 
species names of the seven strains were designated as their most closely related strains, namely 
B. subtilis subsp. subtilis MG27, B. velezensis MG33 and MG43, B. pumilus MG52 and MG84, B. 
altitudinis MG75, and B. laterosporus MG64. 
 
 
Fig. 2 Phylogenetic analysis of the selected strains and their reference strains based on the genomic 
sequences. The comparison was conducted with Gegenees using a default setting [33]. The dendrogram was 
constructed in SplitTree [34]. Different groups of bacteria were indicated with different colors of shading. The 
seven strains isolated in this study were indicated with red font. 
 
Genome mining for BGCs 
Bacillus and closely related species form a great reservoir of antimicrobials [7]. In order to evaluate 
the biosynthetic potential of the selected strains, their genomic sequences were analyzed by 
antiSMASH 5.0 [35] for mining of nonribosomal peptide synthetase (NRPS), polyketide synthetase 
(PKS), NRPS-PKS hybrid, and terpene BGCs, and by BAGEL4 [36] for mining of bacteriocin BGCs. 
Among the genus of Bacillus, the B. subtilis subgroup members (B. subtilis subsp. subtilis MG27, B. 
velezensis MG33, and B. velezensis MG43) harbor abundant NRPSs and PKSs (Fig. 3a) and the 
majority of the BGCs are assigned to known products (Fig. 3b, Additional file 1: Table S2). The 



















S2), including type III PKS, a homodimeric iterative polyketide synthase recently found present in 
microorganisms [37]. The total size of the BGCs in B. subtilis subsp. subtilis MG27 is approximately 
176 kb and accounts for 4.2% of the genome size (Fig. 3d). This percentage is in line with the 
estimation of other B. subtilis strains, which is 4-5% on average [38]. B. velezensis MG33 and MG43 
devote around 8.9% and 8.4% of their genomes to synthesis antimicrobial metabolites, respectively 
(Fig. 3d). This result is similar to the estimation of Bacillus velezensis FZB42, which is 8.5% [39]. 
The B. pumilus subgroup members (B. pumilus MG52, B. pumilus MG84, and B. altitudinis MG75) 
possess 8 to 11 BGCs (Fig. 3a). The abundance of terpene is an outstanding characteristic of this 
subgroup (Fig. 3a). Most of the BGCs from this group remain unknown, especially bacteriocins and 
terpenes (Fig. 3c, Additional file 1: Figure S2, Figure S3). The B. pumilus subgroup members devote 
2.9% to 4.2% of their genomes to BGCs. 
B. laterosporus has drawn increasing attention in recent years because of its outstanding ability of 
antimicrobial production. Borogols [40], brevibacillins [41], tauramamide [42], brevicidine [43], 
laterocidine [43], etc. are antimicrobials reported in the past two decades. Genome mining reveals 
that B. laterosporus MG64 harbors the most abundant gene clusters among the seven strains, which 
reach a total number of 26 (Fig. 3a). Five NRPSs were assigned to brevicidine, auriprocine, 
tyrocidine, petrobactin, bogorol, respectively (Fig. 3b, Additional file 1: Table S2). Up to 21 BGCs in 
B. laterosporus MG64 remained unknown and the majority of them are NRPS, NRPS-PKS hybrid, 
and bacteriocin (Fig. 3c, Additional file 1: Figure S2, Figure S3). The total size of the BGCs is 
approximately 500 kb, which accounts for 9.7% of the genome (Fig. 3d). This percentage is higher 
than Bacillus velezensis (8.5%) and Streptomyces avermitilis (6.4%), which are well-known 
antimicrobial producing strains [39, 44]. This result suggests the great value of B. laterosporus MG64 
in biocontrol and pharmaceutical application, for some of its natural products might have the 





















Fig. 3 Numbers of BGCs harbored by the strains and the percentage of the total size of BGCs in the genomes. 
(a) total number of BGCs in the strains. (b) number of reported BGCs in the genomes of strains. (c) number of 
unknown BGCs found in the strains. BGCs that have different numbers of genes or show less than 70% protein 
identity to the reported ones were regarded as novel.  (d) the percentage of BGCs sizes in the genomes.  
 
Potential novel modular BGCs  
NRPS, PKS, and NRPS-PKS hybrid are modular enzymes that synthesize secondary metabolites, 
some of which are well-known weapons for plant disease control [8]. Modular BGCs found in the 
selected strains with all essential modules (starting module, elongation module, termination module) 
were listed in Fig. 4. Despite the abundantly identified BGCs in B. velezensis MG33, one modular 
gene cluster showing no similarity to known BGCs was found (Fig. 4a). This BGC consists of 9 
genes and has a total size of 40 kb. The cooccurrence of NRPS domains and PKS domains indicates 
it is a hybrid of both. The NRPS modules incorporate six amino acid residues while PKS modules 



















final product because the antimicrobials (surfactin, fengycin, bacillomycin D, bacilysin, difficidin, etc.) 
produced by B. velezensis MG33 are well-known for killing different kinds of pathogens [8, 19].   
An interesting BGC discovered in B. pumilus MG52, B. pumilus MG84, and B. altitudinis MG75 is 
partially identical to lichenysin (Fig. 4b), which is a surfactin family lipopeptide biosurfactant 
produced by Bacillus licheniformis. Lichenysin is not only involved in direct pathogen antagonism 
but also affects the colonization of bacteria to plant, thus regarded as important in biocontrol [8]. 
This lichenysin-like BGC contains six genes, and four of them showed more than 50% sequence 
identity to the lichenysin BGC. Furthermore, the amino acid residues incorporated by these four 
genes are identical to lichenysin as well. However, there are two additional genes in between lchAC 
and lchAD (Fig. 4b). They encode four modules, which are responsible for the incorporation of four 
residues (Fig. 4b). Whether the additional genes are functional or not remains unclear. On the one 
hand, a thioesterase (TE) domain was encoded by lchAC, indicating that the biosynthesis of the 
lichenysin is likely not affected. On the other hand, other B. pumilus strains also showed this 
interesting phenomenon (data not shown), which suggests this is likely to be an evolutionary 
horizontal gene transfer. Experimental proofs are needed to answer this interesting question. 
Another unique NRPS-PKS hybrid BGC in B. pumilus MG52 and MG84 contains thirteen genes and 
encodes ten modules (Fig. 4c). This gene cluster showed 21% similarity to paenilamicin, an 
antibacterial and antifungal NRPs-PKs hybrid produced by Paenibacillus larvae [45]. However, 
neither the order of genes nor the predicted amino acid composition shows similarity to paenilamicin, 
indicating the putative novelty of the final product. B. pumilus MG52 and MG84 displayed potent 
activity against bacterial pathogens (Table 1). However, well-known antibacterial compounds were 
not found by the genome mining (Additional file 1: Table S2). This suggests the potential functionality 
of these novel BGCs.  
Three potential intact and novel BGCs were discovered in B. laterosporus MG64 (Fig. 4). The first 
one is a 32-kb NRPS-PKS hybrid BGC (Fig. 4d). This BGC contains seven genes and encodes six 
NRPS modules and two PKS modules. This gene cluster does not show any similarity to the reported 
BGCs, indicating its great novelty. The second one is a 25-kb NRPS that contains nine genes (Fig. 
4e). Six modules are encoded by the three core biosynthetic genes, indicates the incorporation of 
six amino acids. This BGC showed an 11% similarity to zwittermycin A, an NRPs-PKs hybrid 
produced by B. cereus [46]. However, the type of BGCs and the gene numbers are different from 
zwittermycin A, suggesting the putative novelty of the final product. The third one is also identified 
to be an NRPS (Fig. 4f). This BGC is around 27 kb in size and is constituted with two large core 
biosynthetic genes, which encode seven modules. The structure of this peptide remained unclear 
owing to the diverse function of a TE domain [47]. Bogorol and brevicidine that are identified by the 



















the antibacterial activity of B. laterosporus MG64. However, the antimicrobials responsible for its 
antifungal and antioomycetal activity (Table 1) are not yet clear. Therefore, the three BGCs identified 
here are potentially functional.  
 
 
Fig. 4 Potential intact and novel BGCs discovered in the genomes of selected strains. (a) an NRPS-PKS hybrid 
discovered in B. velezensis MG33. (b) a lichenysin-like NRPS-PKS hybrid present in the strains from the B. 
pumilus subgroup. (c) an unknown NRPS-PKS hybrid found in both B. pumilus MG52 and MG84. (d) a potential 
novel NRPS-PKS hybrid harbored by B. laterosporus MG64. (e-f) two potential novel NRPSs present in B. 
laterosporus MG64. Amino acid residues predicted by antiSMASH was indicated inside the A domains. Cluster 
number in the brackets corresponding to those in Figure S2. Genes with different functions are shown in 
different colors: orange, additional biosynthetic genes; wine-red, core biosynthetic genes; grey, unknown-
function genes. 
 
Potential novel bacteriocin BGCs  
Bacteriocins are ribosomally synthesized antimicrobial peptides that mainly kill bacteria closely 
related to producers. They are classified into three main classes: class I small ribosomally produced 
and posttranslationally modified peptides (RiPPs), class II unmodified peptides, and class III large 



















bacteriocins, sactipeptides, linear azole-containing peptides, thiopeptides, glycocins, and lasso 
peptides) are the most well-studied, wide-distributed, and active peptides [7, 49]. Potential novel 
RiPPs BGCs with predicted precursors discovered in the selected strains are listed in Fig. 5.  
One circular bacteriocin BGC was harbored by both B. pumilus MG52 and MG84 (Fig. 5a). The 
gene cluster contains six genes. The precursor peptide contains 96 amino acids and the C terminus 
(from I33 to F96) showed 39% identity to amylocyclicin, which is a 6381-Da circular bacteriocin 
produced by B. velezensis FZB42 and showed to be active against closely related Gram-positive 
bacteria [50]. However, the rest of the genes show very low similarity to amylocyclicin BGC (data 
not shown), which indicates putative novel modification patterns. The potent activity of B. pumilus 
MG52 and MG84 against the Gram-positive bacterium S. scabies (Table 1) and the lack of known 
antimicrobials in their genomes (Additional file 1: Table S1) suggest the potential activity of this 
circular bacteriocin. 
B. altitudinis MG75 harbors two circular bacteriocin BGCs (Fig. 5). The first one constitutes six genes 
(Fig. 5b). Its precursor peptide contains 108 amino acids and showed 67% protein identity to 
enterocin AS-48, which is a model circular bacteriocin produced by Enterococcus [51]. The second 
circular bacteriocin from B. altitudinis MG75 potentially contains 10 genes (Fig. 5b). The precursor 
peptide comprises 118 amino acids and the C terminus (from L58 to W118) showed 52% identity to 
enterocin NKR-5-3B, which is a broad-spectrum antimicrobial produced by Enterococcus faecium 
NKR-5-3 [52]. B. altitudinis MG75 did not antagonize the Gram-positive bacterium S. scabies 
(Table1). Therefore, the functionality of these circular bacteriocins remains unclear. 
B. laterosporus MG64 harbors one circular bacteriocin and one lanthipeptide (Fig. 5). The BGC of 
circular bacteriocin contains seven genes (Fig. 5d). The core biosynthetic gene encodes a 58-amino 
acid peptide, which showed 62% protein identity to laterosporulin and 52% to laterosporulin10, both 
of which are produced by B. laterosporus and display antimicrobial activity against several bacterial 
pathogens [53, 54]. The lanthipeptide BGC from B. laterosporus MG64 (Fig. 5e) contains five genes. 
The second, fourth, and fifth genes were annotated as lanB (dehydratase), lanC (cyclase), and lanD 
(decarboxylase), respectively, which are commonly found in lanthipeptide BGCs. The core 
biosynthetic gene encodes a 43-amino acid peptide, which showed 39% similarity to both 
gallidermin and epidermin, two cationic lanthipeptides produced by Staphylococcus and displayed 
activity against a wide range of Gram-positive bacteria [55]. The antibacterial activity of  B. 
laterosporus MG64 is likely conferred by bogorol and brevicidine [40, 43]. Therefore, we cannot 





















Fig. 5 Potential novel bacteriocins with predicted precursor peptides. The BGCs were predicted by BAGEL4 
[36]. (a) a circular bacteriocin found in both B. pumilus MG52 and MG84. (b-c) two circular bacteriocins 
discovered in B. altitudinis MG75. (d) a circular bacteriocin and (e) a lanthipeptide harbored by B. laterosporus 
MG64. The potential core peptides are indicated in red. The potential cleavage sites are indicated with arrows. 
The numbers indicate the position of amino acid residues.  
Conclusions 
In this study, we identified 7 potential PGPR strains, out of 90 strains screened, that can antagonize 
both phytopathogens and plant-originated mammalian pathogens, thus showing the possibility to 
employ PGPR to protect the food chain of grass-ruminant-human. Further mining into the genomes 
of the potential PGPR strains reveals a great number of BGCs, including known and potential novel 
ones. We show the great potential of B. pumilus subgroup strains in bacteriocin and terpene 
production and the great values of B. laterosporus MG64 in the production of natural products, which 
may also have pharmaceutical potential. Furthermore, eleven potential intact and novel BGCs were 



















bacteriocins and one lanthipeptide). Further efforts will be directed to identify these interesting 
secondary metabolites as well as their contribution to biocontrol. 
 
Methods 
Plant material, Bacterial isolation, and Strains  
Perennial ryegrass seeds (cultivar Barsprinter) used in this study were provided by the company 
Barenbrug in Nijmegen, the Netherlands. Bacterial isolation from rhizosphere soil samples has been 
described previously and the genomic sequences of the most promising strains (MG27, MG33, 
MG43, MG52, MG64, MG75, and MG84) were placed in GenBank under accession no. of 
QJJA00000000, QJJB00000000, QJJC00000000, QJIZ00000000, QJJD00000000, 
QIMF00000000, and QJJE00000000, respectively [25]. The seven promising strains were also 
deposited in the NCCB collection (the Netherlands) under the accession numbers from 
NCCB100736 to NCCB100742.  
Identification of bacterial strains 
The cells of each bacterial isolate were collected by centrifuging at 10,000 rpm for 1 min and 
suspending in Mili-Q water. The suspension was heated at 100 ˚C for 10 min and centrifuged at 
10,000 rpm for 1 min after cooling down to room temperature. The supernatant was used as 
template DNA in a PCR to amplify 16S rRNA for characterization. PCR amplifications were 
conducted with bacterial-specific 16S rRNA primers 27F (5’-AGAGTTTGATCMTGGCTCAG-3’) and 
1492R (5’-CGGTTACCTTGTTACGACTT-3’) as well as the high fidelity Phusion polymerase 
(Thermo Fisher Scientific). PCR products were purified with a NucleoSpin Gel and PCR Clean-up 
kit (Macherey-Nagel) and sequenced at Macrogen Inc. The resulted partial sequences of 16S rRNA 
were aligned with relevant type strains with Muscle [56] in MEGA7 [57]. A neighbor-joining 
consensus tree [58] was constructed based on the alignment. The main parameters used were as 
follows: Bootstrap method and 1000 bootstrap replications for phylogeny test [59], Tamura-Nei 
model for nucleotide substitution [60], Gamma distribution for rate variation among sites, and 
complete deletion for treatment of gaps. The resulted phylogenetic tree was visualized and modified 
in iTOL [61]. 
In vitro antagonistic assay 
Bacterial pathogens were streaked on LB plates and incubated at 28 ˚C overnight. The colonies 
were suspended in LB broth and mixed with melted LB medium (cool down to 45 ˚C) at a final 
concentration of 1 × 10-6 CFU/ml before pouring plates. After solidification, 5 µl bacterial solution 
(OD600 = 1.0) made with isolates was inoculated onto the plate. The plates were incubated at 28 ˚C 
for 48 h before measuring the diameters of inhibition halos. Fungal and oomycetal pathogens were 



















plug (5 mm diameter) with fungal hyphae or oomycete spore was cut and inoculated onto the center 
of a new TSA plate. A 5 µL sample of each bacterial solution at an OD600 of 1.0 was spotted 2 cm 
away from the plug symmetrically. Plates were double sealed with parafilm and incubated at 28 ˚C 
for another 5 days. The antagonistic activities were then documented. 
Plant growth-promoting assay 
For surface sterilization, the ryegrass seeds were pre-treated with 0.3 M HCl for 6 h, followed by 
submerging in 2% sodium hypochlorite for 5 min and then washed with sterile water for 10 times to 
remove HCl and sodium hypochlorite completely. The seeds were germinated on wet sterile filter 
paper in a large petri-dish which was sealed with parafilm and then incubated at 25 ˚C without light. 
After germination for 5 days, the ryegrass seedlings were then transferred to fresh ½ MS (Duchefa 
Biochemie) plates solidified with 0.8% plant agar (Duchefa Biochemie). After 2 days growing in ½ 
MS plates, 5 µl bacterial solution in 10 mM MgSO4 with an OD600 of 1.0 was inoculated, while the 
same amount of 10 mM MgSO4 solution was used as control. For root tip inoculation assays, the 
bacterial solution was inoculated to the root tip of each seedling. To study the volatile effect, the 
bacterial solution was inoculated onto the center of a small LB agar plate that forms a physically 
separated compartment inside the ½ MS medium plate. After co-culture for 7 days. The ryegrass 
seedlings were harvested and the biomass of shoot and root were measured separately. A one-way 
ANOVA analysis using a Tukey post-hoc test was conducted with SPSS (P < 0.05) to evaluate the 
significance. 
Genome sequencing and phylogenetic analysis 
The genome sequences of the selected strains were determined as described previously [25]. 
Genome-scale comparison of the seven bacterial strains and other relevant strains were conducted 
with Gegenees [33] based on a fragmented nucleotides alignment with a setting of 200/100. Based 
on the alignment, a dendrogram was constructed in SplitTree 4.14.4 [34] with a neighbor-joining 
method and visualized in iTOL [61]. 
Genome mining for BGCs 
The genome mining for biosynthetic gene clusters of antimicrobial compounds including NRPs, PKs, 
NRPs-PKs hybrids, bacteriocins, and terpenes was conducted with antiSMASH 5.0 [35] and 
BAGEL4 [36]. Each draft genome was assembled into a pseudomolecule using a closely related 
strain as a reference before applying to the pipelines. The genes predicted from both pipelines were 
further confirmed with protein BLAST. BGCs that have different numbers of genes or show less than 






















PGPR: Plant growth-promoting rhizobacteria; BGCs: Biosynthetic gene clusters; NRPs: 
Nonribosomal peptides; PKs: Polyketides; NRPSs: Nonribosomal peptide synthetases; PKSs: 
Polyketide synthetases; ISR: Induced systemic resistance; VOCs: Volatile organic compounds; 
RiPPs: Ribosomally produced and posttranslationally modified peptides. TE: Thioesterase; A: 
Adenylation; PCP: Peptidyl carrier protein; C: Condensation; E: Epimerization; AT: Acyltransferase; 
KS: Keto-synthase; Atd: Trans-acyltransferase docking; DH: Dehydratase; KR: Keto-reductase; 
CAL: Co-enzyme A ligase domain; ACP: Acyl-carrier protein 
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Table S1. Screening of bacterial isolates for antagonistic strains  










MG18 - + MG55 + + MG69 - - 
MG27 + + MG56 + + MG73 + - 
MG28 + + MG57 + + MG74 + + 
MG32 + + MG58 + - MG75 + - 
MG33 + + MG59 + - MG77 + - 
MG37 + + MG60 - - MG79 + - 
MG39 + + MG61 - + MG82 + + 
MG42 + + MG62 - + MG84 + - 
MG43 + + MG63 - + MG85 - + 
MG44 - - MG65 + + MG89 - - 
MG51 + + MG66 - - MG90 - + 
MG52 + - MG67 + +    
MG53 + - MG68 - -    
B. cereus 
group 
MG4 - - MG22 - - MG70 - - 
MG10 - - MG23 - - MG71 - - 
MG11 - + MG25 + - MG72 + - 
MG14 - - MG26 - - MG78 - - 
MG15 - - MG30 - - MG80 - - 
MG16 - - MG31 - - MG81 + - 
MG17 - - MG34 - - MG83 - - 
MG19 - - MG38 - - MG86 - - 
MG20 - - MG46 - - MG87 - - 




MG1 - - MG9 - - MG41 - - 
MG2 - - MG13 - - MG45 - - 
MG3 - - MG29 - - MG47 - - 
MG6 - - MG35 - - MG49 + - 
MG7 - - MG36 - -    




MG5 - - MG24 - -    
MG12 - - MG50 - -    
Solibacillus - MG54 - - MG76 - -    
Brevibacillu
s 
- MG64 + +       
Xtg is short for X. translucens pv. graminis. Mo stands for M. oryzae. The selected strains are indicated in 




















Table S2. Known antimicrobial BGCs found in the genomes of selected strains 
Strain Locus tag in NCBI Size (bp) Type 
Antimicrobial 
compound 
 B. subtilis 
MG27 
HS3_01760 - HS3_01767 7284 NRPS Bacilysin 
HS3_01800 - HS3_01807 6939 Bacteriocin  Subtilosin A 
HS3_02375 - HS3_02387 19594 NRPS Bacillibactin  
HS3_02542 - HS3_02557 77097 PKS Bacillaene  
HS3_03507 - HS3_03511 8075 Bacteriocin  Subtilomycin  
HS3_03670 - HS3_03673 26146 NRPS Surfactin 
HS3_04320 - HS3_04321 7516 NRPS Fengycin (partial) 
HS3_04464 - HS3_04466 7668 NRPS Fengycin (partial) 
B. velezensis 
MG33 
HS9_00027 - HS9_00030 37245 NRPS Bacillomycin D (Iturin) 
HS9_00297 - HS9_00308 70109 PKS Bacillaene 
HS9_00628 - HS9_00636 53268 PKS Macrolactin 
HS9_02290 - HS9_02296 7298 NRPS Bacilysin 
HS9_03348 - HS9_03351 26159 NRPS Surfactin  
HS9_03453 - HS9_03455 9288 Bacteriocin  Amyloliquecidin  
HS9_03812 - HS9_03824 19408 NRPS Bacillibactin 
HS9_03966 - HS9_03972* 
72103 PKS Difficidin 
HS9_02738 - HS9_02740* 
HS9_03835 - HS9_03839 3934 Bacteriocin  Amylocyclicin 
HS9_02779 - HS9_02780 11419 NRPS Fengycin (partial) 
HS9_02781 3672 NRPS Fengycin (partial) 





54848 PKS Macrolactin 
C2W63_00883 - 
C2W63_00894 
70106 PKS Bacillaene 
C2W63_01016 - 
C2W63_01019 
37286 NRPS Bacillomycin D (Iturin) 
C2W63_01638 - 
C2W63_01649 
66186 PKS Difficidin 
C2W63_02562 - 
C2W63_02568 
7298 NRPS Bacilysin 
C2W63_03182 - 
C2W63_03187 
4173 Bacteriocin  Amylocyclicin 
C2W63_03197 - 
C2W63_03209 
19410 NRPS Bacillibactin 
C2W63_03554 - 
C2W63_03556* 
26159 NRPS Surfactin  
C2W63_01267 - 
C2W63_01268 
11908 NRPS Fengycin (partial) 
C2W63_01269 3789 NRPS Fengycin (partial) 
C2W63_01043 - 
C2W63_01044 
8025 NRPS Fengycin (partial) 
B. altitudinis 
MG75 










55318 NRPS Brevicidine 
C2W64_03725 - 
C2W64_03728 
41606 NRPS Auriprocine 
C2W64_03774 - 
C2W64_03778 
37314 NRPS Tyrocidine 
C2W64_04196 - 
C2W64_04201 
7104 NRPS Petrobactin 
C2W64_00401 - 
C2W64_00410 
54323 NRPS Bogorol 
Known BGCs were not found for the strain of B. pumilus MG52.  
* only these genes can be found in the NCBI database, but the whole operon was found in the 





















Figure S1. Plant growth-promotion effects of the selected strains on perennial ryegrass. (a) plant growth-
promotion effect of root-tip inoculation of bacteria. (b) effect of VOCs produced by candidate strains on the 
growth of perennial ryegrass. Sterile water was used as a control. Three replicates were used for each 
treatment. Different letters indicate significant differences between treatments (One-way ANOVA, Tukey post-




















Figure S2. Potential novel NRPS, PKS, NRPS-PKS hybrid, terpene BGCs mined from AntiSMASH 5.0. Each 
draft genome was assembled into a pseudomolecule using a closely related strain as a reference before 
applying to the pipeline. BGCs that have different numbers of genes or show less than 70% protein identity to 
the reported ones were regarded as novel. Multiple gene clusters in the same call from antiSMASH were 





















Figure S3. Potential novel bacteriocin BGCs mined from BAGEL4. Each draft genome was assembled into a 
pseudomolecule using a closely related strain as a reference before applying to the pipeline. BGCs that have 
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We report a new class of cationic circular peptides, which display outstanding bioactivity against 
Gram-negative bacteria. We also report the mode of action of these relacidines, which is affecting 
the oxidative phosphorylation process of cells. Our study provides a comprehensive understanding 
of this new class of nonribosomal peptides and is a solid base for their application in biocontrol and 
pharmacy. 
Summary 
The development of sustainable agriculture and the increasing antibiotic resistance of human 
pathogens call for novel antimicrobial compounds. Here, we describe the extraction and 
characterization of a class of cationic circular lipopeptides, for which we propose the name 
relacidines, from the soil bacterium Brevibacillus laterosporus MG64. Relacidines are composed of 
a fatty acid side chain (4-methylhexanoic acid) and 13 amino acid residues. A lactone ring is formed 
by the last five amino acid residues and three positively charged ornithines are located in the linear 
fragment. Relacidines selectively combat Gram-negative pathogens, including phytopathogens and 
human pathogens. Further investigation of the mode of action revealed that relacidine B binds to 
the lipopolysaccharides (LPS) but does not form pores in the cell membrane. We also provide proof 
to show that relacidine B does not affect the biosynthesis of the cell wall and RNA. Instead, it affects 
the oxidative phosphorylation process of cells and diminishes the biosynthesis of ATP. Transcription 
of relacidines is induced by plant pathogens, which strengthens the potential of B. laterosporus 
MG64 to be used as a biocontrol agent. Thus, we identified a new group of potent antibiotic 
compounds for combating Gram-negative pathogens of plants or animals. 
















Antimicrobials are substances that kill or inhibit the growth of microorganisms. They are of great 
value in different applications. Some of them are being used as weapons for plant disease biocontrol 
[1], while others are used as antibiotics for preventing and curing bacterial infections in animals, 
including humans [2]. The discovery of novel antimicrobials is of paramount importance not only for 
the development of sustainable agriculture but also to overcome antibiotic resistance, which has 
become one of the biggest threats to human health in recent decades.  
Soil is an ecosystem that hosts a large and diverse population of microorganisms [3]. Microbes 
develop strategies to adapt to fluctuating soil environments and to survive in the competition with 
other organisms. Production of antimicrobials is one of the most potent strategies for this adaptation 
[4]. Thus, soil microorganisms form a natural reservoir of antimicrobials [2]. Screening of soil 
microorganisms that harbor novel biosynthetic gene clusters (BGCs) against pathogens is a 
traditional but efficient way to discover novel antimicrobials. 
In a previous study, we isolated a rhizosphere bacterium, Brevibacillus laterosporus MG64, which 
displayed potent activity against plant pathogens and mammalian pathogens [5]. Brevibacillus is a 
genus of bacteria reclassified from Bacillus based on the 16S rRNA sequence analysis [6]. It is a 
rich resource for antimicrobials and many compounds have been isolated and characterized [7]. For 
instance, gramicidin S, loloatins, tyrocidines, etc. were discovered from Brevibacillus brevis [8-10], 
while tauramamide, bogorols, laterosporulin, etc. were isolated from B. laterosporus [11-14]. The 
current study was initiated to unveil novel antimicrobials produced by B. laterosporus MG64, which 
harbors abundant novel BGCs [5]. The bioactivity against different kinds of pathogens and the 
underlying mode of actions of the bioactive compounds were further investigated and dissected in 
order to evaluate their potential in applications. 
Results 
Purification and identification of relacidines 
We previously isolated B. laterosporus MG64 from an agricultural rhizosphere sample and showed 
that this organism has several biosynthetic gene clusters encoding potential antimicrobials, and 
secretes compounds that inhibit the growth of bacterial and fungal pathogens [5]. To characterize 
these antimicrobials, supernatant from a B. laterosporus MG64 culture was precipitated using 
ammonium sulfate and applied to HPLC for purification. Each peak that eluted from the HPLC was 
collected for an in vitro activity test using X. campestris pv. campestris as an indicator. Two peaks 













determine their molecular masses. The first peak showed m/z values of 1549.82 and 1571.80, 
corresponding to a singly protonated compound [M + H]+ and its sodium-cationized ion [M + Na]+, 
respectively. The second peak showed m/z values of [M + H]+ 1563.83 and [M + Na]+ 1585.82 
(Figure S2). The similar elution time and molecular mass suggested that they belong to the same 
class of compounds. We designated them as relacidine A and relacidine B, respectively. Relacidines 
represent some of the major secondary metabolites produced by B. laterosporus MG64. With the 
method used, around 0.2 mg of relacidine A and 0.5 mg of relacidine B can be obtained from one 
liter of culture. 
To further characterize the compounds, the contents of both peaks were applied to LC-MS/MS 
analysis. As shown in Figure S3, both compounds were identified to contain a fragment of Tyr-Trp-
Orn-Orn-Gly-Orn-Trp. With this information and the prediction by antiSMASH [15], we successfully 
identified the gene cluster of relacidines (Figure 1a). This gene cluster contains five genes, including 
two ATP-binding cassette transporter genes (rlcA and rlcB), two large core biosynthetic genes (rlcC 
and rlcD).  and one drug resistance transporter gene (rlcE). The core biosynthetic genes encode 13 
modules, among which the module 4 to module 7 incorporating the identified fragment of Orn-Orn-
Gly-Orn (Figure 1a, Figure S3). According to the prediction, the final product should contain 13 
amino acid residues. However, the signals from the C terminus were largely missing in the LC-
MS/MS data, suggesting the potential existence of a cyclic structure, which is prevalent in natural 
products. To confirm this hypothesis, each compound was hydrolyzed with 2 M NaOH, desalted, 
and subjected to LC-MS/MS analysis. The signals at the C termini were found after hydrolysis, 
indicating the presence of a ring in the original compounds (Figure 1b and 1c). The ring of relacidine 
A was determined to be constituted of Thr-Ile-Gly-Ser-Gly, which is in perfect accordance with the 
prediction from antiSMASH (Figure 1a). Relacidine B has the same b ions as relacidine A, but the y 
ions show a difference of 14 Da, which indicates their difference at the last two amino acid residues 
of the C terminal region (Figure 1b-c). Residue Ser-12 (the number indicates the position of the 
amino acid residue, the same for the rest below) was predicted with high confidence by antiSMASH, 
and therefore we speculate the last amino acid residue of relacidine B to be Ala. The fatty acid tail 
and the first amino acid residue are predicted to be C7H13O1 and Ser, respectively, which is 














Figure 1. Characterization of biosynthetic gene cluster and structure of relacidines. (a) Gene cluster of 
relacidines predicted by antiSMASH. ABC transporter genes are indicated in red; core biosynthetic genes are 
shown in green; drug resistance related gene is labeled with blue. The letters in the adenylation domains 
represent the predicted amino acid residues. Tandem MS analysis of hydrolyzed relacidine A (b) and relacidine 
B (c). Peptides were hydrolyzed with 2 M NaOH and desalted before applying to LC-MS/MS. (d) 1H-1H TOCSY 
and 1H-1H NOESY NMR crosspeaks of relacidine B. 
The structure of relacidine B was further confirmed by 1D and 2D NMR spectroscopy, where 1H 













identify the 1H and 13C signals of the different amino acid residues. All chemical shifts found were 
consistent with the MS/MS results. The structure of the fatty acid side chain was found to be 4-
methylhexanoic acid (Figure 1d). Cross-peaks in the 1H-1H-NOESY NMR verified the amino acid 
sequence found for this peptide in MS/MS (Figure 1d). Moreover, NOESY cross-peaks of both Ile10 
and Ala-13 with Thr-9 confirmed the presence of the lactone macrocycle (Figure 1d). The chemical 
shift assignments are summarized in Table S1.  
Taken together, relacidines are identified as novel lipopeptides that are constituted with a fatty acid 
tail (4-methylhexanoic acid) and 13 amino acid residues. Moreover, the last amino acid residue was 
linked to Thr-9 with an ester bond, thus forming a lactone ring (Figure 1d). Relacidines contain three 
positively charged ornithine residues, resulting in a net positive charge at neutral pH conditions, and 
therefore are classified as cationic peptides, which are considered to be attractive therapeutic 
candidates to combat Gram-negative pathogens [16, 17]. 
Antibacterial activity and mechanism of action 
The relacidines were assessed for antibacterial activity. Phytopathogens (Xanthomonas species, 
Pseudomonas syringae, Pectobacterium carotovorum, and Ralstonia syzygii), food pathogen 
(Bacillus cereus), and human pathogens (E. coli ET8, Klebsiella pneumoniae, Pseudomonas 
aeruginosa, Staphylococcus aureus, and Enterococcus faecium) were tested in order to evaluate 
the potential of relacidines in different applications. As shown in Table 1, the relacidines displayed 
potent activity against all the Gram-negative bacteria tested. The minimum inhibitory concentration 
(MIC) values are in the range of 0.25-2 µg/ml (0.16-1.29 µM), which is comparable to that of 
polymyxin B, a cationic peptide antibiotic commonly used to treat infections caused by multiple drug-
resistant pathogens [18]. The addition of exogenous lipopolysaccharides (LPS) from E. coli increase 
the MIC values of both relacidines and polymyxin B, suggesting their binding to LPS. Relacidines 
did not affect the growth of the tested Gram-positive bacteria (i.e. Staphylococcus aureus subsp. 
aureus 533 R4, Bacillus cereus ATCC 14579, and Enterococcus faecium LMG16003) at a 
concentration up to 32 µg/ml. A similar phenomenon was observed for polymyxin B, where activity 
against Gram-positive bacteria was not observed. 
The plant pathogen X. campestris pv. campestris was used to study the mode of action of relacidine 
B because of its great sensitivity. A growth curve was first determined to understand the efficacy of 
relacidines. Growth inhibition is defined as a drop in the increase of the optical density of a culture 
compared to the control. As shown in Figure 2a, the control cells are continuously growing, while 
the cells treated with a relacidine or polymyxin B displayed slower growth after a defined period of 
time, followed by an absence of growth. The effective time of relacidines is around 2.5 h when 
applied at 1 × MIC and a faster effect was observed when the concentrations used are higher. 
Polymyxin B acts faster than relacidines when applied at the same MIC level. A time-kill assay was 













was significantly reduced after 30 min of exposure to relacidines at ten times the MIC (Figure 2b), 
which confirms the bactericidal effect of relacidines.  





Relacidine A Relacidine B Polymyxin B 
Gram-
negative 
Xanthomonas campestris pv. campestris 
NCCB92058 
0.5 0.25-0.5 ≤0.06 
X. campestris pv. campestris 
NCCB92058 + LPS (100 µg/mL) 
4 4 8 
Xanthomonas translucens pv. graminis 
LMG587 
0.25 0.25 ≤0.06 
Pseudomonas syringae pv. antirrhin 
LMG2131 
0.5 0.5 0.12 
Pseudomonas syringae pv. tomato 
DC3000 
0.5 0.5 0.12 
Pectobacterium carotovorum LMG5863 2 0.5 0.25 
Ralstonia syzygii subsp. syzygii 
LMG6969 
2 1 0.25 
Escherichia coli TOP10 2 2 0.25 
E. coli TOP10 + LPS (100 µg/mL) 8 8 8 
E. coli ET8 2 2 0.25 
Klebsiella pneumoniae LMG20218 2 2 0.25 
Pseudomonas aeruginosa PAO1 2 2 0.5 
Gram-
positive 
Staphylococcus aureus subsp. aureus 
533 R4 
>32 >32 >32 
Bacillus cereus ATCC 14579 >32 >32 >32 
Enterococcus faecium LMG16003 >32 >32 >32 
 
A common mechanism of action employed by a lot of antibiotics, including cationic peptides, is 
interfering with membrane integrity [17]. We analysed whether relacidine B can permeabilize the cell 
membranes of X. campestris pv. campestris using a combination of two fluorescent DNA dye, one 
(SYTO9) green and membrane permeable, and the other (Propidium Iodide) red and membrane 
impermeable. Cells treated with polymyxin B, a cationic peptide antibiotic known to disrupt cellular 
membranes [19], were stained red, indicating that membranes were damaged. In contrast, cell 
membranes remain intact after treating with relacidine B and DMSO (control) for up to 7 h, indicating 
that relacidine B does not form holes in the cell membrane (Figure 2c).  
Next, we investigated the membrane potential of cells treated with relacidine B using the potential 
sensitive membrane dye DiSC(3)-5 [20]. Considering that cationic peptides may affect the 













treatment did not affect the signal regardless of the presence of cells. In contrast, the cationic peptide 
polymyxin B caused an increase in the blank, but the relative intensity of the signal is higher when 
cells were present. This is in accordance with its pore-formation in the cell membrane.  Relacidine 
B, which is identified to be a cationic peptide in this study, is compatible with the dye and the 
fluorescence signal was decreased when the cells were present. This suggests the hyperpolarizing 
effect of relacidine B on cell membranes and further proved the integrity of cell membranes.  
 
Figure 2. Growing curve, killing curve, membrane permeability, and membrane potential effect of 
relacidines. (a) Growing curve of X. campestris pv. campestris exposed to relacidines. The overnight culture 
was diluted with fresh LB  to an OD600 of 0.05 and dispensed into a 96-well plate (100 µL each well). Compounds 
were added at different concentrations when the cells reach the early stationary phase. (b) Killing curve of 
relacidines to X. campestris pv. campestris. All compounds were added at a concentration of 2.5 µg/mL. (c) 
Membrane permeability of relacidine B. X. campestris pv. campestris cells (OD600 = 0.2) were treated with 
different compounds (DMSO and 0.5 µg/mL relacidine B for up to 7 h, and 1 µg/mL polymyxin B for 5 min). 
Cells were washed with PBS buffer and stained with SYTO9 and PI before inspecting with a microscope. (d) 
Membrane potential effect of relacidine B. The membrane potential dye DiSC(3)-5 was added at a final 
concentration of 6 µM. Relacidine B and polymyxin B were added at final concentrations of 0.5 µg/mL and 1 
µg/mL, respectively. The fluorescence signal intensity is relative to the stabilized signal after adding DiSC(3)-5  
(0 min). Con, control (Milli-Q water), RelB, relacidine B; PlyB, polymyxin B. ns, no significant difference; *, 
significant difference (T-test, p < 0.05), **, very significant difference (T-test, p < 0.01). 
 
Inhibition of macromolecule (such as peptidoglycan, RNA, etc.) biosynthesis is another common 













affected by relacidine B, incorporation of the fluorescent D-amino acid analog HADA 
(hydroxycoumarin-carboxylic acid-amino-D-alanine) was followed. The incorporation of HADA in the 
cells treated with relacidine B or DMSO (negative control) was not affected, while that in the cells 
exposed to ceftriaxone (positive control) was significantly reduced (Figure S4). This result suggests 
that relacidine B does not abolish the biosynthesis of peptidoglycan.  A competition experiment in 
which lipid II was added to relacidine before treatment confirmed that the peptidoglycan precursor 
lipid II, which is the target for many membrane-active peptides, is not the target for relacidine (Figure 
S5). The slow effect of relacidine B is similar to that of rifampicin, an antibiotic that inhibits RNA 
biosynthesis. To investigate RNA synthesis during relacidine treatment, incorporation of [53H] 
uridine in RNA was followed over time. As shown in Figure S6, rifampicin blocks incorporation of 
[53H] uridine, whereas relacidine had no effect and was comparable to the control. This result 
indicates that relacidine B does not affect the biosynthesis of RNA. 
Next, the effects of relacidine B on cellular metabolism were studied. The addition of relacidine B 
caused a drop in the intracellular ATP concentration of cells compared to DMSO-treated cells 
(negative control, Figure 3a). The positive control, carbonyl cyanide m-chlorophenyl hydrazone 
(CCCP), a compound known to inhibit the oxidative phosphorylation of cells, caused a more drastic 
drop in intracellular ATP. Notably, cells treated with relacidine B for up to 2 h did not affect the growth 
curve (Figure 2a) and the integrity of the cell membrane (Figure 2c), suggesting that the ATP drop 
is caused by the cellular metabolism but not the cell death. A possible explanation for the decrease 
in intracellular ATP would be that ATP synthetase is targeted by relacidine B. This is unlikely 
however, as E. coli cells, in which enhanced substrate-level phosphorylation [21] can compensate 
for the absence of ATP synthetase, are also killed by relacidine B. A comparison of the sensitivity 
of wild type and atp (ATP synthetase gene) mutants of E. coli to relacidine B confirmed this, showing 
similar MIC values for all strains (Table S2). 
To further investigate the cause of the decrease of ATP levels in bacteria treated with relacidine B, 
the NADH level of cells was determined using resazurin, which is reduced to resorufin by NADH in 
the presence of NADH dehydrogenase [22-26]. The NADH level of cells treated with relacidine B 
was higher than that of the control, although both of them showed the same trends of increase, 
whereas polymyxin B and rifampicin blocked the reduction after 30 min and 250 min, respectively 
(Figure 3b). This result indicates that relacidine B increases NADH of cells. The increase of the 
NADH level and the decrease of the ATP level suggest that the oxidative phosphorylation process 
of cells is affected by relacidine B (Figure S7). More precisely, either the electron transport chain is 















Figure 3. Relacidine B affects the ATP and NADH level of cells. (a) ATP concentration of X. campestris pv. 
campestris cells treated with compounds. Relacidine B was added at a concentration of 0.25 µg/mL. CCCP (40 
µg/mL) was used as a positive control and DMSO is used as a negative control. (b) NADH level of X. campestris 
pv. campestris cells treated with antimicrobials. Resazurin was added to the culture at a final concentration of 
0.1 mg/mL. Relacidine B, rifampicin, and polymyxin B were added at final concentrations of 0.25 µg/mL, 0.125 
µg/mL, and 1 µg/mL, respectively. DMSO was used as a negative control. RelB, relacidine B; Rif, rifampicin; 
PlyB, polymyxin B. 
 
Expression of relacidines during the interaction with pathogens 
Various strains of B. laterosporus have been reported to have good biocontrol potential [27-30]. A 
B. laterosporus strain isolated from honeybees was even reported to have a probiotic effect on the 
host [31]. Notably, all of these biocontrol strains (if the genomic sequence is available) were found 
to harbor an unidentified BGC that showed high similarity to relacidines (Figure S8). Given the 
effectiveness of relacidines in combating pathogens, the potential of their newly isolated producer, 
B. laterosporus MG64, to be used as a biocontrol agent or probiotic culture was evaluated. The 
expression and production of relacidines during the interaction with two plant pathogens (X. 
campestris pv. campestris and P. syringae pv. tomato) and two human pathogens (K. pneumoniae 













inhibition activity against X. campestris pv. campestris and P. syringae pv. tomato grown at 28 ℃. 
Both plant pathogens clearly induced the expression of the core biosynthetic gene (rlcC) of the BGC. 
The relacidine peptides were also discovered in the cell extracts, however, the presence of the 
pathogens did not seem to result in higher amounts of relacidine in the cell extracts. No inhibition 
was observed when B. laterosporus MG64 was cocultured with K. pneumoniae and E. coli at 37 ℃, 
even though its secondary metabolites, relacidines, displayed potent activity against these two 
pathogens. Further inspection of the transcripts revealed that rlcC was expressed when growing 
alone, but down-regulated when interacting with the two human pathogens and that no relacidine 
peptides were detected in the cell extracts, regardless of the presence of the human pathogens. 
Together, these results suggest B. laterosporus MG64 can be a good biocontrol strain for plants, 
but it is likely not suitable to be used as probiotic. 
 
Figure 4. Investigation of expression of relacidines during the interaction with two plant pathogens (left 
panel) and two human pathogens (right panel) at transcriptional and metabolic levels. The expression 
of a relacidine biosynthetic gene (rlcC) was tested with real-time PCR using three replicates. Different 
lowercase letters indicate a significant difference (ANOVA, p < 0.001) between treatments. The production of 
relacidines was analyzed by HPLC. Controls are producers growing on LB plates without pathogens. Xcc, X. 
campestris pv. campestris NCCB92058; Pst, P. syringae pv. tomato DC3000; Kp, K. pneumoniae LMG20218; 














Here, we identified two relacidines as members of a novel class of cationic cyclic lipopeptides. They 
have both similarities and differences compared to brevicidine and laterocidine, which are also 
antimicrobials produced by Brevibacillus laterosporus [32]. Brevicidine is different from relacidines 
in the first amino acid residue (Ser-1 in relacidines is replaced by Asn-1 in brevicidine) and the 
lactone ring (the Gly-13 in relacidines is absent in brevicidine) (Figure S9). Laterocidine is different 
from relacidines in the fatty acid side chain and the lactone ring: C7H13O1 and Gly-Ser-Gly/Ala in 
relacidines are replaced by C9H17O1 and Asn-Gly-Gly in laterocidine, respectively (Figure S9). Apart 
from the differences, brevicidine, laterocidine, and relacidines share outstanding characteristics. All 
of them contain a linear cationic chain and a hydrophobic lactone ring (Figure S9), both of which 
were considered crucial for the antibacterial activity [32].  
The structure of relacidines, as well as of the recently reported brevicidine and laterocidine, is novel 
compared to other cationic cyclic lipopeptides such as tyrocidines, gramicidin S, and polymyxins 
(Figure S10), some of which are considered antibiotics of the last resort for combating multidrug-
resistant bacteria [33]. First of all, they contain a cationic linear fragment constituted with a fatty acid 
tail and eight amino acid residues. Gramicidin S and tyrocidines do not possess a linear fragment 
and polymyxins contain a shorter cationic linear fragment constituted with a fatty acid tail and three 
amino acid residues (Figure S10). Also, the ring of relacidines is formed by an ester bond, in contrast 
to the peptide bond found in gramicidin S, tyrocidines, and polymyxins (Figure S10). Moreover, the 
ring of relacidines is constituted with 5 amino acid residues while that of gramicidin S, tyrocidines, 
and polymyxins contain 10, 10, and 7 amino acid residues, respectively (Figure S10). Lastly, the 
ring of relacidines is uncharged, unlike gramicidin S, tyrocidines, and polymyxins have 2, 1, and 4 
positive charges, respectively (Figure S10).  
Relacidines selectively combat Gram-negative pathogens, which is similar to the structurally related 
peptides brevicidine and laterocidine [32]. Another class of cationic peptides, polymyxins, also 
displays potent activity against Gram-negative bacteria but not against Gram-positive bacteria. The 
similarity of the inhibitory spectra of these peptides is believed to be related to their structures. Both 
relacidines and polymyxins possess a cationic linear fragment, which is proven to be important for 
binding to the anionic lipopolysaccharide (LPS) of Gram-negative cells [17]. Apart from the inhibitory 
spectra, the antimicrobial potency of relacidines is comparable to that of polymyxins, which are used 
in the treatment of infections caused by multi-drug resistant Gram-negative bacteria. Moreover, 
research on brevicidine and laterocidine showed that they have a low risk of resistance development 













a major concern in recent decades. All these factors show the great potential of relacidines, 
brevicidine, laterocidine for pharmaceutical applications. 
Likely because of the structural uniqueness, relacidines, as well as brevicidine and laterocidine, 
display a different mode of action compared to other cationic cyclic peptides, which disrupt the 
cellular membranes and resulting in cell death. Our results show that relacidines bind to LPS but do 
not form pores in the cell membrane (Figure 2c). This is in line with an investigation on brevicidine 
and laterocidine [32]. We also provide evidence to show that relacidines do not affect the 
biosynthesis of peptidoglycan and RNA (Figure S4-S6). Instead, they affect the oxidative 
phosphorylation of cells, thus disrupting the biosynthesis of ATP (Figure 3a), which supplies energy 
for metabolisms. There are two possible mechanisms employed by relacidines to affect the oxidative 
phosphorylation. First of all, it can be an uncoupler of ATP synthase and the ETC. The ETC is a 
process of electron transfer from electron donors to electron acceptors. Meanwhile, it couples the 
transfer of protons across the cellular membrane, thus creating a proton-motive force. An uncoupler 
can disrupt the proton gradient and affect the biosynthesis of ATP. CCCP is a typical uncoupler that 
carries protons across the membrane and disrupts the biosynthesis of ATP [34, 35]. Additionally, 
relacidine B can also be an inhibitor of the protein complexes that constitute the electron transport 
chain, thus disrupting proton export. Examples of such compounds are rotenone and antimycin A 
that bind to complex I and complex III, respectively [36-41]. Both mechanisms result in a higher 
intracellular proton concentration, thus explaining the hyperpolarization of the cellular membrane 
(Figure 2d). Future studies will be directed to reveal which exact mechanism is employed by 
relacidines.  
Our previous study showed that B. laterosporus MG64 can inhibit a broad range of pathogens [5]. 
In this study, by inspecting the production of the potent antimicrobial relacidines during the 
interaction with plant pathogens, we show that B. laterosporus MG64 can be applied as a biocontrol 
agent. The application of B. laterosporus in biocontrol of pathogenic microorganisms, insects, and 
nematodes has been reported previously [27-29, 42-44]. Some B. laterosporus strains were even 
used as probiotics [31, 45]. However, from the perspective of relacidines production during 
interaction with pathogens, B. laterosporus MG64 seems not suitable to be used as probiotics in 
animals, including humans. The abolishment of relacidine production is more likely a result of 
unfavorable growing temperatures (37 ℃) than inhibition by pathogens (Figure 4). 
Experimental Procedures 













The producing strain, B. laterosporus MG64, was grown in Lennox broth (LB) overnight. The 
overnight culture was then diluted 100 times in fresh LB broth and incubated at 28 ˚C with agitation 
for 18 h. The supernatant was collected by centrifuging at 10,000 × g for 10 min and the secondary 
metabolites were precipitated with ammonium sulfate to 40% saturation. The precipitates were then 
dissolved in Milli-Q water and filtered through a 0.45 µm cellulose acetate membrane to achieve 
crude extracts. The crude extracts were applied to a reverse high-performance liquid 
chromatography (HPLC) for purification. An analytical C-18 column was used and the mobile phases 
were HPLC-grade water supplemented with 0.1% trifluoroacetic acid (TFA) (solvent A) and 
acetonitrile supplemented with 0.1% TFA (solvent B). The compounds were eluted with a linear 
gradient of solvent B (from 15 % to 45%) in 30 min at a flow rate of 1.0 ml/min. A UV-detector set at 
a wavelength of 280 nm was used to monitor the effluents. All the peaks were collected separately 
and their antibacterial activities were tested against a plant pathogen Xanthomonas campestris pv. 
campestris.  
LC-MS/MS analysis 
The active compounds were characterized by liquid chromatography-tandem mass spectrometry 
(LC-MS/MS). An Ultimate 3000 UHPLC system coupled with a Q-Exactive OrbitrapTM-based mass 
spectrometer (Thermo Scientific, San Jose, CA, USA) was used. The UHPLC system was equipped 
with a kinetex WVO-C18 column (2.6 µm particles, 100 × 2.1 mm, Phenomenex) and the mass 
spectrometer was equipped with a HESI-II electrospray source. The mobile phases of the LC were 
water with 0.1% formic acid and acetonitrile with 0.1% formic acid. In each run, a 10 µL sample was 
injected and separated with mobile phases at a flow rate of 500 µl min−1. The MS/MS data was 
acquired with a spray voltage of 3.5 kV (positive mode) and a capillary temperature of 275 ˚C. The 
m/z range was set to 300 to 2000 and the resolution was 70,000. MS/MS data were recorded in 
targeted MSMS using PRM mode. In order to investigate the amino acid composition of the lactone 
ring, peptides were hydrolyzed in 2 M NaOH and desalted with an open column filled with C18 silica 
gel spherical (Sigma, United States) before applying to LC-MS/MS.  
NMR spectroscopy 
Prior to NMR analysis, the isolated peptide was purified further by RP-HPLC (XBridge C8 250 mm 
analytical column, solvent A: 0.1 % FA in ACN, solvent B: 0.1 % FA in ddH2O, gradient 90 % B to 
30 % B over 40 minutes, flow: 0.5 mL/min.) and the pure fractions were pooled and lyophilized. 
Around 1 mg of compound was dissolved in 0.5 mL DMSO-d6. A Brüker Ascend 600 MHz 













NOESY NMR spectra. Chemical shifts in 1H NMR spectra were internally referenced to solvent 
signals (DMSO-d6 at δH = 2.50 ppm, δC = 39.51 ppm). 
Minimal inhibitory concentration (MIC) test 
The MICs of relacidine A and B were tested with the standard broth dilution method (Wiegand et al., 
2008). Polymyxin B was used as a reference. MHB medium was used for all the bacteria tested. 
Peptides were diluted from 32 µg/mL to 0.06 µg/mL in a two-fold serial dilution and cells were 
adjusted to a concentration of 5.0 × 105 CFU/mL. The 96-well plate was incubated at 28 ˚C for 36 h 
and the OD600 was measured with a Tecan Infinite F200 Pro Luminometer. The lowest concentration 
that causes invisible growth of bacteria was defined as the MIC values. The experiment was done 
in quadruplicate for each peptide and each strain. 
Bacterial growth kinetics and time-kill assay 
X. campestris pv. campestris was first inoculated in LB broth and incubated at 28 ˚C overnight. The 
overnight culture was then diluted with fresh LB to an OD600 of 0.03 and distributed in a 96-well plate. 
The plate was incubated in a microplate spectrophotometer (1000 rpm, 28 ˚C) until OD600 reached 
0.05. Relacidines was added at concentrations of 0.25 µg/mL (1 × MIC) and 2.5 µg/mL (10 × MIC). 
Polymyxin B was added at a concentration of 0.625 µg/mL (10 × MIC, lower concentration of 
polymyxin B does not affect the growth of cells although its MIC value is ≤ 0.06 µg/mL). The same 
amount of DMSO was added as a control. The plate was incubated at the same condition for 20 h 
and the growth kinetics were monitored. Each treatment was done in quadruplicate. For the time-
kill assay, all compounds were added at a concentration of 2.5 µg/mL when the OD600 reached 0.1. 
At each time point (0, 30, 60, and 90 min), 10 µL of culture was tenfold serially diluted and plated 
on LB agar plates. After incubation at 28 ˚C for 36 h, colonies were counted and the number of CFU 
per mL was calculated.    
Membrane permeability assay 
A commercial LIVE/DEAD Baclight Bacterial Viability Kit (Invitrogen) was used to test the integrity 
of the cell membrane of X. campestris pv. campestris after treatment with peptides. Cells were grown 
in LB overnight and diluted to an OD600 of 0.2. Relacidine B was added at a concentration of 0.25 
µg/mL (1×MIC), while polymyxin B was added at a concentration of 1 µg/mL. The same amount of 
DMSO was added to the control. Cells were treated at room temperature for 30 min before harvest. 
The harvested cells were washed and resuspended in 200 µl 0.9% saline (NaCl) solution. Two 
different dyes (3.34 mM SYTO9 and 20 mM propidium iodide) were added at a ratio of 1:1 (v/v). 













before being imaged using a Nikon Ti-E microscope (Nikon Instruments, Tokyo, Japan) equipped 
with a Hamamatsu Orca Flash 4.0 camera. 
Membrane potential assay 
Fresh X. campestris pv. campestris cells were inoculated in MHB medium and grown until OD600 
reached 0.4. The culture was two times diluted with fresh MHB medium and dispensed in a 96 well 
plate. The membrane potential dye DiSC(3)-5 was added to a final concentration of 6 µM. The 
fluorescence signal (excitation 633 nm, emission 660 nm) was allowed to stabilize for 20 min in a 
microplate spectrophotometer (BioTek Synergy Mx). After stabilization, relacidine B and polymyxin 
B were added at final concentrations of 0.5 µg/mL and 1 µg/mL, respectively. Milli-Q water was used 
as a negative control. Blanks (without cells) were used to show that the signal change is not caused 
by the interaction of the dye and compounds. The fluorescence signal was then monitored for 60 
min at an interval of 5 min with a microplate spectrophotometer. Three replicates were used for each 
treatment. 
Hydroxycoumarin-carboxylic acid-Amino-D-Alanine (HADA) incorporation assay 
D-amino acids are involved in peptidoglycan biosynthesis of diverse bacteria (Lam et al., 2009). 
HADA is a fluorescent D-amino acid analogue that can be used for monitoring the peptidoglycan 
synthesis activity of bacteria (Kuru et al., 2015). Cells were grown in LB broth until OD600 reached 
0.2. Relacidine B was added at a concentration of 0.25 µg/mL and cells were kept growing for 
another 2, 4, and 5 h. DMSO was used as a negative control while ceftriaxone (4 µg/mL) was used 
as a positive control. At each time point, cells were treated with 500 µM HADA for 24 min. After 
treatment, cells were washed twice with PBS buffer. Incorporation of HADA was inspected with a 
Nikon Ti-E microscope (Tokyo, Japan) equipped with a Hamamatsu Orca Flash 4.0 camera. 
Lipid II binding assay 
Generally, lipid II from Gram-negative bacteria has meso-diaminopimelic acid (mDAP) on residue 3, 
while that from Gram-positive bacteria has lysine [48]. Both types were used in the lipid II binding 
assay. An overnight culture of the indicator strain (X. campestris pv. campestris) was added to 
melted LB agar at a final concentration of 0.2% (v/v) before pouring plates. Lipid II and relacidine B 
were mixed at different ratios (0.5, 1, and 2) before spotting onto the plate. The plate was incubated 
at 28 °C overnight. The binding of lipid II and relacidine B is indicated by the decrease of halo size. 













The BacTiter-GloTM Microbial cell viability assay kit (Promega) was used to determine the 
intracellular ATP concentration of X. campestris pv. campestris. Cells were grown in LB broth until 
OD600 reached 0.2. Relacidine B was added at a concentration of 0.25 µg/mL (1 × MIC) and the 
DMSO was used as a solvent control. Carbonyl cyanide m-chlorophenyl hydrazine (CCCP), an 
uncoupler of oxidative phosphorylation, was used as a positive control (40 µg/mL). Cells were 
treated at 28 ˚C for 0, 1, 2, 3 h. At each time point, 100 µL cell culture was added to 100 µL BacTiter-
GloTM reagent and incubated at room temperature for 5 min. Luminescence was with a Tecan Infinite 
F200 Pro luminometer and the intracellular ATP concentration was calculated with a standard curve 
made with a commercial ATP solution. 
Resazurin assay 
Nonfluorescent resazurin can be reduced to fluorescent resorufin in a NAD(P)H dependent manner 
in the presence of NAD(P)H dehydrogenase [22-26]. Therefore, the resazurin/NAD(P)H 
dehydrogenase/NAD(P)H system can be used to detect the NAD(P)H level of cells. X. campestris 
pv. campestris cells were grown in LB broth until OD600 reached 0.1. Resazurin was added to the 
culture at a final concentration of 0.1 mg/ml. Relacidine B, rifampicin, and polymyxin B were added 
at final concentrations of 0.25 µg/mL, 0.125 µg/mL, and 1 µg/mL, respectively. DMSO was used as 
a negative control. Blanks (without cells) revealed that the signal change is not caused by the 
interaction of resazurin and compounds. Fluorescence was recorded at a wavelength of 560 nm 
every 20 min over a period of 4 h with a BioTek Synergy Mx 96-well plate reader. 
Determining relacidine expression during the interaction with different pathogens 
A fresh culture of each pathogen was mixed with melted agar (around 45 ℃) before preparing plates. 
B. laterosporus MG64 was inoculated (10 µL inoculum with an OD600 of 1.0) at the center of each 
plate containing pathogens. The plates were incubated at 28 ℃ or 37 ℃ based on the growth 
temperature of the indicator strain. After 2 days, the inhibition against pathogens was documented 
with photos and B. laterosporus MG64 cells were collected for further analysis. The total RNA was 
extracted using the High Pure RNA isolation kit (Roche Diagnostics Nederland BV) and 500 µg of 
each RNA sample was used for reverse transcription using the SuperScript™ III Reverse 
Transcriptase (Invitrogen) following the instruction manual. The cDNAs were 5-times diluted to make 
templates. The primers used in the qPCR are as follows: Housekeeping gene: rpoB-forward, 
CCAAGACATTTCGCCAATCC; rpoB-reverse, CGTTCCTTCGACTCGTCTAC. Target gene: rlcC-
forward, TCGACAGTACGATGCCTTTC; rlcC-reverse, GAGCTTCGCCATCAACAC. The qPCR 
mixture contained with 1 µL template, 0.6 µL forward primer, 0.6 µL reverse primer, 7.8 µL distilled 













95 ℃ 3 min, 95 ℃ 30 s, 57 ℃ 30 s, 72 ℃ 30 s, 72 ℃ 5 min and 40 cycles were used. The relative 
expression of relC is calculated with the 2-ΔΔCT method. The metabolites were extracted from the 
cells with 50% acetonitrile and lyophilized. The compounds were redissolved in Milli-Q water and 




We thank Prof. Matthias Heinemann from the University of Groningen (the Netherlands) and Prof. 
Hirotada Mori from Nara Institute of Science and Technology (Japan) for providing the E. coli ATP 
synthase mutants. The authors thank Johan Kemmink for the help and discussion about the NMR 
analysis. Z. Li and X. Zhao are financially supported by the Chinese Scholarship Council (CSC). 
R.H. de Vries and G. Roelfes acknowledge financial support from the Netherlands Organisation for 
Scientific Research (NWO, Vici grant 724.013.003) and the Ministry of Education Culture and 




1. Ongena M, Jacques P: Bacillus lipopeptides: versatile weapons for plant disease biocontrol. Trends 
Microbiol 2008, 16(3):115-125. 
2. Chandra N, Kumar S: Antibiotics producing soil microorganisms. In: Antibiotics and Antibiotics 
Resistance Genes in Soils: Monitoring, Toxicity, Risk Assessment and Management. Edited by 
Hashmi MZ, Strezov V, Varma A. Cham: Springer International Publishing; 2017: 1-18. 
3. Roesch LF, Fulthorpe RR, Riva A, Casella G, Hadwin AK, Kent AD, Daroub SH, Camargo FA, 
Farmerie WG, Triplett EW: Pyrosequencing enumerates and contrasts soil microbial diversity. ISME 
J 2007, 1(4):283-290. 
4. Davies J: What are antibiotics? Archaic functions for modern activities. Mol Microbiol 1990, 4(8):1227-
1232. 
5. Li Z, Song C, Yi Y, Kuipers OP: Characterization of plant growth-promoting rhizobacteria from 
perennial ryegrass and genome mining of novel antimicrobial gene clusters. BMC Genomics 2020, 
21(1):157. 
6. Shida O, Takagi H, Kadowaki K, Komagata K: Proposal for two new genera, Brevibacillus gen. nov. 
and Aneurinibacillus gen. nov. Int J Syst Evol Microbiol 1996, 46(4):939-946. 
7. Yang X, Yousef AE: Antimicrobial peptides produced by Brevibacillus spp.: structure, classification 













8. Gause GF, Brazhnikova MG: Gramicidin S and its use in the treatment of infected wounds. Nature 
1944, 154(3918):703-703. 
9. Gerard JM, Haden P, Kelly MT, Andersen RJ: Loloatins A− D, cyclic decapeptide antibiotics produced 
in culture by a tropical marine bacterium. J Nat Prod 1999, 62(1):80-85. 
10. Hotchkiss RD, Dubos RJ: The isolation of bactericidal substances from cultures of Bacillus brevis. J 
Biol Chem 1941, 141(1):155-162. 
11. Desjardine K, Pereira A, Wright H, Matainaho T, Kelly M, Andersen RJ: Tauramamide, a lipopeptide 
antibiotic produced in culture by Brevibacillus laterosporus isolated from a marine habitat: structure 
elucidation and synthesis. J Nat Prod 2007, 70(12):1850-1853. 
12. Barsby T, Warabi K, Sorensen D, Zimmerman WT, Kelly MT, Andersen RJ: The Bogorol family of 
antibiotics: template-based structure elucidation and a new approach to positioning enantiomeric pairs 
of amino acids. J Org Chem 2006, 71(16):6031-6037. 
13. Todd Barsby MTK, Stéphane M. Gagné, Raymond J. Andersen: Bogorol A produced in culture by a 
marine Bacillus sp. reveals a novel template for cationic peptide antibiotics. Org Lett 2001, 3(3):437-
440. 
14. Singh PK, Chittpurna, Ashish, Sharma V, Patil PB, Korpole S: Identification, purification and 
characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9. PLoS 
One 2012, 7(3):e31498. 
15. Blin K, Shaw S, Steinke K, Villebro R, Ziemert N, Lee SY, Medema MH, Weber T: antiSMASH 5.0: 
updates to the secondary metabolite genome mining pipeline. Nucleic Acids Res 2019, 47(W1):W81-
W87. 
16. Hancock REW: Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect 
Dis 2001, 1(3):156-164. 
17. Ntwasa M: Cationic peptide interactions with biological macromolecules. In: Binding Protein. 2012. 
18. Velkov T, Roberts KD, Nation RL, Thompson PE, Li JJFm: Pharmacology of polymyxins: new insights 
into an ‘old’class of antibiotics. Environ Microbiol 2013, 8(6):711-724. 
19. Khondker A, Dhaliwal AK, Saem S, Mahmood A, Fradin C, Moran-Mirabal J, Rheinstadter MC: 
Membrane charge and lipid packing determine polymyxin-induced membrane damage. Commun Biol 
2019, 2:67. 
20. Te Winkel JD, Gray DA, Seistrup KH, Hamoen LW, Strahl H: Analysis of antimicrobial-triggered 
membrane depolarization using voltage sensitive dyes. Front Cell Dev Biol 2016, 4:29. 
21. Peter R Jensen OM: Carbon and energy metabolism of atp mutants of Escherichia coli. J Bacteriol 
1992, 174(23):7635-7641. 
22. Winartasaputra H, Mallet VN, Kuan SS, Guilbault GGJCc: Fluorometric and colorimetric enzymic 
determination of triglycerides (triacylglycerols) in serum. Clin Chem 1980, 26(5):613-617. 
23. Barnes S, Spenney JGJCca: Stoichiometry of the NADH-oxidoreductase reaction for dehydrogenase 
determinations. Clin Chim Acta 1980, 107(3):149-154. 
24. De Jong DW, Woodlief WGJBeBA-E: Fluorimetric assay of tobacco leaf dehydrogenases with 
resazurin. Biochim Biophys Acta 1977, 484(2):249-259. 
25. Hanson NQ, Freier EJCc: Effect of protein on the determination of total bile acids in serum. Clin Chem 
1983, 29(1):171-175. 
26. Shahangian S, Ash KO, Rollins DEJJoat: An enzymatic method for the analysis of formate in human 













27. Prasanna L, Eijsink VG, Meadow R, Gaseidnes S: A novel strain of Brevibacillus laterosporus 
produces chitinases that contribute to its biocontrol potential. Appl Microbiol Biotechnol 2013, 
97(4):1601-1611. 
28. Saikia R, Gogoi DK, Mazumder S, Yadav A, Sarma RK, Bora TC, Gogoi BK: Brevibacillus laterosporus 
strain BPM3, a potential biocontrol agent isolated from a natural hot water spring of Assam, India. 
Microbiol Res 2011, 166(3):216-225. 
29. de Oliveira EJ, Rabinovitch L, Monnerat RG, Passos LK, Zahner V: Molecular characterization of 
Brevibacillus laterosporus and its potential use in biological control. Appl Environ Microbiol 2004, 
70(11):6657-6664. 
30. Miljkovic M, Jovanovic S, O'Connor PM, Mirkovic N, Jovcic B, Filipic B, Dinic M, Studholme DJ, Fira 
D, Cotter PD et al: Brevibacillus laterosporus strains BGSP7, BGSP9 and BGSP11 isolated from 
silage produce broad spectrum multi-antimicrobials. PLoS One 2019, 14(5):e0216773. 
31. Khaled JM, Al-Mekhlafi FA, Mothana RA, Alharbi NS, Alzaharni KE, Sharafaddin AH, Kadaikunnan S, 
Alobaidi AS, Bayaqoob NI, Govindarajan M et al: Brevibacillus laterosporus isolated from the digestive 
tract of honeybees has high antimicrobial activity and promotes growth and productivity of honeybee's 
colonies. Environ Sci Pollut Res Int 2018, 25(11):10447-10455. 
32. Li YX, Zhong Z, Zhang WP, Qian PY: Discovery of cationic nonribosomal peptides as Gram-negative 
antibiotics through global genome mining. Nat Commun 2018, 9(1):3273. 
33. Mogi T, Kita K: Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics. Cell Mol 
Life Sci 2009, 66(23):3821-3826. 
34. Heytler Pg Fau - Prichard WW, Prichard WW: A new class of uncoupling agents--carbonyl cyanide 
phenylhydrazones. Biochem Biophys Res Commun 1962, 7(4):272-275. 
35. Heytler PG: uncoupling of oxidative phosphorylation by carbonyl cyanide phenylhydrazones. I. Some 
characteristics of m-Cl-CCP action on mitochondria and chloroplasts. Biochemistry 1963, 2(2):357-
361. 
36. Palmer G, Horgan DJ, Tisdale H, Singer TP, Beinert HJJoBC: Studies on the respiratory chain-linked 
reduced nicotinamide adenine dinucleotide dehydrogenase XIV. Location of the sites of inhibition of 
rotenone, barbiturates, and piericidin by means of electron paramagnetic resonance spectroscopy. 
1968, 243(4):844-847. 
37. Ma X, Jin M, Cai Y, Xia H, Long K, Liu J, Yu Q, Yuan J: Mitochondrial electron transport chain complex 
III is required for antimycin A to inhibit autophagy. Chem Biol 2011, 18(11):1474-1481. 
38. Xia D, Yu Ca Fau - Kim H, Kim H Fau - Xia JZ, Xia Jz Fau - Kachurin AM, Kachurin Am Fau - Zhang 
L, Zhang L Fau - Yu L, Yu L Fau - Deisenhofer J, Deisenhofer J: Crystal structure of the cytochrome 
bc1 complex from bovine heart mitochondria. Science 1997, 277(5322):60-66. 
39. Maguire JJ, Kagan Ve Fau - Packer L, Packer L: Electron transport between cytochrome c and alpha 
tocopherol. Biochem Biophys Res Commun 1992, 188(1):190-197. 
40. Campo ML, Kinnally Kw Fau - Tedeschi H, Tedeschi H: The effect of antimycin A on mouse liver inner 
mitochondrial membrane channel activity. J Biol Chem 1992, 267(12):8123-8127. 
41. Alexandre A Fau - Lehninger AL, Lehninger AL: Bypasses of the antimycin a block of mitochondrial 
electron transport in relation to ubisemiquinone function. Biochim Biophys Acta (BBA)-Bioenergetics 
1984, 767(1):120-129. 
42. Panda AK, Bisht SS, DeMondal S, Senthil Kumar N, Gurusubramanian G, Panigrahi AK: Brevibacillus 
as a biological tool: a short review. Antonie Van Leeuwenhoek 2014, 105(4):623-639. 
43. Zhen S, Kaiqi L, Changxu L, Jian Y, Ruicheng J, Xunli L: Isolation and characterization of a potential 













44. Tian B, Li N, Lian L, Liu J, Yang J, Zhang KQ: Cloning, expression and deletion of the cuticle-degrading 
protease BLG4 from nematophagous bacterium Brevibacillus laterosporus G4. Arch Microbiol 2006, 
186(4):297-305. 
45. Sanders ME, Morelli L, Tompkins TJCrifs, safety f: Sporeformers as human probiotics: Bacillus, 
Sporolactobacillus, and Brevibacillus. Compr Rev Food Sci Food Saf 2003, 2(3):101-110. 
46. Lam H, Oh D-C, Cava F, Takacs CN, Clardy J, de Pedro MA, Waldor MK: D-amino acids govern 
stationary phase cell wall remodeling in bacteria. Science 2009, 325(5947):1552-1555. 
47. Kuru E, Tekkam S, Hall E, Brun YV, Van Nieuwenhze MS: Synthesis of fluorescent D-amino acids 
and their use for probing peptidoglycan synthesis and bacterial growth in situ. Nat Protoc 2015, 
10(1):33. 
48. Cochrane SA, Findlay B, Bakhtiary A, Acedo JZ, Rodriguez-Lopez EM, Mercier P, Vederas JC: 
Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II. Proc Natl Acad Sci 

















Figure S1. HPLC chromatogram of bioactive compounds extracted from B. laterosporus MG64. The two peaks 
showed the most potent activity toward X. campestris pv. campestris were labeled as A and B, respectively.  
 
 
Figure S2. LC-MS analysis of the two bioactive compounds isolated from B. laterosporus MG64. The ions at 
m/z (z = 1) 1549.82 and 1563.83 represent the singly protonated [M + H]+ of relacidine A-B, respectively. Their 
















Figure S3. Fragmentation of relacidines by tandem MS to generate b and y ions. b ions are indicated in blue 














Table S1. Chemical shift (ppm) assignments of relacidine B (d6-DMSO).  
Amino acid Position δ 13C NMR δ 1H NMR Amino acid Position δ 13C NMR δ 1H NMR 
Ser1 1-NH 
 




1 54.6 4.29 
 
28 52.9 4.68 
 
2 61.4 3.50 
 





30 123.8 7.11 
 






4 35.9 2.81 / 2.64 
 
32 111.0 7.31 
 
5 129.8 6.88 
 
33 120.6 7.04 
 
6 114.6 6.56 
 





35 118.2 7.57 
 




8 27.1 3.14 / 2.93 
 
36 53.2 4.64 
 
9 123.6 7.14 
 






38 14.1 0.98 
 




12 120.6 7.04 
 
39 56.5 4.15 
 
13 118.0 6.96 
 
40 35.4 1.64 
 
14 118.2 7.57 
 





42 10.5 0.86 
 
15 51.5 4.32 
 
43 14.8 0.85 
 




17 24.4 1.51 
 
44 43.5 3.90 / 3.35 
 







45 56.3 4.10 
 
19 51.6 4.34 
 
46 60.4 3.80 / 3.68 
 




21 24.4 1.50 
 
47 48.0 4.39 
 
22 38.6 2.69 
 
48 16.9 1.41 
Gly6 23-NH 
 
8.32 FA F-1 32.6 2.11 
 
23 41.7 3.77 / 3.72 
 





F-3 33.3 1.26 
 
24 51.5 4.32 
 
F-4 28.4 1.28 / 1.09 
 
25 29.2 1.42 / 1.29 
 
F-5 10.9 0.81 
 
26 24.4 1.27 
 
F-6 18.6 0.81 
 
27 overlap 2.51 




















































































































1HNMR of relacidine B (d6-DMSO) 
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.0































































































































Figure S4. The effects of peptides on HADA incorporation during cell wall biosynthesis. DMSO was used as a 
negative control and ceftriaxone (4 µg/mL) was used as a positive control. X. campestris pv. campestris cells 
were treated with compounds (up to 5 h for DMSO and relacidine B and 30 min for ceftriaxone) and pulsed with 
HADA for 30 min. The white bar represents 5 µm. The signal indicates the incorporation of HADA, which is 




Figure S5. Lipid II was mixed with compounds at different ratios before spotting onto the plate, which contains 
the indicator strain X. campestris pv. campestris. Nisin was used as a negative control. D or L in the bracket 
means a Gram-negative or Gram-positive type of lipid II was used. The plate was incubated at 28 °C overnight 














Figure S6. RNA biosynthesis of X. campestris pv. campestris after treating with compounds. [53H] uridine was 
used as a precursor for RNA biosynthesis. Radioactivity was recorded by liquid scintillation counting. DMSO is 
a negative control while rifampicin is a positive control. Both rifampicin and relacidine B were added at a final 
concentration of 2×MIC. Two replicates were used for each treatment and the mean values are shown. 
 
 
Table S2. MICs relacidine B against E. coli MG1655 wild type strain and its atp knock out mutants. 
Strain  MIC (µg/mL) Strain  MIC (µg/mL) 
E. coli MG1655 (WT) 0.5 ΔatpE 1.0 
ΔatpA 0.5 ΔatpF 1.0 
ΔatpB 0.5 ΔatpG 1.0 
ΔatpC 1.0 ΔatpH 0.5 
ΔatpD 1.0 ΔatpI 1.0 
 















Figure S7. Schematic presentation of the effect of relacidine B on the oxidative phosphorylation of cells. 
Complex I, NADH dehydrogenase; complex II, succinate dehydrogenase; complex III, cytochrome c reductase; 
complex IV, cytochrome c oxidase; Q, quinone. The electron transport chain is indicated by a green curve. The 
change of NADH and ATP concentration after treatment with relacidine B are indicated with yellow arrows (up, 
increase; down, decrease).  
 
 
Figure S8. BGCs harbored by biocontrol strains of B. laterosporus that show high similarity to the relacidines 





























































































































































Figure S9. Structure comparison of relacidines, brevicidine, and laterocidine. The parts of brevicidine and 
laterocidine that are different from relacidines were indicated in red. The thirteenth amino acid residues in 















Figure S10. Structure comparison of relacidines, polymyxins, gramicidin S, and tyrocidines. The positive-
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Nonribosomal peptides (NRPs) form a class of secondary metabolites that are of paramount 
importance in different applications including biocontrol and pharmacy. In this study, we characterize 
four novel bogorol variants (bogorol I-L) and four succilins (succilin I-L, containing a succinyl group 
that is attached to the Orn3/Lys3 in bogorol I-L) from the biocontrol strain B. laterosporus MG64. We 
show that these peptides employ an adenylation pathway for lipoinitiation, which is different from 
the usual pattern of lipopeptides. Moreover, the formation of valinol was proven to be mediated by 
a terminal reductase domain and a reductase encoded by the gene bogI. Furthermore, succinylation, 
which is a novel type of modification in NRPs, was discovered. We show that bogorols combat both 
Gram-positive and Gram-negative bacteria by forming pores in the cell membranes. Our study 
provides a comprehensive understanding of bogorols and succilins and extends the knowledge of 
the biosynthetic machinery of lipopeptides. 
Keywords 
Bogorol variants, succilins, Brevibacillus laterosporus, biosynthesis, lipoinitiation, reduction, 























Nonribosomal peptides (NRPs) are a class of secondary metabolites synthesized by megaenzymes 
named nonribosomal peptide synthetases (NRPSs). NRPs display diverse properties, some of 
which can help the producer to survive in natural environments. Surfactins and viscosins are 
essential for the motility of Bacillus subtilis and Pseudomonas putida, respectively [1-4]. Massetolide 
A and rhamnolipid are involved in biofilm formation of different Pseudomonas species [5-7]. 
Bacillibactin and petrobactin are siderophores that can chelate iron and making it available for 
Bacillus species [8, 9]. Many NRPs display antimicrobial activity against a broad range of 
microorganisms, including bacteria, fungi, oomycetes, viruses, etc. Because of this important 
property, some NRPs such as surfactins and iturins are used as biocontrol agents to defend against 
plant diseases [10], while others such as daptomycin and polymyxin are used as antibiotics to treat 
animal and human diseases caused by pathogenic bacteria [11, 12].  
Brevibacillus is a genus belonging to the Firmicutes, one of the phyla with a great abundance of 
NRPS enzymes [13]. Brevibacillus spp. form a rich source of NRPs, which has been known for many 
decades. Tyrocidine and Gramicidin S, two cyclic lipopeptides with potent antibacterial activity, were 
discovered from Brevibacillus brevis in the 1940s [14, 15]. A class of linear cationic lipopeptides 
including bogorols, BT peptide, BL-A60, and brevibacillins, was discovered from Brevibacillus 
laterosporus in the past two decades [16-20]. Brevicidine, laterocidine, and relacidines, a class of 
cationic lipopeptides that selectively combat Gram-negative bacteria, were characterized from B. 
laterosporus in the past two years [21]. Even so, we believe that the biosynthetic potential of 
Brevibacillus spp., especially B. laterosporus, has been underestimated. On the one hand, the 
genome mining of B. laterosporus MG64, a plant growth-promoting rhizobacterium from perennial 
ryegrass, revealed that around 80% of the biosynthetic gene clusters (BGCs) has not been assigned 
to known products yet [22]. On the other hand, some structurally similar NRPs produced by 
Brevibacillus spp. were overlooked [23]. For example, bogorols, BT peptide, and brevibacillins share 
similar structures but have different amino acid residues in the second, fourth, fifth or ninth positions. 
A minor difference of the amino acid residues has been shown to affect the biological properties of 
the bogorols: a replacement of isoleucine by valine at the fourth position decreases the antibacterial 
activity severely [17]. Therefore, more attention should be paid to the characterization of the rich 
variety of NRPs from Brevibacillus spp. 
In this study, we aimed to identify and characterize novel NRPs produced by the biocontrol strain B. 
laterosporus MG64, which showed very good activity against a variety of pathogens, including plant 
pathogens and mammalian pathogens [22]. Furthermore, we investigate the biosynthesis and the 





















Purification and characterization of bioactive peptides from B. laterosporus MG64 
We previously isolated a biocontrol strain B. laterosporus MG64 that can inhibit a wide range of plant 
pathogens and mammalian pathogens [22]. To identify and characterize the bioactive compounds, 
B. laterosporus MG64 was inoculated in LB broth for 24 h and the supernatant was used to extract 
the metabolites with a column filled with C18 silica gel. The crude extract was further purified with 
HPLC and the different peaks that were collected were screened for bioactivity against X. campestris 
pv. campestris, a Gram-negative pathogen that causes bacterial wilt in perennial ryegrass, and 
Bacillus cereus, a Gram-positive bacterium that causes food spoilage. The major peaks (labeled 
peak 1-3 in Figure S1) showed bioactivity against both strains and were selected for further 
characterization.  
Four different compounds were characterized by LC-MS/MS (Figure S2). Compounds 1 and 2 have 
the same mass of 1555.06 Da (m/z 778.53 [M+2H]2+). The clear signals of y and b ions indicated 
the presence of Val (5), Orn (1), Ile (1), Lys (2), Tyr (1) (Figure S2a). The difference between 
compounds 1 and 2 are the amino acid residues at positions 4 and 5, where compound 1 has Ile4-
Val5 and compound 2 has these inverted. The total mass and the amino acid composition of both 
compounds are similar to bogorols, which form a class of linear peptides that are constituted with a 
fatty acid tail (2-hydroxy-3-methylvaleric acid) and 13 amino acid residues (including a valinol at the 
last position) [16, 17]. The bogorol biosynthetic gene cluster identified from antiSMASH also 
supports this hypothesis (Figure 1a). With the reference of bogorol, we successfully identified the 
components at both termini, namely C6H11O2-Dhb for N-terminus (b2 = 198.11, Figure S2a) and 
Leu-Valinol for C-terminus (y2 = 217.19, Figure S2a). However, Leu9 in the reported bogorols is 
replaced by Val9 in compounds 1 and 2. Therefore, we propose them to be novel variants of bogorol. 
Similarly, compounds 3 (m/z 785.54 [M+2H]2+) and 4 (m/z 792.54 [M+2H]2+) were identified to be 
novel variants of bogorol as well. Compared to compounds 1 and 2, compound 3 has a 14-Da 
increase in mass, which is a result of two consecutive Ile residues at positions 4 and 5 (Figure S2b). 
Compound 4 has Lys instead of Orn at position 3, which is the only difference from compound 3 
(Figure S2c). Compounds 1-4 were therefore nominated as bogorol I-L, respectively (Figure 1b).  
The structures of bogorol K and bogorol L were further confirmed with 1H NMR, 1H-1H TOCSY NMR, 
and 1H-1H NOESY NMR (Figure S3). Their chemical shift (ppm) assignment (partial) are shown in 
Table S1 and Table S2, respectively. A Marfey-type analysis [24] was also conducted to detect the 
configuration of amino acids in bogorol K and bogorol L. Both compounds have an L-configuration 





















The Orn in position 3 of bogorol K is in D-configuration, which suggests the Lys in bogorol L should 
also be a D-configuration. The other two Lys residues in positions 7 and 10 of both compounds 
displayed either D- or L-configuration, which could not be distinguished from each another. This 
result is consistent with the prediction from antiSMASH, where epimerization domains were 
predicted at the 3rd, 7th, and 11th modules (Figure 1a). 
Fortuiously, we found another group of peptides (5-8) that have masses of 1655.10 (5 and 6), 
1669.11 (7), and 1683.10 Da (8), which is 100 Da more than those of  bogorol I-L, respectively. They 
are eluted from HPLC in the same order as bogorol I-L, but with a longer elution time (Figure S1, 
peak 4-6). Further analysis in tandem MS data revealed that these peptides are likely products of a 
succinyl group attached to the Orn3 or Lys3 of bogorol I-L with a peptide bond (Figure 1b, Figure S4). 
In the NMR analysis, the succinylation at Orn3 in peptide 7 was supported by the appearance of 2 
methylene signals at 2.28 and 2.36 ppm which shared a strong correlation in the 1H-1H TOCSY 
NMR (Figure 1c, Figure S5). Both signals showed NOESY cross-peaks with an amide N-H signal at 
7.79 ppm, which in turn showed a correlation with the signal of the δ-CH2 of Orn3 at 2.98 ppm in 
both TOCSY and NOESY NMR (Figure 1c, Figure S6 and S7). The downfield shift of this δ-H from 
2.76 (in bogorol K) to 2.98 ppm is consistent with the acetylation of the Orn3 amine resulting in a 
more electron-withdrawing amide (Table S4). This result confirms the attachment of a succinyl group 
at the end of the side chain of the Orn3. Therefore, we nominate compounds 5-8 as succilin I-L, 






















Figure 1. Bogorols and succilins produced by B. laterosporus MG64. (a) Gene cluster of bogorols 
harbored by B. laterosporus MG64. Green, core biosynthetic gene; blue, transport-related gene; gray, unknown 
gene; red, additional biosynthetic gene. (b) structures of bogorols and succilins characterized by LC-MS/MS 
and NMR. (c) 2D NMR correlations (red: 1H-1H-TOCSY, blue: 1H-1H-NOESY) confirming succinylation at the 

























The bogorol family of peptides contain a fatty acid tail at the N terminus, which is a representative 
characteristic of lipopeptides. The lipid tails of lipopeptides are usually incorporated into the peptides 
through a starter condensation (C) domain [25]. However, such a domain was not found in the gene 
cluster of bogorols (Figure 1a), suggesting a potentially novel lipidation of bogorols. Inspection on 
the biosynthetic modules reveals an additional module that is encoded by the gene bogJ. The 
knockout mutant of bogJ in B. laterosporus LMG15441, a transformable bogorol-producer, impaired 
the production of bogorols completely (Figure 2a, Figure S8), suggesting that gene bogJ is essential 
for the biosynthesis of bogorols. To investigate the potential substrate activation by this module, a 
phylogenetic tree involving the 14th adenylation (A) domain and the other A domains from the 
bogorol gene cluster, as well as other A domains that are known to activate alpha-hydroxy acid, was 
constructed. The result revealed that A14 is phylogenetically far away from other A domains in the 
bogorol gene cluster. Instead, it was clustered together with A domains that activate alpha-hydroxy 
acid (Figure 2b). Further inspection revealed that such A domains are normally followed by a 
ketoreductase (KR) domain. They form a special module together with a peptidyl carrier protein 
(PCP) domain. A similar module was found in another gene cluster from B. laterosporus MG64 
(Figure S9a). This gene cluster was identified to be auriprocine, a lipopeptide originally identified 
from B. laterosporus PE36 (Figure S9a) [26]. Interestingly, the fatty acid tail of auriporcine, which is 
incorporated by the A-KR-PCP module, is the same as that of bogorols (Figure S9b). All these 
results suggest that the lipoinitiation of bogorols is mediated by the module encoded by bogJ. This 
lipoinitiation is different from the usual pattern employed by most of the NRPs, in which the fatty acid 
is activated by ligating to a coenzyme A in the presence of a fatty acid coenzyme ligase and the 
activated fatty acid is then incorporated into the assembly line by a starter C domain (Figure 2c) [25]. 
In the case of bogorols, a 3-methyl-2oxopentanoic acid was first activated by the A domain, which 
usually activates amino acid residues. After activation, the α-keto acid was reduced into 2-hydroxy-
3-methylvaleric acid by the KR domain and entered the next module under the guidance of a 






















Figure 2. Adenylation domain-mediated lipoinitiation of bogorol peptides. (a) Production of bogorols by 
the wild type and ΔbogJ mutant of B. laterosporus LMG15441. Strains were grown in MEM broth for 48 h and 
extracted with a C-18 column filled with silica gel. The extracted products were subsequently subjected to HPLC. 
(b) A phylogenetic tree of A domains from  the bogorol gene cluster harbored by B. laterosporus MG64 and 
reference A domains that incorporate hydroxy acid. Auripocine is retrieved from B. laterosporus PE36 while 
cereulide and valinomycin are retrieved from the miBIG database. The A domains activating alpha-hydroxy 
acids are indicated in red. (c) The usual pattern of fatty acid incorporation in NRPs. CoA: coenzyme A, FACL: 
fatty acid coenzyme ligase; (d) The pattern of bogorols incorporating fatty acid.  
 
The formation of valinol is mediated by two reductases 
An outstanding characteristic of bogorol family peptides is the presence of a valinol (an alcohol form 
of valine) at the C-terminus. Its formation is mediated by two possible mechanisms: 1) valinol is 
incorporated by the corresponding module; 2) valine is incorporated and then reduced into a valinol. 
The first mechanism was considered more straightforward and energy-saving. However, analysis of 
adenylation (A) domains indicates that A13 shows very high similarity to other A domains that 
incorporate valine (Figure 2b). Therefore, the second mechanism is more likely to be employed. 
Investigation of the gene cluster led us to the discovery of two reductases: terminal reductase 
domain (TD) in BogF, and an aldo/keto reductase BogI. TD is responsible for the release of the 
peptide chain from the PCP domain in a reduction pathway [28] while the function of BogI was 
unknown. To investigate the latter, the gene bogI in B. laterosporus LMG15441 was knocked out, 
resulting in the formation of a new group of compounds. These new peptides have masses that are 
2 Da less than those of the wild type (Figure 3a and 3b, Figure S10). This mass reduction 





















valine was first reduced to the aldehyde form when released by the TD domain, then further reduced 
to the alcohol form by BogI (Figure 3c). A comparison of the antibacterial activity of bogorols in the 
two different forms revealed that the alcohol form has a better activity, underlining the importance 
of the reduction for biological activity (Figure 3d). 
 
Figure 3. The formation of valinol in bogorol peptides. Bogorols and their intermediates (aldehyde form) 
produced by wild type strain (a) and ΔbogI mutant (b) of B. laterosporus LMG15441, respectively. The masses 
(Da, based on MALDI-TOF analysis) of the three major compounds produced by each strain are indicated. (c) 
The two-step formation of alcohol form amino acids in bogorol family peptides. (d) Spot on lawn assay of 
aldehyde form and alcohol form bogorols. X. campestris pv. campestris NCCB92058 was used as an indicator. 
Each compound was added at the same amount, namely 10 µL of a 200 µg/mL stock.  
Succinylation occurring in lipopeptides 
In this study,  a novel class of peptides with an additional succinyl group attached to the Orn3/Lys3 
residue of bogorols were identified as succilins. This modification is not observed in B. laterosporus 
LMG15441 (Figure S11), suggesting that succilins are not not always formed when borogols are 
produced. A comparison of the flanking genes of the bogorol BGC reveals some specific genes in 
each strain (Figure S12a). However, the annotation of these genes did not result in a potential 
candidate, which was expected to be a transferase based on the similar modification, mannosylation, 
of ramoplanin [29, 30]. Further investigation of the gene cluster revealed two transferases, bogN 
and bogR, which are present in both strains (Figure S12a). However, the expression of bogN and 
bogR from B. laterosporus MG64 in B. laterosporus LMG15441 did not result in the productin of 
succilins, suggesting they are not responsible for succinylation (Figure S12b, Figure S12c). 
Interestingly, we found that bogorols were detected from B. laterosporus MG64 after 14-h incubation 
in our experiment, whereas succilins were only detected with MALDI-TOF after 16 h and with HPLC 




















concentration, and is likely mediated by enzymes. However, the responsible gene is still unclear and 
further research using transcriptomics and/or heterologous expression is needed. 
 
Figure 4. The production of bogorols and succilins by B. laterosporus MG64 at different time points. 
Fresh cells (10 µL culture with an OD600 of 1.0) were inoculated in 50 mL MEM broth and grown at 28℃ for 
14 h, 16 h, 18 h, 20h, respectively. The compounds were extracted from the supernatant at each time point 
and analyzed with HPLC and MALDI-TOF. 
 
Antibacterial activity and mechanism of action 
To investigate the potential of the newly identified bogorols and succilins for different applications, 
the antibacterial activity of bogorol K, bogorol L, and succilin K was assessed using plant pathogens 
(Xanthomonas species, Pseudomonas species, Pectobacterium carotovorum, and Ralstonia 
syzygii), a food pathogen (Bacillus cereus), and human pathogens (P. aeruginosa, Klebsiella 
pneunomiae, Escherichia coli, and Staphylococcus aureus) as indicators. As shown in Table 1, 
bogorol K and bogorol L displayed potent activity against the Gram-positive pathogens tested (MIC 
values range from 1 to 4 µg/mL). Bogorol K an L were also active against various Gram-negative 
pathogens, except for the human pathogen P. aeruginosa and plant pathogen P. carotovrum and R. 
syzygii, which are not inhibited by both compounds until their concentrations reach 32 µg/mL. Their 
antibacterial potency is similar to that of brevibacillin, a structurally similar lipopeptide. Succilin K, 
which is derived from bogorol K by succinylation at Orn3, only showed weak activity against 
Xanthomonas spp. and the Gram-positive pathogens tested, and the MIC values are at least 4 times 






















Table 1 MIC values of the identified compounds against different bacteria. 
Pathogen 
 MIC (µg/mL)  
Bogorol K (3) Bogorol L (4) Succilin K (7) Brevibacillin 
Xanthomonas campestris pv. 
campestris NCCB92058 
4 2 32 2 
Xanthomonas translucens pv. 
graminis LMG587 
8 4 16 2 
Pseudomonas syringae pv. antirrhin 
LMG2131 
16 8 >32 8 
Pseudomonas syringae pv. tomato 
DC3000 
16 8 >32 16 
Pseudomonas aeruginosa PAO1 32 32 >32 32 
Klebsiella pneunomiae LMG20218 16 32 >32 16 
Escherichia. coli ET8 8 8 >32 8 
E. coli MG1665 16 16 >32 16 
Pectobacterium carotovorum 
LMG5863 
>32 >32 >32 ND 
Ralstonia syzygii subsp. syzygii 
LMG6969 
>32 32 >32 ND 
Staphylococcus aureus subsp. aureus 
533 R4 
2 2 16 1-2 
Bacillus cereus ATCC 14579 2 2 32 2 
Enterococcus faecium LMG16003 4 2 16 1-2 
ND: not determined. 
 
The Gram-positive human pathogen S. aureus subsp. aureus 533 R4 and the Gram-negative plant 
pathogen X. campestris pv. campestris NCCB92058 were used to investigate the mode of action of 
bogorol K. As shown in Figure 5a, bogorol K inhibited the growth of Staphylococcus within 15 min, 
which is comparable to the positive control nisin. The addition of lipoteichoic acid (LTA), an important 
constituent of the cell wall of gram-positive bacteria, did not affect the activity of bogorol K against 
Staphylococcus, suggesting that bogorol K does not bind to LTA, in contrast to nisin (Figure 5a). 
Moreover, the addition of lipid II originating from Gram-positive bacteria did not decrease the 
inhibition zone of bogorol K towards Staphylococcus (Figure S14a), suggesting that bogorol K does 
not bind to Gram-positive type lipid II. However, the membrane permeability assay showed that 
bogorol K forms pores in the cell membrane of Staphylococcus, similar to the positive control nisin 
(Figure 5b). Bogorol K inhibited the growth of the Gram-negative bacterium X. campestris within 15 
min and showed a weaker binding to the lipopolysaccharide (LPS) compared to polymyxin B (Figure 




















permeability assays revealed that bogorol K disrupts the cellular membrane of X. campestris as it 
does to that of Gram-positive bacteria (Figure 5d). Collectively, the results show that bogorol K 
employs the same mechanism for killing Gram-negative as for Gram-positive bacteria by forming 
holes in the cellular membrane. 
 
 
Figure 5 Mode of action employed by bogorol family of peptides. (a) Killing curve and LTA binding assay of 
bogorol K on S. aureus. (b) Permeabilization of bogorol K to the cell membrane of S. aureus (c) Killing curve 
and LPS binding assay of bogorol K on X. campestris. (d) Permeabilization of bogorol K to the cell membrane 
of X. campestris. Permeabilization of bogorol K and succilin K to the outer membrane (e) and inner membrane 
(f) of X. campestris, respectively. The permeabilization of the outer membrane is indicated by the staining of 
NPN to the hydrophobic part, while the PI indicates the inner membrane permeabilization. The MIC values of 
bogorol K and succilin K are around 2.5 µM and 20 µM, respectively. Con: control, BogK: bogorol K, PlyB: 
polymyxin B, SucK: succilin K. 
 
We also investigated the cause of the difference in antibacterial activity between bogorol K and 
succilin K using two different dyes, 1-N-phenylnaphthylamine (NPN) and propidium iodide (PI). The 
hydrophobic NPN cannot penetrate the intact outer membrane of Gram-negative bacteria. However, 
once this membrane is damaged, NPN will bind to the phospholipid layer and become fluorescent. 
PI binds to DNA and emits fluorescence only when the inner membrane is damaged. Consequently, 
a combination of both dyes can be used to show the difference between bogorol K and succilin K in 





















both the outer membrane and inner membrane of X. campestris when applied above 2.5 mM (Figure 
5e and 5f). In contrast, succilin K barely showed penetration to neither the outer membrane nor the 
inner membrane at the same concentration as bogorol K (Figure 5e and 5f). This result suggests 
the outer membrane is the first barrier to succilins, and that the Orn3 in bogorols plays an important 
role in penetrating the outer membrane.  
Synergistic effect of relacidine and bogorol  
Apart from discovering novel antibiotics, combining existing antibiotics is another strategy to combat 
the increasing number of drug-resistant bacteria [31]. Here we investigated the synergistic effect of 
relacidine, a compound that affects the oxidative phosphorylation in cells (unpublished data), and 
bogorol, a compound that was proven to cause damage to the cell membranes in this study. Both 
compounds are produced by B. laterosporus MG64 but employ different modes of action. A study 
of their synergistic effect could lead to a better understanding of the antibacterial mechanism of B. 
laterosporus MG64 as well as its potential in different applications. As shown in Table 2, relacidine 
B and bogorol K displayed a synergistic effect on all the pathogens tested, including Gram-negative 
plant pathogen X. campestris, P. syringae pv. antirrhin, P. syringae pv. tomato and Gram-positive 
human pathogen S. aureus subsp. aureus. This result suggests that B. laterosporus MG64 may 
employ a combination of compounds to combat other bacteria, thus making it better capable of 
occupying desirable niches in the natural environment. 
 
Tabel 2 Synergistic effect of relacidine B and bogorol K 
Pathogen MICa MICb MICab MICba FICI 
Xanthomonas campestris pv. campestris 
NCCB92058 
4 0.5 0.5 0.125 0.375 
Pseudomonas syringae pv. antirrhin 
LMG2131 
16 0.5 2 0.0625 0.25 
Pseudomonas syringae pv. tomato 
DC3000 
16 0.5 2 0.0312 0.1875 
Staphylococcus aureus subsp. aureus 
533 R4 
2 64* 0.5 2 0.2812 
 
Note: The unit of MIC values is µg/mL.  MICa, MIC value of bogorol K alone; MICab, MIC value of bogorol K 
when relacidine B is present; MICb, MIC value of relacidine B alone; MICba, MIC value of relacidine B when 
bogorol K is present; FICI value below 0.5 indicate a synergistic effect of the two peptides. 























In this study, we characterized four novel bogorol variants (bogorol I-L) from the biocontrol strain B. 
laterosporus MG64. The bogorol variants show at least one amino acid residue in differences to the 
structurally similar peptides (Table S5) [16-20]. Leu9 in bogorol B is replaced by Val9 in bogorol I, 
while Leu2 in brevibacillin is replaced by Val2 in bogorol K. Bogorol J has different amino acids at 
positions 5 and 9 compared to bogorol C, while bogorol L is different at positions 2 and 3 compared 
to brevibacillin. Nevertheless, the newly characterized peptides share many characteristic features 
with the reported ones. First of all, they are linear lipopeptides containing three positively charged 
amino acid residues (Orn or Lys), which contribute to the hydrophilicity of the peptides. Moreover, 
the bogorol family peptides have highly conserved fragments, and residues at position 1, positions 
6-8, and positions 10-13 show no difference between variants. Moreover, the C-terminus of all the 
peptides contain a valinol, the alcohol form of valine.  
We also characterized four novel succilins (succilin I-L) from the same strain, B. laterosporus MG64. 
Succilins are similar to bogorols, except that an additional succinyl group was attached to the side 
chain of Orn3/Lys3. This modification alters the chemical properties of succilins. First of all, the 
masses of succilins are 100-Da larger than their corresponding bogorols. Moreover, the polarity of 
the peptides is decreased. As a result, they are eluted later than bogorols (Figure S1) and have a 
lower solubility in water (data not shown). Besides, succilins only retain one positive charge, 
compared to the three in bogorols. These changes, especially the polarity and charges, result in a 
negative effect on the bioactivity of peptides (Table 1). This is considered reasonable because i) the 
phospholipid of the cell membrane in bacteria is negatively charged and has an electrostatic 
attraction to the cationic peptides [32]. A decrease of charges, therefore, causes a weaker 
penetration to the membrane (Figure 5e and 5f). ii) the amphipathic property of peptides is important 
for bioactivity. Too high or too low hydrophobicity could dramatically decrease antimicrobial activity 
[33]. To the best of our knowledge, this is the first report on succinylation of NRPs. Similar modified 
peptides were not detected in B. laterosporus LMG15441 (Figure S11), which also produce bogorols. 
The biological function of succilins remains unknown, but a higher production of succilins on agar 
plates using bogorols as a reference (Figure S15) suggests that they are possibly involved in motility 
or biofilm formation, which needs further investigation. 
Although several variants of bogorol have been reported [16-20], their biosynthesis was unclear to 
date. In this study, we successfully unraveled the biosynthesis process of bogorols and succilins 
with both in silico analysis and experimental methods (Figure S16). We reveal that the lipoinitiation 
of bogorols does not follow the usual pattern observed in other lipopeptides, which is mediated by 





















by a special module A-KR-PCP. Such modules are reported to incorporate α-keto acids and are 
normally found in depsipeptide, a group of compounds containing both hydroxy acid residues and 
amino acid residues [27]. Modules that incorporate α-keto acid are found in natural products 
including cereulide [34, 35], valinomycin [36, 37], cryptophycin [38], kutzneride [39], and hectochlorin 
[40]. However, these modules were located in between other modules that incorporate amino acids, 
which suggests that they are not responsible for lipoinitiation. In contrast, such modules in bogorols 
are encoded by an independent gene bogJ. A C domain following the A-KR-PCP module and a TD 
domain at the end of the last module encoded by bogEF suggests that bogJ is responsible for the 
lipoinitiation (Figure S16). To the best of our knowledge, only bogorols and auriprocine employ such 
a novel lipoinitiation pathway. This expands our knowledge of lipoinitiation in natural products and 
provides a possible pathway for the engineering of lipid tail in NRPs. 
We also reveal the pathway leading to the formation of valinol in bogorols. The aldehyde form of 
bogorols is released from the PCP domain by the TD and further reduced to the alcohol form by a 
reductase encoded by gene bogI (Figure S16). A similar process in gramicidin A was reported to 
happen in the presence of a TD, the aldoreductase LgrE, and the electron donor NADPH in vitro 
[41]. A similar reduction in myxochelin A was reported to be mediated by the TD alone [42], which 
is different from the two-step process found in bogorols and gramicidin A. A previous study on BT 
peptides revealed that the valinol at the C-terminus confers the peptides with protease resistance 
[20]. Our results also reveal that the aldehyde form of bogorols is less active to pathogens than the 
alcohol form. Therefore, the formation of valinol is of vital importance for the biological activity of 
these peptides. 
Succinylation is commonly found in proteins of diverse organisms including bacteria, yeasts, and 
animals [43, 44]. Studies have shown that succinylation is possibly relevant to numerous human 
diseases associated with mitochondria [45]. However, the reports on the succinylation of secondary 
metabolites is highly uncommon. The only report is on the ribosomal peptides subtilin and entianin, 
which are produced by Bacillus subtilis [46]. The succinylation of subtilin and entianin occurs at a 
tryptophan residue at position 1 and is affected by the concentration of glucose in the growth medium 
as well as the transition state regulator AbrB [46]. In this study, we report the first succinylation 
occurring in NRPs. Compared to other modifications such as halogenation, glycosylation, sulfation, 
etc., in NRPs [47], succinylation makes a more profound difference in the chemical properties of 
peptides and its occurrence likely demands a high concentration of substrate (Figure 4). The 
mechanism of succinylation in succilins remained unknown and further research will be directed to 




















The bogorol family of peptides was initially reported to have potent bioactivity against Gram-positive 
bacteria and weak bioactivity towards Gram-negative bacteria [16-19]. However, we show that 
bogorol K and bogorol L also have potent activity to Gram-negative bacteria, especially 
Xanthomonas species. We also show that bogorol K targets the cell membrane of both Gram-
positive and Gram-negative bacteria. This result is similar to the study on the mode of action of 
brevibacillin on Gram-positive bacteria [48]. The membrane-targeting mechanism makes bogorol a 
promising candidate for studies on the synergistic effect of antimicrobials. Bogorols damage the cell 
membranes and remove the barrier to other compounds that target intracellular components. This 
is supported by the synergistic effect of bogorols and relacidines (Table 2), a class of compounds 
affecting the oxidative phosphorylation of cells (data unpublished). Further research will be directed 
to further evaluate its potential in different applications.  
Material and methods 
Extraction and purification of antimicrobial compounds from B. laterosporus MG64 
A fresh colony of B. laterosporus MG64 was inoculated in 3 ml Lennox broth (LB) and incubated at 
28 ˚C overnight with shaking. The overnight culture was then diluted with fresh LB to an OD600 of 
1.0 as inoculum. One milliliter of inoculum was inoculated into 100 ml of fresh LB broth and incubated 
at 28 ˚C with shaking of 220 rpm for 24 h. After centrifugation at 10,000 × g for 10 min, the 
supernatant was collected and applied to a column filled with 10 g C18 silica gel (Sigma-Aldrich, 
97727-U). After washing with 20 ml of 20 % acetonitrile with 0.1% trifluoroacetic acid (TFA), the 
crude extract was eluted with 20 ml 95% acetonitrile with 0.1% TFA. The crude extract was 
lyophilized and re-dissolved in Milli-Q water. After filtering with a 0.45 µm cellulose acetate 
membrane, an aliquot of crude extract was applied to high-performance liquid chromatography 
(HPLC) equipped with an analytical C-18 column (3.6 µm particles, 250 × 4.6 mm, Phenomenex) 
for purification. A linear gradient of water with 0.1% TFA (solvent A) and acetonitrile with 0.1% TFA 
(solvent B) was used to separate compounds. In each run, solvent B was linearly increased from 
15% to 60% within 45 min at a flow rate of 0.5 ml/min. The effluent was monitored with a UV-detector 
at a wavelength of 214 nm. Every single peak was collected and concentrated with lyophilization 
before testing activity against Xanthomonas campestris pv. campestris (Xcc). 
Structure elucidation  
LC-MS/MS. The antimicrobial compounds were applied to liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) to determine the amino acid sequences. An Ultimate 3000 UHPLC 
system equipped with a Kinetex WVO-C18 (2.6 µm particles, 100 × 2.1 mm) column (Phenomenex) 





















USA) equipped with a HESI-II electrospray source was coupled to the UHPLC system. Each sample 
(10 µL) was injected into LC and separated with water (with 0.1% formic acid) and acetonitrile (with 
0.1% formic acid) at a flow rate of 500 µl min−1. A spray voltage of 3.5 kV (positive mode) and a 
capillary temperature of 275 ˚C were used. The samples were measured in positive mode from m/z 
300 to 2000 at a resolution of 70,000. MS/MS data were recorded either in DDA-top10 setup or 
targeted MSMS using PRM mode at a resolution of 17500.  
NMR. Prior to NMR analysis, the peptides were purified by RP-HPLC as described above and the 
pure fractions were pooled and lyophilized. The peptides were obtained as white solids (0.5 - 1 mg) 
and were dissolved in 0.5 mL DMSO-d6. 1H NMR, 1H-1H-TOCSY NMR, and 1H-1H-NOESY NMR 
spectra were recorded on a Brüker Ascend 600 MHz spectrometer. Chemical shifts in 1H NMR 
spectra were internally referenced to solvent signals (DMSO-d6 at δH = 2.50 ppm).  
Genome editing with the CRISPR-Cas9 system 
To knock out the bogI or bogJ genes in B. laterosporus LMG15441, vector pJOE8999 harboring the 
clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) system was 
employed [49]. Single-guided RNA (sgRNA) fragments were ligated into Eco31I sites of pJOE8999 
after annealing. Short fragments located up-stream and down-stream of the sgRNA were PCR 
amplified with the primers listed in Table S6. The template for homologous repair was achieved with 
overlap PCR of the up-stream and down-stream fragments and ligated into the SfiI sites of the 
pJOE8999 to make the final construct.  
To prepare competent cells, a single colony of B. laterosporus LMG15441 was inoculated in LBS 
medium (LB medium with 0.5 M sorbitol) and incubated at 37 ˚C with shaking (220 rpm) overnight. 
The overnight culture was diluted 100 times into fresh LBS medium and grown until OD600 reached 
0.8-0.9. Cells (100 mL) were cooled on ice for 5 min and centrifuged at 5,000 g at 4 ˚C for 5 min to 
collect the cells. The pellet was washed four times with electroporation buffer (0.5 M sorbitol, 0.5 M 
mannitol, and 10% glycerol) and finally resuspended in the same buffer. One microgram of the 
reconstructed vector was mixed with 100 µl competent cells in an electroporation cuvette (1 mm) 
and shock with 2.0 kV voltage, 25 µF capacitance, 200 Ω resistance. One milliliter of recovery 
medium (LM medium with 0.5 M sorbitol and 0.38 M mannitol) was added immediately and the cells 
were incubated at 28 ˚C with 150 rpm shaking for 3-5 h. The cells were plated on LB plates with 30 
µg/ml kanamycin and 0.2% mannose for inducing the expression of Cas9 protein. The plate was 
incubated at 28 ˚C for 24 h and colonies were checked with colony PCR. 




















The mutants and wild type strain of B. laterosporus LMG15441 were grown in MEM broth at 28 ℃ 
overnight (16 h). The overnight culture was diluted with MEM broth to an OD600 of 1.0. Each 20 µL 
diluted culture was inoculated in 50 mL MEM broth and the cells were incubated at 28 ˚C for 48 h. 
The supernatant was collected by centrifuging at 10,000 g for 2 min. The compounds were extracted 
as described above and dissolved in Milli-Q water before filtering through a 0.45 µm cellulose 
membrane. The bogorol peptides were purified with HPLC as described above and identified with 
matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry. 
Production time of bogorols and succilins 
To investigate the production time of bogorols and succilins, the producer was grown in MEM broth 
overnight. The overnight culture was diluted to an OD600 of 1.0. For each 50 mL MEM broth, 10 µL 
diluted bacterial culture was added. The cells were grown at 28 ℃ for 14 h, 16 h, 18 h, 20h, 
respectively. At each time point, the supernatant was collected and the compounds were extracted 
as described above. The extracts were lyophilized and dissolved in Milli-Q water before applying to 
HPLC and MALDI-TOF for analyzation. 
Antibacterial assays 
The MICs of the peptides were determined with the broth dilution method [50]. MHB medium was 
used for all the indicator bacteria. The concentration of bacteria was adjusted to 5.0 × 105 CFU/mL 
in each well. The compounds (32 µg/mL) were two-fold serial diluted in the 96-well plate. OD600 was 
measured using the Tecan Infinite F200 Pro Luminometer after incubating at 28 ˚C for 36 h and the 
MIC values were defined as the lowest concentration that completely inhibit the growth of indicator 
bacteria.  
Killing dynamics and LPS/LTA binding assay 
Overnight cultures of X. campestris pv. campestris and Staphylococcus aureus subsp. aureus were 
diluted to an OD600 of 0.05 in a 96-well plate and incubated in a microplate spectrophotometer (1000 
rpm, 28 ˚C). When the OD600 reached 0.1, bogorol K (dissolved in DMSO) were added to each well 
at a final concentration of 8 µg/mL (2×MIC) and the same volume of DMSO was used as a negative 
control. Polymyxin B (1 µg/mL) was used as a positive control for X. campestris pv. campestris while 
nisin (2 µg/mL) was used for S. aureus subsp. aureus. Exogenous lipopolysaccharide (LPS, 0.1 
mg/mL) or lipoteichoic acid (LTA, 0.1 mg/mL) was added to investigate the association with peptides. 
The growth curve in the following 3 h was recorded with the same microplate spectrophotometer at 
the same condition and four replicates were used for each treatment. The release of growing 





















Membrane permeability assay 
Membrane integrity of X. campestris pv. campestris and S. aureus subsp. aureus after treatment 
with bogorol was tested with the commercial LIVE/DEAD Baclight Bacterial Viability Kit (Invitrogen). 
Briefly, the overnight culture of each strain was diluted to an OD600 of 0.2. Bogorol K (dissolved in 
DMSO) was added to a concentration of 8 µg/mL (2×MIC) and the same volume of DMSO was 
added to the negative control. Polymyxin B was used as a positive control for X. campestris pv. 
campestris while nisin was used for S. aureus subsp. aureus. After treating at room temperature for 
15 min, cells were harvested (10,000 g for 2 min) and washed with 0.9% saline solution. Cells were 
finally suspended in 200 µl 0.9% saline solution and two different dyes (3.34 mM SYTO9 and 20 
mM propidium iodide) were added at a ratio of 1:1 (v/v). After staining at dark for 15 min, cells were 
mounted on 1% agarose pads and analyzed with a Nikon Ti-E microscope (Japan). 
NPN and PI staining assay 
X. campestris pv. campestris cells were grown in LB broth at 28 ℃ overnight. The overnight culture 
was diluted 100 times with fresh LB broth and grown until OD600 reached 1.0. The cells were 
collected (5,000 g for 3 min) and washed with HEPES buffer twice. The cells were resuspended in 
HEPES buffer and the OD600 was adjusted to 1.0. Both NPN and PI were added to the cells at a 
final concentration of 30 µM. The mixture was distributed to a 96-well plate, which DMSO, bogorol 
K, and succilin K were added before. The concentration range of each compound was 1.25 mM, 2.5 
mM, 5 mM, and 10 mM. The fluorescent signal at 350/420 was recorded every 10 min during a 
period of 1 h and normalized with OD600. Three replicates were used in each treatment. 
Synergy test 
The synergistic effect of bogorol K and relacidine B was tested using a checkerboard method [51]. 
Briefly, the bogorol K was two-fold series diluted in each column while relacidine B was diluted with 
the same method in each row in a 96-well plate. The fresh cells were added to each well at a final 
concentration of 5 × 105 CFU/mL. The plate was incubated at 28 ℃ for 24 h and the OD600 was 
recorded. The fractional inhibitory concentration index (FICI) was calculated using the following 
formula FICI = MICab/MICa + MICba/MICb. MICa and MICb are the MIC values of bogorol K and 
relacidine B alone, respectively. MICab is the MIC value of relacidine B in the presence of relacidine 
B while MICba is the other way around. The FICI value suggests a synergistic (≤ 0.5), addictive (> 
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Figure S1. HPLC chromatogram of compounds extracted from B. laterosporus MG64. Three different peaks 
display potent activity toward X. campestris pv. campestris and B. cereus are labeled as peak 1, 2, and 3, 
respectively. They were identified to be bogorol variants. Peak 4-6 were identified to be succilins. Both peak 1 
and peak 4 were identified to be a combination of two different compounds (compound 1 and 2 for peak 1, 























Figure S2. Fragmentation of bogorol I and J (compound 1 and 2, panel a), bogorol K (compound 3, panel b), 
and bogorol L (compound 4, panel c) by tandem MS to generate b and y ions. The b ions were indicated in 
blue, while the y ions were indicated in red. The different amino acids of bogorol I and bogorol J are indicated 













































Table S1. Partial chemical shift (ppm) assignments of bogorol K (d6-DMSO).  
Residue NH 1Hα 1Hβ Others 
FA  3.79 OH
β1, 5.61; CHβ2, 1.71 CH2γ1, 1.38/1.12; CH3γ2, 0.88; CH3δ1, 0.80 
Dhb-1 9.15  5.93 CH3
γ1, 1.78 
Val-2 7.81 4.24 2.11 CH3γ, 0.87 
Orn-3 8.08 4.42 1.68 CH2γ, 1.55; CH2δ, 2.76; NH2ε, 7.63 
Ile-4 7.85 4.28 1.70 CH2γ1, 1.35/1.02* 
Ile-5 8.00 4.17 1.69 CH2γ1,1.43/1.04 
Val-6 7.81 4.18 1.93  
Lys-7 7.93 4.38 1.63 CH2γ, 1.26; CH2δ, 1.48; CH2ε, 2.70; NH2ζ,7.64 
Val-8 7.86 4.22 1.91  
Val-9 7.88 4.11 1.94  
Lys-10 7.78 4.24 1.43/1.32* CH2γ, 1.05; CH2δ, 1.42; CH2ε, 2.65; NH2ζ, 7.65 
Tyr-11 8.09 4.47 2.84/2.60 CHδ, 6.99; CHε, 6.62 
Leu-12 8.08 4.24 1.38 CH3δ1, 0.82; CH3δ2, 0.76* 
Valinol-13 7.40 3.53 CH2β1, 3.34; CHβ2, 1.80 CH3γ, 0.81 
*Tentative assignment due to overlap, but in accordance with the literature [18]. 
1H NMR of bogorol K (3) 
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.0


















































































Table S2. Partial chemical shift (ppm) assignments of bogorol L (d6-DMSO).  
Residue NH 1Hα 1Hβ Others 
FA  3.79 OH
β1, 5.61*; CHβ2, 1.72 CH2γ1, 1.38/1.13; CH3γ2, 0.88; CH3δ1, 0.80 
Dhb-1 9.11  5.97 CH3
γ1, 1.79 
Val-2 7.79 4.24 2.11 CH3γ, 0.87 
Lys-3 8.08 4.34 1.63/1.55 CH2γ, 1.28; CH2δ, 1.48; CH2ε, 2.70; 
Ile-4 7.79 4.24 1.70  
Ile-5 7.99 4.17 1.71 CH2γ1,1.41/1.05 
Val-6 7.78 4.17 1.94  
Lys-7 7.94 4.37 1.63 CH2γ, 1.27; CH2δ, 1.48; CH2ε, 2.70; 
Val-8 7.86 4.21 1.93  
Val-9 7.88 4.11 1.94  
Lys-10 7.78 4.24 1.42/1.31* CH2γ, 1.05; CH2δ, 1.42; CH2ε, 2.65; 
Tyr-11 8.09 4.47 2.84/2.61 CHδ, 6.99; CHε, 6.62 
Leu-12 8.09 4.24 1.39 CHγ, 1.35*; CH3δ1, 0.81; CH3δ2, 0.76 
Valinol-13 7.40 3.54 CH2β1, 3.34; CHβ2, 1.81 CH3γ, 0.81 
*Tentative assignment due to overlap, but in accordance with the literature [47]. 
1H NMR of bogorol L (4) 
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0

















































































Table S3. Marfey analysis of bogorol K (3) and bogorol L (4). 
Standard Retention Time (min.) bogorol K (3) bogorol L (4) 
L-Val 10.30 10.25 10.21 
D-Val 12.05 - - 
L-Leu 12.06 12.02 11.98 
D-Leu 13.76 - - 
L-Ile 11.76 11.71 11.68 
D-Ile 13.60 - - 
L-Phe (standard) 11.98 11.93 11.89 
L-Tyr 6.59 / 9.14 - - 
D-Tyr 6.58 / 9.77 6.44 / 9.69 6.41 / 9.65 
L-Orn 4.55 / 4.91 - - 
D-Orn 4.04 / 4.89 3.80 / 4.69 - 
L-Lys 5.14 / 5.61 4.84 / 5.39 4.85 / 5.38 
D-Lys 5.12 / 4.78 4.78 / 4.50 4.79 / 4.51 
L-(S)Vol 9.94 9.87 9.84 























Figure S4. Fragmentation of succilin I and J (compound 5 and 6, panel a), succilin K (compound 7, panel b), 
and succilin L (compound 8, panel c) by tandem MS to generate b and y ions. The b ions were indicated in 
blue, while the y ions were indicated in red. The different amino acids of succilin I and succilin J are indicated 










































































1H NMR of succilin K (7) 
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0




















































































Figure S5. 1H-1H-TOCSY NMR correlation of the methylene signals of the succinyl group of succilin K (7). 
 
 
Figure S6. 1H-1H-TOCSY NMR correlation of the delta methylene of Orn3 with the amide NH of the 






















Figure S7. 1H-1H-NOESY NMR correlations of the succinyl methylenes with the amide NH of the 
succinyl group of succilin K (7). 
 
Table S4. Partial chemical shift (ppm) assignments of succilin K (d6-DMSO).  
Residue NH 1Hα 1Hβ Others 
FA 
 
3.77 OHβ1, 5.61; CHβ2, 1.72 CH2γ1, 1.37/1.12; CH3γ2, 0.88; CH3δ1, 0.79 
Dhb-1 9.08 
 
5.99 CH3γ1, 1.79 
Val-2 7.76 4.25 2.10 CH3γ, 0.86 
Orn-3 (Suc) 8.12 4.31 1.63/1.52 CH2γ, 1.41/1.33; CH2δ, 2.98; NHε, 7.79; CH2suc1, 
2.28; CH2suc2, 2.36 
Ile-4 7.78 4.21 1.71 
 
Ile-5 8.01 4.16 1.72 CH2γ1,1.43/1.05 
Val-6 7.84 4.16 1.94 
 
Lys-7 8.01 4.35 1.63 CH2γ, 1.27; CH2δ, 1.48; CH2ε, 2.70; 
Val-8 7.89 4.20 1.93 
 
Val-9 7.89 4.10 1.94 
 
Lys-10 7.82 4.24 1.41/1.32* CH2γ, 1.04; CH2δ, 1.41; CH2ε, 2.65; 
Tyr-11 8.11 4.47 2.84/2.61 CHδ, 6.99; CHε, 6.62 
Leu-12 8.10 4.24 1.39 CHγ, 1.35*; CH3δ1, 0.82; CH3δ2, 0.76 
Valinol-13 7.40 3.53 CH2β1, 3.34; CHβ2, 1.80 CH3γ1, 0.82; CH3γ2, 0.80 






















Figure S8. MALDI-TOF analysis of extracts from wild type and ΔbogJ mutant of B. laterosporus LMG15441. 

























Figure S9. (a) Biosynthetic gene cluster of bogorol and auriporcine. The modules responsible for fatty acid 
incorporation are indicated with purple shading. The unfunctional modules in auriporcine BGC are indicated in 
grey shading. (b) The structures of bogorol and auriporcine. The fatty acids of both compounds are indicated 
with red shading. 
 
Figure S10. MALDI-TOF analysis of extracts from wild type and ΔbogI mutant of B. laterosporus LMG15441. 























Figure S11. LC-MS of extracts from B. laterosporus MG64 (up) and LMG15441 (down). Bogorols are found in 
both strains, while succilins are only found in B. laterosporus MG64. z in the labels indicate the charges of the 
ions. 
 
Figure S12. (a) Flanking genes of the bogorol BGC in B. laterosporus MG64 and LMG15441. Blue, present in 
both strains; green, only present in B. laterosporus MG64; red, only present in B. laterosporus LMG15441; 
purple, transferase. The table presents the annotation of some of the genes. (b) MALDI-TOF of extracts from 
B. laterosporus LMG15441 with heterologous expression of the gene bogN (C2W64_00415, from B. 
laterosporus MG64). (c) MALDI-TOF of extracts from B. laterosporus LMG15441 with heterologous expression 






















Figure S13, MALDI-TOF analysis of extracts from B. laterosporus MG64 at after 14-h (top) and 16-h (down) 
incubation. The Figure shows that succilins are found at 16 h but not at 14 h. 
 
 
Figure S14. Lipid II binding assay. Lipid II was mixed with compounds at different ratios before spotting onto 
the plate, which contains an indicator strain. Nisin was used as a control. D or L in the bracket means a Gram-
negative or Gram-positive type of lipid II was used. The plate was incubated at 28 °C overnight before recording 





















Table S5. Comparison of bogorol and succilin peptides 
Position FA 1 2 3 4 5 6 7 8 9 10 11 12 13 
Bogorol A C6H11O2 Dhb Leu Orn Ile Val Val Lys Val Leu Lys Tyr Leu Valinol 
Bogorol B C6H11O2 Dhb Val Orn Ile Val Val Lys Val Leu Lys Tyr Leu Valinol 
Bogorol C C6H11O2 Dhb Val Orn Val Val Val Lys Val Leu Lys Tyr Leu Valinol 
Bogorol D C6H11O2 Dhb Met Orn Ile Val Val Lys Val Leu Lys Tyr Leu Valinol 
Bogorol E C6H11O2 Dhb Met-O Orn Ile Val Val Lys Val Leu Lys Tyr Leu Valinol 
Brevibacillin C6H11O2 Dhb Leu Orn Ile Ile Val Lys Val Val Lys Tyr Leu Valinol 










 Dhb Leu Orn Ile Val Val Lys Val Leu Lys Tyr Leu Valinol 
Bogorol I (1) C6H11O2 Dhb Val Orn Ile Val Val Lys Val Val Lys Tyr Leu Valinol 
Bogorol J (2) C6H11O2 Dhb Val Orn Val Ile Val Lys Val Val Lys Tyr Leu Valinol 
Bogorol K (3) C6H11O2 Dhb Val Orn Ile Ile Val Lys Val Val Lys Tyr Leu Valinol 
Bogorol L (4) C6H11O2 Dhb Val Lys Ile Ile Val Lys Val Val Lys Tyr Leu Valinol 
Succilin I (5) C6H11O2 Dhb Val Orn-S Ile Val Val Lys Val Val Lys Tyr Leu Valinol 
Succilin J (6) C6H11O2 Dhb Val Orn-S Val Ile Val Lys Val Val Lys Tyr Leu Valinol 
Succilin K (7) C6H11O2 Dhb Val Orn-S Ile Ile Val Lys Val Val Lys Tyr Leu Valinol 
Succilin L (8) C6H11O2 Dhb Val Lys-S Ile Ile Val Lys Val Val Lys Tyr Leu Valinol 
Note: The position number of conserved residues are indicated in black. The newly identified peptides and their closest 
peptides are indicated in the same background color, and the different residues in the characterized peptides are indicated 
in red font. FA: fatty acid. 
 
Figure S15. LC-MS analysis of extracts from B. laterosporus MG64 grown on LB agar plates. Cells were grown 





















Figure S16. The biosynthetic process of bogorols and succilins. A, adenylation domain; KR, ketoreductase 
domain; T, thiolation domain; C, condensation domain; E, epimerization domain; TD, terminal reductase 























Table S6. Primers used in this study. 
Name Sequence Purpose 
bogJ-sgRNA-F TACGATTAGTAGAAAGTGTTTACG Knock out of bogJ 
bogJ-sgRNA-R AAACCGTAAACACTTTCTACTAAT Knock out of bogJ 
bogJ-up-SfiI-F aaGGCCaacgaGGCCGTAGCTCCGCTTCACAGTAG Knock out of bogJ 
bogJ-up-R GGCGTTCTTCCTTGTCTCCTCCTGCTCTATG Knock out of bogJ 
bogJ-down-F GGAGGAGACAAGGAAGAACGCCCTATTTCTG Knock out of bogJ 
bogJ-down-SfiI-R aaGGCCttattGGCCGCTTGTAACGCTTGCAATG Knock out of bogJ 
bogI-sgRNA-F TACGGAAGCCGTCTCAGTTAGACG Knock out of bogI  
bogI-sgRNA-R AAACCGTCTAACTGAGACGGCTTC Knock out of bogI  
bogI-up-SfiI-F aaGGCCaacgaGGCCTATGTAGCGGCTGTAAAGGG Knock out of bogI  
bogI-up-R AGTAGGTGGCCACGGGAGCACTTTAACTCAG Knock out of bogI  
bogI-down-F AGTGCTCCCGTGGCCACCTACTAAGGAAGAG Knock out of bogI  
bogI-down-SfiI-R aaGGCCttattGGCCTAACCCGATCTTGAGGCTTG Knock out of bogI  
pJOE8999-check-F Cgtgtgatgcgaattcttgac Knock out of bogI  
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Brevibacillus is a genus of Gram-positive bacteria that is prevalent in various environments. It has 
been reported to have good biocontrol potential. However, in-depth studies on the interaction of 
Brevibacillus and other bacteria are rare. In this study, we conducted a transcriptomic analysis of 
the biocontrol strain B. laterosporus MG64 during interaction with two different pathogens, i.e. plant 
pathogen Xanthomonas campestris and animal pathogen Pithomyces chartarum. We reveal that 
the altered expression of sporulation genes and secondary metabolite biosynthetic BGCs is likely a 
response pattern of B. laterosporus MG64 to other microorganisms. Sporulation genes are 
downregulated by other microbes likely because of higher demand for secondary metabolites, which 
are produced by vegetative cells. Depending on the competitor, B. laterosporus MG64 adjusts the 
expression of secondary metabolite biosynthetic BGCs and retains those that can antagonize the 
specific competitor. Our study leads us to a better understanding of the interaction of B. laterosporus 
MG64 and different pathogens and sheds light on three potentially active BGCs that have not been 
assigned to any known products. Future studies will be directed to the identification and 
characterization of these compounds. 
 
Keywords  
Transcriptomics, microbe-microbe interaction, Brevibacillus laterosporus, sporulation, secondary 


























Brevibacillus is a genus of rod-shaped Gram-positive bacteria that are found in diverse environments 
including soil and water [1]. Many Brevibacillus strains have been reported to display biocontrol 
potential [1]. For example, a Brevibacillus brevis strain isolated from the rhizosphere of cotton 
effectively promotes the growth of cotton [2]. Brevibacillus laterosporus Lak1210 originating from 
mangrove marsh soil can produce chitinase that inhibits fungal pathogens and insects [3]. Another 
B. laterosporus strain isolated from the digestive tract of honeybees was able to stimulate the 
productivity of honeybees’ colonies [4]. Brevibacillus spp. are also strong producers of antimicrobials 
[5]. Linear lipopeptides such as bogorols [6, 7] and brevibacillins [8, 9], cyclic nonribosomal peptides 
including Gramicidin [10], loloatins [11], brevicidine [12], and bacteriocins like laterosporulin  [13] 
and laterosporulin 10 [14] are produced by Brevibacillus spp. These antimicrobials have either been 
used as biocontrol weapons for controlling plant diseases or as antibiotics for the treatment of animal 
diseases [5]. 
In a previous study, we isolated the biocontrol strain B. laterosporus MG64 that displayed potent 
bioactivity against various plant pathogens and animal pathogens [15]. Some of the antimicrobial 
compounds produced by B. laterosporus MG64 were also identified. However, most of the 
biosynthetic gene clusters (BGCs) remain unknown and cannot be identified with the traditional 
methods. The co-culture of microorganisms has been reported to offer some great advantages (such 
as yield enhancement, de novo compound induction, etc.) on the identification of natural products, 
compared to monoculture growth [16, 17]. Many novel compounds were identified through the co-
culturing of microorganisms. For example, phexandiols and phomesters were identified through the 
co-culture of Phoma sp. and Armillaria sp. [18]. Harziaphilic acid is isolated from the co-culture of 
Trichoderma harzianum M10 and Talaromyces pinophilus F36CF [19]. Therefore, the co-culture 
method is considered very suitable for the identification of novel compounds produced by B. 
laterosporus MG64. 
Transcriptomics in combination with the co-culturing of microorganisms can provide a better 
understanding of microbe-microbe interactions. It can also help to distinguish the active BGCs (those 
that show altered expression during the interaction are considered to be likely active) from the silent 
ones. For example, a transcriptomic study on Serratia plymuthica revealed that pyrrolnitrin BGC is 
induced when co-cultured with Rhizoctonia solani [20]. However, studies on direct microbe-microbe 
interactions are relatively rare, especially on the interaction of Brevibacillus and other microbes. In 
this study, we aimed to get a better understanding of the interaction of the biocontrol strain B. 
laterosporus MG64 and two different pathogens, i.e. the Gram-negative plant pathogen 























Pithomyces chartarum that originates from grass and causes facial eczema in ruminants. We were 
in particular interested in its secondary metabolites biosynthetic genes, and their expression in 
response to pathogens. 
 
Results and discussion 
Global transcriptional profiles of B. laterosporus MG64 in response to pathogens 
B. laterosporus MG64 is a plant growth-promoting rhizobacterium (PGPR) isolated from the 
rhizosphere of perennial ryegrass. It displays a broad inhibitory spectrum towards plant pathogens 
and animal pathogens [15, 21]. In order to study the response of B. laterosporus MG64 to different 
pathogens, a transcriptomic study was conducted using the Gram-negative phytopathogen 
Xanthomonas campestris pv. campestris and the fungal animal pathogen Pithomyces chartarum as 
indicators. More than 5 million reads were generated by RNA-seq for each sample. The qualify reads 
(after quality check with FastQC  [22] and trimmed with Trimmomatic [23]) were mapped to the 
genome of B. laterosporus MG64 to deduce the RPKM values of genes, which were used to the 
compare the transcriptomes of B. laterosporus MG64 in response to different pathogens. The 
statistics of the differentially expressed genes (DEGs) were analyzed with T-REx [24]. As shown in 
Figure 1, during the interaction with X. campestris pv. campestris, a total of 170 genes were 
significantly changed, 70 genes of which were upregulated and 100 genes were downregulated. In 
response to P. chartarum, 60 genes were upregulated while 43 genes were downregulated.  
DEGs showing the same trend or different trends 
Only 10 genes showed the same trends in response to different pathogens, of which 4 genes 
upregulated and 6 genes downregulated (Figure 1e, Table 1). Among the upregulated genes, 
C2W64_00473 is annotated as a formate C-acetyltransferase, which participates in pyruvate 
metabolism of bacteria [25]. C2W64_02128 encodes a protein containing a PKD domain, which was 
found conserved and important for many bacterial collagenases and proteases [26, 27]. 
C2W64_00998 is identified to be a membrane-associated protease, which is important for a wide 
range of physiological processes of bacteria [28]. The last one upregulated gene encodes a 
hypothetical protein. Among the downregulated genes, C2W64_00668 encodes a YhfH family 
protein, which is repressed by the stress response regulation gene MgsR [29]. C2W64_01829 and 
C2W64_01902 are annotated as anti-sigma F factor and stage IV sporulation protein A (spoIVA), 
respectively. Both proteins are involved in the regulation of sporulation in Firmicutes [30]. 























aldehyde [31]. The functions of the rest two downregulated genes (C2W64_04305 and 
C2W64_03144) encodes proteins containing unknown function domains. These results suggest a 
similar alteration on the membrane protein associated genes and sporulation relevant genes. 
Further research is needed to determine how these genes exactly regulate the adaptation of B. 
laterosporus MG64 to different pathogens. 
 
 
Figure 1. Analysis of differentially expressed genes (DEGs) of B. laterosporus MG64 in response to pathogens. 
Volcano plots of DEGs of B. laterosporus MG64 to X. campestris (a) and P. chartarum (b). The number of up 
and downregulated DEGs of B. laterosporus MG64 to X. campestris (c) and P. chartarum (d). Venn diagram 





























Table 1. Altered gene showing the same trend to different pathogens 
 
Gene Annotation 
Upregulated by both 
pathogens 
C2W64_00473 formate C-acetyltransferase 
C2W64_00435 hypothetical protein 
C2W64_02128 PKD domain-containing protein  
C2W64_00998 membrane-associated protease 1 
Downregulated by both 
pathogens 
C2W64_04305 DUF3870 domain-containing protein 
C2W64_00668 YhfH family protein  
C2W64_01829 anti-sigma F factor  
C2W64_00103 aldehyde dehydrogenase 
C2W64_03144 DUF4367 domain-containing protein  
C2W64_01902 stage IV sporulation protein A 
 
The response of B. laterosporus MG64 to X. campestris 
The response of B. laterosporus MG64 to the Gram-negative plant pathogen X. campestris was 
investigated carefully. Three stress response genes are upregulated by X. campestris (Table 2). 
Among them, C2W64_04147 and C2W64_04149 belong to the TerD family protein, which is a part 
of the stress response system related to metal sensing [32] while C2W64_02315 is identified to be 
a universal stress protein, which is commonly induced by various stresses including nutrient 
starvation, antibiotics presence, and metal presence [33]. This result suggests that the presence of 
X. campestris likely creates a metal-dependent stressful condition for B. laterosporus MG64. 
However, this stress did not induce sporulation, which is a process of microorganism forming spores 
to protect themselves from stress. On the contrary, we observed a total of 25 sporulation relevant 
genes downregulated from 2.6 to 19.5 fold during the interaction with X. campestris (Table 2). These 
genes are members of the SigF, SigE, SigG, and SigK regulons, which primarily control the 
sporulation of firmicutes at the transcriptional level [34, 35]. C2W64_01830 encodes the RNA 
polymerase sigma factor sigF, which is activated when the spoIIAA (C2W64_01828) is 
dephosphorylated and antagonizes the anti-sigma factor spoIIAB (C2W64_01829) [36-38]. The 
activated SigF regulon then activates the SigE (C2W64_01528), a sigma factor crucial for the 
forespore engulfment and coat proteins synthesis, in the mother cell [30, 39-41]. C2W64_03288, 























bridge the forespore and the mother cell [42-44]. This bridging is crucial for the activation of SigG 
(C2W64_01527), which is possibly involved in the engulfment [42-45]. The spoIIID (C2W64_03287) 
and SigE jointly activate SigK, which is essential for the cortex and coat formation [46, 47]. The 
downregulation of these genes implies that the presence of X. campestris likely delays the 
sporulation of B. laterosporus MG64, thus focusing on combating other bacteria.  
Regulation of secondary metabolite production is one of the most effective strategies to combat 
other bacteria. Indeed, a total of 9 genes are altered during the interaction with X. campestris, of 
which 8 upregulated and 1 downregulated. These genes are from three different BGCs including 
two nonribosomal synthetases (NRPSs) and one bacteriocin (Figure 2). C2W64_00360 is a core 
biosynthetic gene (rlcC) of relacidines, a class of novel cationic cyclic lipopeptides that combat 
Gram-negative bacteria (unpublished data) (Figure 2a). The upregulation of rlcC is consistent with 
our previous real-time PCR results (unpublished data) and suggest that relacidines are important 
for antagonizing X. campestris, which was also confirmed experimentally (unpublished data). The 
other seven upregulated genes are from the same NRPS (Figure 2b). C2W64_02020 and 
C2W64_02021 encode seven NRPS modules and has been described by us previously [15]. The 
other five genes are potential modification genes (Figure 2b). However, the function of these genes 
remains unclear, thus making the final product of this gene cluster difficult to predict. 
The downregulated bacteriocin is a Linear azole-containing peptide (LAP) type lanthipeptide (Figure 
2c). The open reading frame (ORF) encoding the precursor peptide was predicted by neither 
BAGEL4 nor antiSMASH 5.0 [48, 49]. Here, we manually found this ORF upstream of the three 
modification genes (Figure 2c). The precursor peptide encoded by this ORF contains 118 amino 
acid residues with abundant Cys and Ser residues (Figure 2c), which is an outstanding characteristic 
of LAPs [50, 51]. The last 62 residues are predicted to be the core peptide. C2W64_03088 and 
C2W64_03089 are identified to be clycodehydratases while C2W64_03090 is a dehydrogenase. 
Catalyzed by these enzymes, most of the Ser and Cys will undergo cyclodehydration and 
dehydrogenation and form azoles [50, 52]. The downregulation of this LAP suggests that it is not 
active against X. campestris. This is considered reasonable because LAPs are only found active 
against Gram-positive bacteria, especially those closely related to the producers [51]. Its 
downregulation is a possible strategy to save energy for the production of other active compounds. 
Taken together, as a response to X. campestris, genes encoding stress response proteins are 
upregulated while sporulation genes in sigF, sigE, sigG, and sigK operons are downregulated. 
Besides that, B. laterosporus MG64 was found to adjust its strategy on secondary metabolite 
production when encountered X. campestris, namely upregulating two NRPSs and downregulating 
























Table 2 Downregulated sporulation genes in response to X. campestris pv. campestris 
Genes Annotation  Fold change 
Stress relevant genes 
C2W64_04147 TerD family protein 2.7 
C2W64_02315 universal stress protein 2.1 
C2W64_04149 TerD family protein 2.1 
Sporulation genes 
C2W64_01830 RNA polymerase sporulation sigma factor SigF -2.6 
C2W64_01829 anti-sigma F factor -2.8 
C2W64_04439 spore gernimation protein -3.3 
C2W64_01745 stage III sporulation protein AB -3.4 
C2W64_01528 RNA polymerase sporulation sigma factor SigE -3.6 
C2W64_01769 SpoIVB peptidase -3.7 
C2W64_03145 gamma-type small acid-soluble spore protein -3.8 
C2W64_01828 anti-sigma F factor antagonist -4 
C2W64_01457 stage V sporulation protein SpoVM -4.7 
C2W64_01902 stage IV sporulation protein A -4.8 
C2W64_01751 SpoIIIAH-like family protein -4.9 
C2W64_02158 alpha/beta-type small acid-soluble spore protein -5.3 
C2W64_01256 stage V sporulation protein E -5.4 
C2W64_04294 alpha/beta-type small acid-soluble spore protein -5.6 
C2W64_01744 stage III sporulation protein AA -5.7 
C2W64_01527 RNA polymerase sporulation sigma factor SigG -5.8 
C2W64_03030 sporulation protein -6.2 
C2W64_01309 sporulation protein -6.6 
C2W64_04050 sporulation protein YhbH -7.1 
C2W64_03737 spore coat protein CotJC -7.1 
C2W64_03287 sporulation transcriptional regulator SpoIIID -7.6 
C2W64_04291 sporulation protein YtfJ -8.1 
C2W64_01074 stage V sporulation protein T -8.6 
C2W64_04777 spore coat protein -19.5 
Secondary metabolites 
C2W64_02018 DJ-1/PfpI family protein 3.6 
C2W64_02015 alpha/beta hydrolase 3.6 
C2W64_02016 ThiF family adenylyltransferase 3.6 
C2W64_02017 molybdopterin biosynthesis protein MoeB 3.5 
C2W64_02014 2-isopropylmalate synthase 3.1 
C2W64_02021 non-ribosomal peptide synthase/polyketide synthase 2.3 
C2W64_00360 non-ribosomal peptide synthetase 2.3 
C2W64_02020 amino acid adenylation domain-containing protein 2.2 

























Figure 2. Genes and gene clusters regulated in response to X. campestris. Genes with green labels are 
upregulated during interaction while that with indigo blue labels are downregulated. Yellow, transport-related 
genes; red, core biosynthetic genes; orange, additional biosynthetic genes; grey, unknown genes. 
 
Response of B. laterosporus MG64 to P. chartarum 
During the interaction with P. chartarum, stress relevant genes were not induced, which is different 
from the response to X. campestris. Furthermore, only three sporulation genes were altered, one 
gene of which upregulated and two genes downregulated (Table 3). The downregulation of the anti-
sigma F factor (C2W64_01829) and stage IV sporulation protein A (C2W64_01902) is similar to the 
response to X. campestris. However, the upregulation of the CotS family spore coat protein 
(C2W64_03567) is in contrast to other sporulation relevant genes and cannot be explained thus far. 
We also reveal that a total of six inorganic ion transport genes are altered (Table 3). Among them, 
four genes form the high-affinity phosphate ABC transporter system Pst [53-55]. A study on 
Escherichia coli revealed that this transport system is functional when the extracellular inorganic 
phosphate is below 20 µM [53]. Therefore, the presence of P. chartarum likely altered the 
concentration of inorganic phosphate, and to compete, B. laterosporus MG64 activates the high-

























Figure 3. Gene cluster downregulated by P. chartarum. Genes with indigo blue labels are downregulated. 
Orange, additional biosynthetic gene; red, core biosynthetic gene; grey, unknown genes.  
A total of 13 genes relevant to the biosynthesis of secondary metabolites are downregulated from 2 
to 3.6 folds in response to P. chartarum (Table 3). These genes are from the same gene cluster, 
which is a hybrid of NRPS and polyketide synthetase (PKS). Ten PKS domains and thirteen NRPS 
domains are encoded by this gene cluster. The presence of four acyltransferase domains suggests 
the incorporation of four PK moieties while four adenylation domains indicate the incorporation of 
four amino acid residues (Figure 3). This gene cluster showed a 44% similarity to zwittermicin A, an 
NRP-PK hybrid produced by B. cereus that has potent antifungal activity [56, 57]. However, the 
arrangement of the genes is different from that of zwittermicin A, indicating that this BGC produces 
a potential novel compound. The downregulation of this BGC suggests that this potential novel 
compound is likely not active against P. chartarum and to antagonize this fungal pathogen, B. 
laterosporus MG64 concentrates on the production of other active antimicrobials. 
Taken together, inorganic ion transport proteins, especially the high-affinity phosphate transporters 
are altered during the interaction with P. chartarum. Moreover, an NRPS-PKS hybrid BGC is 
downregulated by the fungal pathogen.  
Conclusion 
In this study, we investigated the transcriptional response of B. laterosporus MG64 to two different 
pathogens, i.e. plant pathogen X. campestris and animal pathogen P. chartarum. We show that B. 
laterosporus MG64 altered the expression of sporulation genes and secondary metabolite BGCs in 
order to cope with other bacteria. Sporulation genes are downregulated possibly to support the 
vegetative growth, during which bacteria produce antimicrobials to compete with other bacteria. 
Besides, B. laterosporus MG64 is likely able to adjust its strategy on the production of secondary 























antimicrobials and downregulate inactive ones. As a result of this potential strategy, two NRPSs 
were found upregulated and one LAP downregulated in response to X. campestris, and one NRPS-
PKS hybrid downregulated by the P. chartarum. Our study leads us to a better understanding of the 
interaction of B. laterosporus MG64 and different pathogens, and sheds light on potential novel 
secondary metabolites. In particular the upregulated ones are interesting because they are likely to 
have potent activity to the microbe they were exposed to. 
Table 3. Secondary metabolites biosynthetic genes in response to P. chartarum 
Genes Annotation  fold change 
Sporulation relevant gene 
C2W64_03567 CotS family spore coat protein 4.7 
C2W64_01829 anti-sigma F factor -2.6 
C2W64_01902 stage IV sporulation protein A -2.8 
Inorganic ion transport protein 
C2W64_03167 phosphate ABC transporter permease PstA 6.5 
C2W64_03166 phosphate ABC transporter ATP-binding protein 5.7 
C2W64_03168 phosphate ABC transporter permease subunit PstC 4 
C2W64_03169 phosphate ABC transporter substrate-binding protein 3.5 
C2W64_01056 zinc ABC transporter substrate-binding protein 2.5 
C2W64_04357 metal ABC transporter permease -2.5 
Secondary metabolites biosynthetic genes 
C2W64_01692 acyltransferase domain-containing protein -2 
C2W64_01693 3-hydroxybutyryl-CoA dehydrogenase -2.2 
C2W64_01689 HAD-IIIC family phosphatase -2.4 
C2W64_01701 GNAT family N-acetyltransferase -2.4 
C2W64_01690 acyl-CoA dehydrogenase -2.5 
C2W64_01699 LLM class flavin-dependent oxidoreductase -2.7 
C2W64_01695 acyl-CoA dehydrogenase -2.9 
C2W64_01691 acyl carrier protein -3 
C2W64_01694 acyl carrier protein -3.1 
C2W64_01696 amino acid adenylation domain-containing protein -3.2 
C2W64_01698 SDR family NAD(P)-dependent oxidoreductase -3.4 
C2W64_01697 amino acid adenylation domain-containing protein -3.6 
C2W64_01700 hypothetical protein -3.6 
 
Material and methods 
Interaction assay 
Two different pathogens, Xanthomonas campestris pv. campestris NCCB92058 and Pithomyces 























the LB plate for 24 h (28 ℃). Colonies were resuspended in phosphate-buffered saline (PBS, pH = 
7.4) buffer. The OD600 of cells was adjusted to 1.0 to achieve inoculum. For the interaction with 
Xanthomonas, fresh pathogen cells were suspended in PBS buffer and added to the melted TSB 
agar (around 45 ℃) to a final concentration around 1 × 106 CFU/mL. After plates solidified, 10 µL of 
MG64 inoculum were spotted onto the center. As a control, the same volume of inoculum was 
inoculated onto blank TSB plates. Plates were sealed with parafilm and incubated at 28 ℃ for 2 
days. For interaction with Pithomyces, fungal were grown on TSB plates for 5 days. An agar plug (5 
mm diameter) containing fungal hyphae was placed at the center of fresh TSB plates. Plates were 
sealed with parafilm and incubated at 28 ℃ to allow the slow-growing fungi to grow for 2 days. After 
2 days, B. laterosporus MG64 (10 µL inoculum) was inoculated on the plates at a distance of 2 cm 
to the fungal plug. As a control, blank TSB plates were treated in the same way as the treated strain. 
Plates were grown at 28 ℃ for another 2 days. For sampling, cells were scraped off and suspended 
in DEPC-treated water before snap freezing in liquid nitrogen. 
RNA extraction  
The RNA was extracted using the Roche RNA isolation kit with some modifications. B. laterosporus 
MG64 cells were suspended in 400 µL DEPC-treated water. Then 500 µL chloroform-isoamyl 
alcohol (24:1 v/v), 50 µL 10% SDS, and 0.5 g glass beads (0.5 µm) were added to the tube. Cells 
were lysed with a Mini-BeadBeater (607, BioSpec, USA) by three rounds of 45 s pulse. Samples 
were centrifuged at 10,000 rpm (4 ℃) for 10 min. The upper phase was transfer to a new tube 
containing 500 µL of chloroform- isoamyl alcohol (24:1). The mixture was centrifuged at 10,000 rpm 
(4 ℃) for 10 min and the upper phase was collected in a new tube. Two volumes of lysis/binding 
buffer were added and mixed with the sample gently. The mixture was transferred to the column 
provided by the manufacturer and centrifuged at 8,000 g for 30 s. DNA was digested by adding 100 
µl DNase buffer, 10 µl DNase I, and 5 µl Ribolock (Fermentas; RNase inhibitor) and incubated at 
room temperature for 30 min. The samples were washed with 500 μL wash buffer I, 500 μL wash 
buffer II, and 200 μL wash buffer II accordingly. The RNA was eluted with RNase free water and the 
quality was checked with the Bioanalyzer (Agilent Technologies, Wilmington, DE, United States) 
RNA sequencing and data analyses 
RNA sequencing was conducted at GATC Biotech (Konstanz, Germany). The quality of raw RNA-
Seq reads was determined with FastQC [22] and the low-quality sequences were trimmed with 
Trimmomatic [23]. The data set was aligned to the genome with STAR-aligner [58]. Gene counts 
were summarized with featureCounts [59]. Differential gene expression analyses were conducted 























compared. p < 0.05 and fold-change > 2 were set as thresholds of significance (TopHits). Functional 
categorization was performed with a web serve genome 2D [60]. The RNA-seq data have been 
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According to the World Health Organization (WHO), around 821 million people were undernourished 
in 2017. This number has been growing in recent years and therefore calls for urgent action to 
produce more food [1]. Although grass is not a traditional crop, it is the basis for the production of 
dairy products and meat. Specifically, perennial ryegrass is an important grass for the forage-
livestock system [2, 3]. However, plant pathogens and animal pathogens are a great threat to its 
application. The production of healthy grass relies on the usage of chemical fertilizers and pesticides. 
However, these chemicals inevitably cause environmental problems. To ensure the sustainable 
development of agriculture, environmentally friendly alternatives are in demand.  
Plant growth-promoting rhizobacteria (PGPR) have been proven to be effective alternatives to 
chemical fertilizers and pesticides because of their great efficacy on plant growth stimulation and 
plant disease control. However, studies about the interaction between PGPR and grass, especially 
perennial ryegrass, are relatively rare. Shoebitz et al. isolated a bacterial strain of Enterobacter 
ludwigii from the rhizosphere of perennial ryegrass, which was able to produce nitrogenase and 
indole-3-acetic acid (IAA) and inhibit mycelial growth and spore germination of Fusarium solani [4]. 
Castellano-Hinojosa et al. isolated a list of nitrogen-fixing bacteria and tested their ability to produce 
IAA, ACC deaminase activity as well as biocontrol activity against Fusarium oxysporum [5]. 
Nevertheless, these studies did not investigate the antimicrobials, which play a key role in pathogen 
control, produced by the isolated PGPR. The work presented in this thesis thus aimed to isolate 
Bacillus species and closely related species from the perennial ryegrass, which have great 
advantages (i.e. antimicrobials production and endospore formation) to be PGPR, and to investigate 
their antimicrobials that potentially involved in biocontrol (Figure 1). 
The biosynthetic potential of Brevibacillus laterosporus is underestimated 
Bacillus spp. are well known for their production of antimicrobials, which have been used in different 
applications. In chapter 2, we described the isolation and screening of 7 potential PGPR strains 
(out of 90 initially isolated), i.e. Bacillus subtilis MG27, Bacillus velezensis MG33 and MG43, Bacillus 
pumilus MG52 and MG84, Brevibacillus laterosporus MG64 and Bacillus altitudinis MG75, from the 
rhizosphere of healthy perennial ryegrass. We also reported abundant biosynthetic gene clusters 
(BGCs) responsible for the production of potentially novel secondary metabolites from their genomic 
sequences, especially that of B. laterosporus MG64. Brevibacillus is a genus of bacteria reclassified 
from Bacillus based on the analysis of 16S rRNA sequences [6]. Species of this genus have been 
reported to display great potential in biocontrol [7]. For example, B. laterosporus ZQ2 strongly 
inhibits the growth of apple pathogens such as Rhizoctonia solani, Fusarium oxysporum, Fusarium 
solani and Physalospora piricola [8]. B. brevis SVC(II)14 is able to enhance the growth of cotton and 
inhibit fungal pathogens [9]. Biocontrol properties of Brevibacillus spp. are associated with the 
production of antimicrobials, many of which have been identified and characterized [10]. However, 



















the biocontrol potential of the B. laterosporus species is likely underestimated. The transcriptomic 
analysis in chapter 5 showed that a linear azole-containing peptide (LAP) and a nonribosomal 
peptide (NRP) harbored by B. laterosporus MG64 are potentially functional during the interaction 
with other microbes. However, these compounds were not identified to date possibly because the 
yield of these compounds is too low, making it difficult to extract and identify. Future research will 
be directed to express these compounds in other hosts such as Escherichia coli and B. subtilis. 
Recent research using a miniBacillus PG10 as a host successfully expressed several lanthipeptides 
[11]. PG10 is derived from B. subtilis by deleting 36% of its genome [12]. It has a clean background 
of metabolites, thus making it easier to identify the compounds. Therefore, PG10 is a promising host 
for heterologous expression of BGCs identified from B. laterosporus MG64. 
B. laterosporus MG64 is a good producer of cationic lipopeptides 
Cationic peptides are found in many organisms and display an enormous variety of structures. 
Consensus features of these peptides are the overall net positive charge and their amphiphilic 
nature. Both features make this class of peptides easier to interact with the bacterial membranes, 
which are anionic and constituted with hydrophilic head groups and hydrophobic cores [13, 14]. 
Therefore, they are considered good antibiotic candidates to cure diseases caused by bacterial 
pathogens, especially Gram-negative ones, which have caused significant public health problems 
in the whole world. We reported a class of cationic circular lipopeptides (relacidines) in chapter 3 
and two classes of cationic linear lipopeptides (bogorols and succilins) in chapter 4. These cationic 
peptides are produced by the same strain, i.e. B. laterosporus MG64.   
Relacidines are constituted with a fatty acid tail and 13 amino acid residues, 3 of which are positively 
charged (Lys/Orn). They are structurally similar to brevicidine and laterocidine, two lipopeptides 
produced by B. laterosporus DSM25 and B. laterosporus LMG15441, respectively [15]. Brevicidine 
and laterocidine show great potential as antibiotics, because 1) they display potent bioactivity 
against Gram-negative human pathogens; 2) they have a low risk of antibiotic resistance; 3) they do 
not cause lysis of erythrocytes; and 4) they have no toxicity against the human cell line HeLa [15]. 
Relacidines have similar structures, inhibitory spectra and mode of action to brevicidine and 
laterocidine. Therefore, they are also considered antibiotic candidates. Moreover, relacidines are 
active against numerous Gram-negative plant pathogens including Xanthomonas and 
Pseudomonas. This suggests their potential application in agriculture, which was not shown for 
brevicidine and laterocidine.  
The bogorol family of peptides (bogorols, brevibacillins, BT peptide and BL-A60) form a class of 
cationic linear lipopeptides that are active against a wide variety of human pathogens and food 
pathogens, especially the Gram-positive ones [16-21]. In chapter 4, we reported four novel variants 
of bogorols (bogorol I-L) and four succilins (succilin I-L). Bogorol I-L has at least one different amino 
acid residue compared to the known ones. Moreover, we showed their bioactivity against plant 
pathogens, including both Gram-positive and Gram-negative ones. This implies their potential in 



















bogorols, in which a succinyl group is attached to the third amino acid residue (Lys/Orn) of bogorols. 
This is the first report of succinylated lipopeptides and this new group of compounds was found to 
display only modest activity against species of Xanthomonas, Bacillus and Staphylococcus. 
 
 
Figure 1. A summary of the works presented in this thesis. We first isolated PGPR strains from perennial 
ryegrass and further mined for secondary metabolites BGCs (chapter 2). Antimicrobials were extracted and 
characterized (including their biosynthesis and mode of action) from the isolated PGPR Brevibacillus 
laterosporus MG64 (chapter 3 and chapter 4). A comparative transcriptomic analysis was used to study the 
interaction of B. laterosporus MG64 and pathogens (chapter 5). 
Mode of action of cationic lipopeptides produced by B. laterosporus MG64 
Many cationic peptides were reported to form pores in cell membranes. However, there is growing 
evidence showing that some cationic peptides are targeting intracellular macromolecules. In 
chapter 3, we investigated the mode of action of relacidines, which is not yet clear for the structurally 
similar peptides brevicidine and laterocidine. We showed that relacidines do not form pores in the 
bacterial cell membrane. This is similar to brevicidine and laterocidine and different to other cationic 
peptides such as polymyxins [15]. Relacidines were also found not to affect the biosynthesis of 
peptidoglycan and RNA. Instead, they affect the oxidative phosphorylation process of cells. 



















to the cells. Therefore, it has become a promising target space for drug development. Several 
compounds were reported to inhibit the oxidative phosphorylation of cells. For instance, bedaquiline 
and delamanid, two recently approved drugs for curing tuberculosis, were shown to target the F1F0 
ATP synthase and respiratory cytochromes, respectively [22-24]. In addition, lansoprazole, a 
prodrug displaying intracellular activity against Mycobacterium tuberculosis, targets the cytochrome 
bc1, the complex III of the electron transport chain [25]. However, reports of lipopeptides targeting 
oxidative phosphorylation are rare. Relacidines are, to the best of our knowledge, the first ones. 
Different from relacidines, the bogorol family of peptides form pores in the cellular membranes of 
both Gram-positive and Gram-negative bacteria (chapter 4). This result is in line with the study on 
brevibacillins [26].  
Biosynthesis of the bogorol family of peptides employ novel modifications 
Many peptides from the bogorol family have been identified in recent years. However, their 
biosynthesis has never been investigated. In chapter 4, we systemically studied the biosynthetic 
pathway of bogorols and succilins. Both classes of compounds are synthesized by the same BGC 
and undergo two modifications: lipoinitiation and reduction. Moreover, succilins also undergo a 
succinylation using bogorols as substrates. 
Lipoinitiaion is typically found in the biosynthetic pathway of lipopeptides. The usual pattern of 
lipinitiation involves two steps: activation of the substrate by ligating it to a coenzyme A (CoA) by 
catalysis of fatty acid CoA ligases (FACL) and incorporation of the activated substrate into the NRPS 
assembly line by catalysis of a starter condensation (C) domain [27]. However, the lipoinitiation of 
bogorols and succilins is different from this usual pattern. It employs an adenylation (A) domain to 
activate the fatty acid. Unlike the FACL encoding genes that are located distantly from the BGC and 
are usually difficult to find, the module responsible for the lipoinitiation of bogorols and succilins is 
encoded by the BGC. Therefore, it is possible to engineer the lipid tail of any NRPs by incorporating 
this module into their BGCs. Moreover, by changing the substrate specificity of the A domain of this 
module, the activity-related lipid tail can be very diverse. However, there is a long way to go before 
realizing this great blueprint.  
The formation of valinol of bogorols and succilins is catalyzed by two different reductases: a terminal 
reductase domain (TD) and a keto-reductase (BogI). The TD is responsible for the release of a 
peptide from the peptidyl peptide carrier protein. This release mechanism is different from that 
mediated by a thioesterase and usually yields an aldehyde-form peptide, which will be further 
reduced to an alcohol form [28]. The second reduction is catalyzed by the keto-reductase BogI in 
the cases of bogorols and succilins. It has been reported that such alcohol-form peptides are 
resistant to proteases [21]. In this study, we also showed that the alcohol-form peptide is more active 




















Succinylation is a modification frequently found in many proteins of both prokaryotes and eukaryotes 
[29-31]. It usually occurs at the lysine residue and likely depends on the succinyl-CoA, which is 
involved in the tricarboxylic acid cycle [30]. Succinylation is also found in bacterial secondary 
metabolites. Subtilin-like ribosomally synthesized and posttranslationally modified peptides (RiPPs) 
contain a succinylated tryptophan at the N-terminus [32, 33]. Succinylation of subtilin-like peptides 
is influenced by the concentration of glucose in the growth medium as well as by the transition state 
regulator AbrB [33]. Our work demonstrates for the first time the succinylation of a lipopeptide. 
However, the responsible enzymes have not been identified yet. An in-depth study using 
comparative genomics and transcriptomics will be needed for their discovery. 
Interaction between B. laterosporus MG64 and pathogens 
In chapter 5, we investigated the response of B. laterosporus MG64 to two different pathogens: the 
Gram-negative plant pathogen X. campestris pv. campestris and the fungal mammalian pathogen 
Pithomyce chartarum. We reveal that the expression of sporulation-relevant genes and secondary 
metabolite biosynthetic genes are altered by both pathogens. This is likely a strategy employed by 
B. laterosporus MG64 to combat competitors. A similar response was observed in the interaction 
between Serratia plymuthica AS13 and the plant pathogen Rhizoctonia solani [34]. In-depth studies 
are needed to reveal the function of specific genes in the microbe-microbe interaction.   
We also showed that relacidines are induced by the plant pathogen Xanthomonas campestris pv. 
campestris and Pseudomonas syringe pv. tomato at the transcriptional level (chapter 3). This 
implies that relacidines play an important role during the interaction of plant pathogens and are 
potentially able to control plant diseases. Also, their producer, B. laterosporus MG64, has the 
potential to be developed into a biocontrol agent. However, the production of relacidines is likely 
affected by temperature (compounds were not detected at 37 ℃). This may limit their application to 
an appropriate region and season. Also, our study is limited to microbe-microbe interaction under 
laboratory conditions. Therefore, the exact effect of relacidines or their producers on controlling plant 
diseases in vivo still requires further investigation. 
 
In summary, we isolated seven PGPR strains (out of 90 initially isolated) from the rhizosphere of 
perennial ryegrass and further investigated the antimicrobials produced by one of the most 
promising strains, B. laterosporus MG64. A total of three different classes of compounds were 
extracted and characterized. The biosynthesis or/and mode of actions of these compounds were 
also thoroughly investigated. Furthermore, the transcriptional response of B. laterosporus MG64 to 
pathogens was studied by transcriptomics, showing that the sporulation-relevant genes and 
secondary metabolites biosynthetic genes were altered. All in all, this thesis work provides a 
comprehensive understanding of the novel potent biocontrol strain B. laterosporus MG64 as well as 
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Plant growth-promoting rhizobacteria (PGPR) form a good alternative to chemical fertilizers and 
pesticides. Moreover, PGPR can produce antimicrobials that have the potential to be antibiotics, 
which is in great demand because of the rapidly emerging antibiotic resistance. The aims of this 
PhD thesis were 1) to isolate and screen effective PGPR strains for use in perennial ryegrass, a 
crucial pasture plant distributed worldwide; 2) to identify novel antimicrobials produced by these 
PGPR strains; 3) to investigate the biosynthetic machinery and mode of action of the novel 
antimicrobials. 
A total of 90 Bacillus strains were isolated from the rhizosphere of perennial ryegrass and seven of 
them displayed outstanding biocontrol activity, namely stimulating the growth of plants and 
antagonizing bacterial and fungal pathogens that are potential threats to the plants and ruminants. 
Further mining into their genome sequences revealed a vast number of biosynthetic gene clusters 
(BGCs) of secondary metabolites, some of which remain unknown. One of the seven PGPR strains, 
MG64, belongs to a relatively less well-known species, Brevibacillus laterosporus. Notably, around 
80% of the BGCs harbored by MG64 have not been assigned to any known products. Further 
characterization of the secondary metabolites produced by MG64 revealed three different classes 
of antimicrobials: relacidines, bogorols, and succilins. Relacidines are a class of cationic circular 
lipopeptides that constituted with a fatty acid side chain (4-methylhexanoic acid) and 13 amino acid 
residues. A lactone ring is formed by the last five amino acid residues and three positively charged 
ornithine residues are located in the linear fragment. Relacidines selectively combat Gram-negative 
bacteria by affecting the oxidative phosphorylation process. Bogorols belong to a class of cationic 
linear lipopeptides that comprise a fatty acid side chain and 13 amino acid residues, three of which 
are positively charged-lysine residues. Bogorols are active against both Gram-positive bacteria and 
Gram-negative bacteria, which is a result of forming pores in the cell membranes. Succilins are 
modified from bogorols by succinylation at Orn3. Succinylation affects the polarity and charges of 
the peptides. As a result, succilins only display modest bioactivity against bacterial pathogens. 
Understanding the biosynthetic machinery of lipopeptides is the basis for further engineering. 
Bogorols and succilins have interesting characteristics: 1) they possess a fatty acid at the N-terminus 
but a starter condensation domain is missing; 2) they contain valinol, an alcohol form of valine, at 
the C-terminus; 3) the occurrence of succinylation at the third amino acid residue (Orn or Lys). These 
characteristics suggest the involvement of novel modifications. Further investigation revealed that 
the lipidation of bogorols and succilins is mediated by an adenylation domain, which is different from 
the usual pattern that employs external fatty acid coenzyme ligase (FACL). The valinol at the C-
terminus is formed by a two-step reduction catalyzed by a terminal reductase (TD) and an aldo/keto 
reductase (BogI). The occurrence of succinylation requires a high concentration of bogorols. 




A comparative transcriptomics study was conducted to investigate the response of B. laterosporus 
MG64 to different pathogens (plant pathogen Xanthomonas campestris and animal pathogen 
Pithomyces chartarum). We showed that the expression of sporulation genes and secondary 
metabolites BGCs are regulated during the interaction with pathogens. Two interesting BGCs, 
including one nonribosomal peptide (NRP) and one linear azol(in)e-containing peptide (LAP), 
potentially function during the interaction with pathogens. Further study will be directed to 
characterize these two compounds. 
This thesis provides a comprehensive understanding of the PGPR strain B. laterosporus MG64, 
including some of its antimicrobials, its interaction with different pathogens, and its potential in 
biocontrol. Moreover, our study of the biosynthesis of bogorols and succilins extends our knowledge 







Plantengroei bevorderende rhizobacteriën (PGPR) vormen een goed alternatief voor kunstmest en 
bestrijdingsmiddelen. Bovendien kunnen PGPR antimicrobiële stoffen produceren die mogelijk als 
antibiotica kunnen dienen, waar veel vraag naar is vanwege de snel opkomende 
antibioticaresistentie. De doelstellingen van dit proefschrift waren 1) het isoleren en screenen van 
effectieve PGPR stammen voor gebruik op Engels raaigras, een cruciale weideplant die wereldwijd 
verspreid is; 2) het identificeren van nieuwe antimicrobiële stoffen die door deze PGPR stammen 
worden geproduceerd; 3) het onderzoeken van de biosynthese en het werkingsmechanisme van de 
nieuwe antimicrobiële stoffen. 
In totaal werden 90 Bacillus stammen geïsoleerd uit de rhizosfeer van Engels raaigras. Hiervan 
toonden zeven uitstekende biocontroleactiviteit, namelijk het stimuleren van de groei van planten 
en het tegengaan van pathogene bacteriën en schimmels die potentiële bedreigingen vormen voor 
de planten en herkauwers. Verder onderzoek naar de bijbehorende genoomsequenties onthulde 
een groot aantal biosynthetische gen clusters (BGC's) van secundaire metabolieten, waarvan 
sommige onbekend blijven. Een van de zeven PGPR stammen, MG64, behoort tot een relatief 
minder bekende soort, Brevibacillus laterosporus. Opmerkenswaardig, ongeveer 80% van de BGC’s 
in het genoom van MG64 zijn niet toegewezen aan bekende producten. Verdere karakterisering van 
de door MG64 geproduceerde secundaire metabolieten bracht drie verschillende klassen van 
antimicrobiële stoffen aan het licht: relacidines, bogorols en succilins. Relacidines zijn een klasse 
van kationische cirkelvormige lipopeptiden die bestaan uit een vetzuurzijketen (4-methylhexaanzuur) 
en 13 aminozuren. Een lactonring wordt gevormd door de laatste vijf aminozuren en drie positief 
geladen ornithine residuen bevinden zich in het lineaire fragment. Relacidines bestrijden selectief 
Gram-negatieve bacteriën door beïnvloeding van het oxidatieve fosforylatieproces. Bogorols 
behoren tot een klasse van kationische lineaire lipopeptiden die een vetzuurzijketen en 13 
aminozuren bevatten, waarvan er drie positief geladen lysine residuen zijn. Bogorols zijn actief 
tegen zowel Gram-positieve bacteriën als Gram-negatieve bacteriën, als gevolg van het vormen 
van poriën in de celmembraan. Modificatie van bogorols via succinylering van Orn3 resulteert in de 
formatie van succilins. Succinylering beïnvloedt de polariteit en ladingen van de peptiden. Hierdoor 
vertonen succilins slechts matige biologische activiteit tegen bacteriële pathogenen. 
Het begrijpen van de biosynthese van lipopeptiden vormt de basis voor verdere engineering. 
Bogorols en succilins hebben interessante eigenschappen: 1) ze hebben een vetzuur aan de N-
terminus, maar er ontbreekt een startcondensatiedomein; 2) ze bevatten valinol, een alcoholvorm 
van valine, aan de C-terminus; 3) het optreden van succinylering van het derde aminozuur (Orn of 
Lys). Deze kenmerken suggereren de betrokkenheid van nieuwe modificaties. Nader onderzoek 
wees uit dat de lipidatie van bogorols en succilins wordt gemedieerd door een adenyleringsdomein, 
dat verschilt van het gebruikelijke patroon dat gebruikmaakt van extern vetzuur co-enzym ligase 
(FACL). Valinol aan de C-terminus wordt gevormd door reductie in twee stappen die wordt 
gekatalyseerd door een terminaal reductase (TD) en een aldo / keto-reductase (BogI). Het optreden 
 
174 
van succinylering vereist een hoge concentratie van bogorols. Het verantwoordelijke enzym blijft 
echter onbekend en toekomstig onderzoek zal zich hierop richten. 
Een transcriptoom studie werd uitgevoerd om de respons van B. laterosporus MG64 op 
verschillende pathogenen (plantpathogeen Xanthomonas campestris en dierpathogeen Pithomyces 
chartarum) te onderzoeken. We toonden aan dat de expressie van sporulatie genen en BGC’s van 
secundaire metabolieten gereguleerd wordt tijdens interactie met pathogenen. Twee interessante 
BGC's, waaronder één niet-ribosomaal peptide (NRP) en één lineair azol(in)e-bevattend peptide 
(LAP), functioneren mogelijk tijdens de interactie met pathogenen. Verder onderzoek zal gericht 
worden op karakterisatie van deze twee peptiden. 
Dit proefschrift biedt een uitgebreid begrip van de PGPR stam B. laterosporus MG64, inclusief 
enkele van de antimicrobiële stoffen, de interactie met verschillende pathogenen, en de 
mogelijkheid voor biocontrole. Bovendien breidt het bestuderen van de biosynthese van bogorols 
en succilins onze kennis uit over de biosynthese van lipopeptiden, die als basis kan dienen voor de 
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Yingying Cong.  
Special thanks to my family:  
亲爱的爷爷奶奶，感谢你们对我的关爱和教育。虽然在外生活总是遇到各种各样得困难，但一想到
有两个老人一直在关心我是不是吃得饱穿得暖，我就感觉非常幸福。亲爱得爸爸妈妈，感谢你们给
与我生命、教养我成人。没有你们一直以来的支持的关心，就没有今天的我。你们是我坚持下去的
动力源泉。感谢我的姐姐、姐夫、哥哥、大嫂以及在我博士期间降生的几个小可爱，你们给我的生
活增添了无限的色彩。希望我的至亲至爱们都能身体健康，顺心顺意！ 
 
